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Abstract!
!
The!risks!of!patients!acquiring!an!infection!as!a!result!of!healthcare!are!considerable,!with!
between!6.4%!and!9.1%!of!patients!in!hospital!found!to!have!an!healthcare!associated!
infection!(HCAI).!!These!infections!account!for!a!considerable!burden!of!disease;!they!are!
associated!with!significant!morbidity!and!mortality,!and!incur!costs!to!the!patient,!
healthcare!organisations!and!society.!!There!is!considerable!evidence!for!measures!that!are!
effective!in!preventing!HCAI,!however!there!are!challenges!in!ensuring!that!healthcare!
workers!are!aware!of!the!risks!and!adhere!to!recommended!practice.!!Surveillance!systems!
that!systematically!capture,!analyse!and!feedback!data!on!rates!of!HCAI!have!been!found!to!
be!a!key!component!of!effective!infection!control!strategies,!especially!when!they!
incorporate!benchmarking.!!The!large!datasets!captured!by!national!surveillance!systems!
also!provide!a!unique!opportunity!to!explore!the!epidemiology!of!HCAI,!factors!that!
contribute!to!their!occurrence!and!their!impact!on!public!health.!!!
!
This!thesis!concerns!the!design!and!application!of!surveillance!systems!for!infections!
associated!with!healthcare.!!It!reflects!the!programme!of!research!originating!from!my!
involvement!with!the!development!and!delivery!of!national!HCAI!surveillance!systems!in!
England!from!the!midK1990s.!!This!research!has!addressed!my!underpinning!hypothesis!that:!!
‘there%are%real%differences%in%rates%of%HCAI%which%reflect%variation%in%clinical%practice%and%
indicate%where%improvement%may%prevent%these%infections’.!!The!thesis!includes!eight!
primary!publications!focused!on!two!key!types!of!HCAI,!surgical!site!infections!(SSI)!and!
bloodstream!infections!(BSI).!!The!publications!related!to!SSI!describe!my!work!on:!the!risks!
of!SSI!in!terms!of!mortality!and!increased!length!of!hospital!stay;!significant!independent!risk!
factors!for!SSI!following!hip!prosthesis;!the!relationship!between!duration!of!operations!and!
risk!of!SSI;!interKcountry!comparisons!of!rates;!an!innovative!approach!to!performance!
monitoring!based!on!funnel!plots;!and!the!impact!of!postKdischarge!surveillance!on!
benchmarking.!!They!are!based!on!the!analysis!of!data!contributed!to!the!national!SSI!
surveillance!system.!!A!further!two!publications!related!to!BSI!explored!trends!in!causative!
pathogens!and!sources!of!methicillin!resistant!Staphylococcus%aureus.!!The!thesis!describes!
the!main!methods!and!findings!of!these!studies,!their!contribution!to!contemporary!
knowledge!and!subsequent!contributions!to!the!field,!illustrating!my!contribution!to!each!of!
the!works!and!my!professional!development!as!a!researcher.!!!
!
This!body!of!work!has!identified!important!trends!in!pathogens!causing!BSI,!in!particular!the!
emergence!of!Escherichia%coli!as!a!major!cause!of!these!infections,!and!provided!evidence!
for!possible!contributory!factors.!!It!has!also!identified!factors!contributing!to!the!reduction!
in!methicillin!resistant!Staphylococcus%aureus!as!a!cause!of!BSI.!!It!has!added!to!the!body!of!
knowledge!on!outcomes!of!SSI,!demonstrating!that!SSI!doubles!the!length!of!hospital!stay!
and!the!more!severe!infections!significantly!increases!the!risk!of!mortality!in!some!types!of!
surgery.!!It!has!informed!the!design!and!delivery!of!SSI!surveillance!systems!in!England!and!
Europe!through!identifying!the!impact!of!key!risk!factors,!such!as!the!duration!of!operation!
and!type!of!hip!replacement!procedure,!and!exploring!the!impact!of!variation!in!application!
of!surveillance!methods,!in!particular!postKdischarge!surveillance,!on!rates!of!SSI.!!It!has!
enhanced!the!value!of!surveillance!as!a!performance!monitoring!through!the!application!of!
innovative!approaches!to!adjusting!and!comparing!rates,!such!as!the!use!of!funnel!plots!for!
the!detection!of!outliers.!!!In!conclusion,!these!analyses!of!data!on!HCAI!have!informed!the!
development!of!national!surveillance!systems,!improved!understanding!of!variation!in!rates,!
and!identified!factors!that!may!influence!them.!!Further!work!is!required!to!enhance!and!
develop!surveillance!systems!in!order!that!they!can!continue!to!support!the!evaluation!of!
effective!infection!prevention!strategies!in!a!rapidly!changing!healthcare!environment.!!
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Chapter(1:(Introduction((
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1(
CHAPTER(1(
(
Introduction(
!
1.1 Origins(and(development(of(the(research(programme((
The(theme(of(this(thesis(is(the(design(and(application(of(surveillance(systems(for(infections(
associated(with(healthcare.((The(origin(of(this(programme(of(research(is(my(involvement(with(the(
development(and(delivery(of(national(healthcare(associated(infections((HCAI)(surveillance(systems(in(
England(from(the(midA1990s(through(to(2013.((These(were(established(with(the(primary(aim(of(
defining(the(risks(of(HCAI(and(supporting(hospitals(to(use(the(data(derived(from(surveillance(as(a(tool(
in(driving(improvements(in(practice(that(could(secure(their(prevention((Cooke(et#al(2000;(Appendix(
1.2).((Integral(to(assuring(the(quality(and(efficacy(of(these(surveillance(systems(has(been(an(onAgoing(
commitment(to(explore(how(the(data(can(be(used(most(effectively(to(inform(practice.((The(
hypothesis(underpinning(my(research(is(that:((‘there#are#real#differences#in#rates#of#HCAI#which#
reflect#variation#in#clinical#practice#and#indicate#where#improvement#may#prevent#these#infections’.((I(
have(therefore(directed(my(research(towards(informing(and(improving(the(design(and(delivery(of(
HCAI(surveillance(systems,(enhancing(understanding(of(health(outcomes,(exploring(implications(for(
public(health,(and(identifying(risk(factors(that(affect(the(acquisition(of(HCAI.(
(
1.2( Theoretical(principles(underpinning(the(research(programme(
When(the(concept(of(infection(related(to(healthcare(interventions(was(first(developed,(the(term(
nosocomial,(derived(from(the(Greek("nosus"(meaning("disease"(and("komeion"(meaning("to(take(
care(of"(was(adopted.((Although,(ironically,(this(term(would(encompass(infection(related(to(any(form(
of(healthcare,(it(was(perceived(to(be(synonymous(with(hospitalAacquired(infections((Emori(et#al(
1991;(Horan(et#al(2008).((As(the(delivery(of(healthcare(in(nonAhospital(settings(became(more(
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2(
widespread,(the(term(healthcare(associated(infection(has(become(more(widely(accepted.((Such(HCAI(
occur(as(a(result(of(the(particular(risks(associated(with(healthcare(that(increase(patients’(
vulnerability(to(infection((Wilson(2006;(Loveday(et#al(2014).((They(include:(
• illnesses(or(conditions(that(impair(the(ability(of(the(immune(system(to(counter(infection;((
• procedures(undertaken(to(treat(or(manage(illness(or(to(deliver(healthcare(that(bypass(
normal(defence(mechanisms(against(infection(e.g.(skin(or(ciliated(mucosa(of(the(respiratory(
tract(
• the(hospital(environment(which(can(facilitate(the(selection(of(pathogens(with(virulence(
factors(
• microorganisms(that(are(able(to(spread(readily(between(patients.((
(
The(risks(of(patients(acquiring(an(infection(as(a(result(of(healthcare(are(considerable.((Recent(
prevalence(surveys(undertaken(in(the(UK(in(1995,(2006(and(2010(indicate(that(between(6.4%(and(
9.1%(of(patients(in(hospital(have(an(HCAI,(with(urinary(tract(infection,(pneumonia,(surgical(site(
infection(and(bloodstream(infection(being(amongst(the(most(common((Emmersen(et#al(1996;(
Smythe(et#al(2008;(Health(Protection(Agency((HPA)(2012).((These(infections(account(for(a(
considerable(burden(of(disease;(they(are(associated(with(significant(morbidity(and(mortality,(and(
incur(costs(to(the(patient,(healthcare(organisations(and(society(in(terms(of(both(treatment(costs(and(
time(away(from(productive(activity((Plowman(et#al#2001;#FabbroAPerray(et#al(2007;#Perenevich(et#al(
2007;(Fukuda(et#al(2011).((My(research(has(been(focused(on(two(key(types(of(HCAI:(bacteraemia(or(
bloodstream(infections((BSI)(and(surgical(site(infection((SSI)(and(the(analysis(of(data(captured(on(
these(infections(by(national(surveillance(systems(in(England.(((
(
1.2.1! Bloodstream!and!surgical!site!infections!
The(presence(of(bacteria(in(the(blood(is(termed(‘bacteraemia’(or(bloodstream(infection((BSI).((In(
recent(prevalence(surveys,(BSI(account(for(7%(of(HCAI((Smythe(et#al(2008,(HPA(2012).((
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Microorganisms(in(the(blood(may(represent(a(secondary,(systemic(infection(from(another(focus(of(
infection(such(as(a(pneumonia(or(urinary(tract(infection,(or(may(be(introduced(directly(into(the(
bloodstream(via(an(invasive(device(such(as(an(intravenous(catheter(when(they(are(commonly(called(
primary(BSI((Warren(et#al(2001).((Whilst(relatively(uncommon,(bloodstream(infections(are(associated(
with(a(high(level(of(mortality((Rojo(et#al(1999;(Plowman(et#al(2001).(((
(
Surgical(site(infections((refer(to(infections(affecting(the(tissues(involved(in(an(operative(procedure(
(Mangram(et#al(1999).((Prevalence(surveys(indicate(that(they(are(the(third(most(common(HCAI,(
accounting(for(14.5%(to(15.7%(of(all(HCAI((Smythe(et#al(2008;(HPA(2012).((The(risk(of(a(patient(
developing(an(SSI(depends(on(a(combination(of(factors((National(Collaborating(Centre(for(Women’s(
and(Children’s(Health((NCCWCH)(2008)(including(the:((
• number(of(microAorganisms(introduced(into(the(operative(site,(
• number(that(remain(when(the(wound(is(closed,(
• ability(of(microAorganisms(to(multiply(and(invade(tissues,(and(the(efficacy(of(the(host’s(
immune(defences(against(them).((((
(
1.2.2! Principles!of!surveillance!
The(term(surveillance(was(defined(by(Alexander(Langmuir,(the(Director(of(the(Epidemiology(
Intelligence(Service(at(the(Centers(for(Disease(Control((CDC)(in(Atlanta(USA,(as(“the(systematic(
collection,(consolidation,(analysis(and(dissemination(of(data(on(specific(diseases”(in(public(health(
practice((Langmuir(1963).((Until(Langmuir(developed(the(concept(of(using(surveillance(to(study(the(
spread(of(disease(the(term(had(been(applied(to(the(practice(of(monitoring(people,(for(example(those(
who(had(been(exposed(to(a(communicable(disease(in(order(to(expedite(quarantine.((The(use(of(data(
on(the(occurrence(of(disease(to(study(their(epidemiology(emerged(from(the(efforts(to(control(
malaria(in(war(zones(during(World(War(II.((The(CDC(was(formed(in(the(USA(from(the(military(
organisations(established(during(the(war(and(charged(with(eradicating(malaria(from(the(14(southern(
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state(of(the(USA(where(the(disease(was(endemic.((It(rapidly(expanded(its(role(to(all(areas(of(
communicable(disease(control.((The(surveillance(systems(established(for(poliomyelitis(in(the(early(
1950s(demonstrated(the(value(of(systematically(capturing(data(on(cases(of(disease(and(then(using(it(
to(evaluate(the(impact(of(the(early(vaccination(programmes((Langmuir(1980).((The(Division(of(
Communicable(Diseases(at(the(World(Health(Organisation((WHO)(subsequently(recognised(
surveillance(as(a(means(of(studying(the(epidemiology(of(a(disease,(using(it(not(only(as(a(tool(for(
research,(but(as(fundamental(to(the(planning(and(evaluation(of(control(measures.((The(success(of(
the(WHO(global(smallpox(eradication(programme(was(driven(by(the(use(of(weekly(reports(of(cases(
detected(in(hospitals(and(health(centres(to(focus(immediate(vaccination(efforts((Raska(1964).((This(
direct(link(between(data(from(surveillance(and(the(control(of(disease(led(to(the(definition(of(
surveillance(being(expanded(to(encompass(the(‘study#of#a#disease#as#a#dynamic#process#involving#the#
ecology#of#the#infectious#agent,#the#host,#the#reservoirs,#and#the#complex#mechanisms#concerned#in#
the#spread#of#infection#and#the#extent#to#which#this#spread#occurs’#(Raska(1964).((If(information(from(
surveillance(is(to(be(effective(in(understanding(and(responding(to(the(distribution(or(spread(of(
disease(a(systematic(approach(to(collection(of(data(is(essential.((This(requirement(highlights(the(
importance(of(the(functional(capacity(and(capability(of(surveillance(systems(to(support(data(
collection,(analysis,(and(dissemination(linked(to(public(health(programmes((Thacker(and(Berkelman(
1988).((
(
1.2.3.!Strategies!to!prevent!healthcare!associated!infections!
Although(the(risks(of(infection(associated(with(healthcare(have(been(recognised(for(almost(as(long(as(
hospitals(have(existed((Selwyn(1991),(modern(organised(structures(to(support(efforts(to(prevent(and(
control(HCAI(only(began(to(develop(in(the(UK(in(the(1940s(with(the(appointment(of(control(of(
infection(officers.((The(problems(caused(by(the(pandemic(of(staphylococcal(infections(that(severely(
affected(hospitals(in(the(late(1960s(drove(the(development(of(a(specialist(infection(control(service(
and(by(2008(the(requirement(to(have(a(comprehensive(infection(control(service(became(enshrined(
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in(law(in(the(form(of(the(HCAI(Code(of(Practice((Nahmias(and(Eickhoff(1961;(Jenner(and(Wilson(2000;(
Department(of(Health(2009).((There(is(an(extensive(body(of(evidence(that(describe(strategies(to(
prevent(HCAI(which(focus(on(practices(used(in(the(general(care(of(patients(in(order(to(prevent(the(
movement(of(pathogens(between(patients,(minimise(the(risk(of(pathogens(being(introduced(into(
invasive(devices(or(during(invasive(procedure;(and(organisationAwide(strategies(to(minimise(the(
emergence(of(antimicrobial(resistant(pathogens(and(spread(between(patients((Loveday(et#al(2014;(
Mangram(et#al(1999;(O’Grady(et#al#2011;(Gould(et#al(2010;(AshiruAOredope(et#al(2012).((However,(
many(researchers(have(highlighted(the(difficulties(of(ensuring(that(healthcare(workers(are(aware(of(
the(risk(of(HCAI(to(patients(in(their(care(and(that(they(adhere(to(recommended(practice((Pittet(et#al(
2000;(Jenner(et#al(2006;(Pronovost(et#al(2006)(In(addition,(whilst(patients(should(expect(to(be(
provided(with(reliable(information(about(risks(of(infection(associated(with(their(healthcare,(in(reality(
this(is(rarely(possible(in(the(absence(of(robust(surveillance(systems((NCCWCH(2008).(
(
1.2.3.1( Role#of#surveillance#in#preventing#HCAI:(Evidence(for(the(potential(impact(of(surveillance(of(
HCAI(as(a(mechanism(to(increase(the(awareness(of(clinical(staff,(improve(adherence(to(best(practice(
and(reduce(rates(of(HCAI(was(first(published(by(Cruse(and(Foord((1973;(1980)(who(analysed(the(
impact(of(10(years(of(surveillance(on(the(epidemiology(of(surgical(site(infection,(demonstrated(key(
factors(that(influenced(the(rate(of(SSI(and(significant(reductions(associated(with(systematic(
monitoring(and(feedback(of(rates(to(surgeons.((Other(studies(have(indicated(that(surveillance(and(
feedback(of(data(to(clinicians(is(essential(for(infection(control(strategies(to(be(effective((Haley(1985;(
Pronovost(et#al(2006).((In(a(review(of(studies(reporting(reductions(in(rates(of(HCAI,(all(the(successful(
quality(improvement(strategies(included(surveillance(and(feedback((Harbarth(et#al(2003).((Enabling(
comparison(with(other(similar(organisations(can(enhance(the(impact(of(surveillance(though(
identifying(outliers(and(motivating(implementation(of(reduction(strategies.((The(potent(effect(of(
benchmarking(of(rates(of(HCAI(in(national(surveillance(systems(has(been(demonstrated(by(significant(
reductions(in(rates(of(SSI(reported(in(hospitals(that(participate(in(national(surveillance(schemes(and(
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report(rates(of(SSI(to(surgeons.((Gastmeier(et#al(identified(a(reduction(in(relative(risk(of(wound(
infections(following(hip(prosthesis(surgery(of(0.54((between(the(first(and(third(year(of(participation(
in(the(German(national(nosocomial(infections(surveillance(system((KISS)((Gastmeier(et#al(2005).((
Geubbels(et#al(also(identified(a(reduction(in(relative(risk(of(surgical(site(infection((SSI)(associated(with(
participation(in(the(Dutch(national(surveillance(system((PREZIES)(between(1996(and(2000((Geubbels(
et#al((2004;(2006a).(Significant(reductions(in(rates(of(SSI(have(also(been(observed(in(hospitals(
participating(in(the(national(surveillance(and(benchmarking(system(in(French((ISOARAISIN)(with(rates(
declining(from(2.04%(to(1.26%((p<0.001)(between(1999(and(2006.((Other(studies(have(reported(
similar(reductions(in(association(with(surveillance(used(for(benchmarking(of(hospitals(to(drive(
improvements(in(performance((Rioux(et#al(2007;(Taylor(et#al(1994;(National(Audit(Office((NAO)(2004;(
Barwolff(et#al(2006).((However,(whilst(external(benchmarks(can(be(a(powerful(driver(for(change(they(
require(considerable(effort(and(coAordination(to(develop(and(must(use(principles(that(assure,(as(far(
as(possible,(the(validity(of(comparisons,(including:(standardised(case(definitions(and(case(finding(
methods;(analysis(that(accounts(for(variation(in(case(mix;(precision(of(estimated(rates(and(period(of(
postAoperative(followAup;(and(assurance(about(the(quality(of(data(through(validation(systems((Cooke(
et#al(2000,(Wilson(et#al(2002;(Gaynes(et#al(2001a;(2000;(Ingraham(2010).(((Despite(key(advances(in(
preventing(HCAI(over(recent(decades,(microbial(pathogens(are(able(to(rapidly(evolve(and(adapt(to(
changing(circumstances(and(surveillance(systems(must(therefore(be(able(to(detect(changing(
epidemiology(in(order(to(direct(appropriate(preventative(strategies.((Using(surveillance(to(support(
effective(benchmarking(and(explore(changing(epidemiology(of(HCAI(are(key(components(of(this(
thesis.((
!
1.2.4! Surveillance!methodology!
The(methodology(used(to(capture(surveillance(data(has(important(implications(for(the(approach(to(
analysis(and(interpretation,(and(in(supporting(comparisons(within(and(between(institutions((Gaynes(
et#al(2001;2000;(Jarvis(2003;(Platt(2005).((Surveillance(of(BSI(is(based(on(data(captured(at(a(
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population(level.((This(approach(comprises(collecting(data(on(the(number(of(reports(of(a(particular(
disease(within(a(given(population.((This(type(of(data(can(be(used(to(describe(and(compare(patterns(
of(disease(and(exposure(to(risk(factors(within(different(populations(and(over(time((HPA(2008a).((In(
my(research(on(this(data(I(have(explored(secular(trends(and(sources(of(these(infections(in(order(to(
improve(understanding(of(their(epidemiology(and(generate(research(questions(about(causes(or(
contributory(factors.((However,(in(the(absence(of(data(on(the(presence(of(risk(factors(in(individuals(
this(type(of(population(level(surveillance(cannot(be(used(to(determine(associations(between(risk(
factors((Hennekens(and(Buring(1987).((In(contrast,(data(for(the(surveillance(of(SSI(is(captured(at(a(
patient(level.((This(enables(the(data(to(be(analysed(to(identify(risk(factors(and(outcomes(of(infection(
as(well(as(exploring(variation(in(rates(of(infection,(the(impact(of(caseAfinding(methods(and(strategies(
for(reliably(comparing(rates(between(centres.((These(are(the(key(concepts(which(underpin(my(
research(studies(on(SSI(that(are(described(in(this(thesis.(
(
1.3 Structure(and(content(of(the(submission(for(PhD(by(publication(
The(thesis(comprises(eight(primary(publications(that(demonstrate(a(coherent(theme(of(research(
related(to(the(design(and(application(of(surveillance(systems(as(a(mechanism(for(improving(
healthcare(outcomes(and(identifying(causal(factors(for(healthcare(associated(infection.((It(also(
includes(eight(secondary(publications(that(underpin(and(further(enhance(the(main(thesis.((The(thesis(
is(structured(as(follows:(
(
Chapter!2:#provides(the(context(for(my(research(by(describing(the(background(and(key(
methodological(concepts(that(underpin(surveillance(of(HCAI(in(England(and(how(these(have(
informed(my(research.((It(includes(a(discussion(of(the(development(of(systems(for(HCAI(surveillance(
in(the(USA(and(UK,(the(metrics(used(for(calculating(rates(of(HCAI,(case(definitions(and(caseAfinding(
methodology,(risk(factors(for(SSI(and(BSI(and(analysis(and(reporting(of(HCAI(surveillance(data.((
(
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Chapter!3:(describes(my(work(on(the(use(of(risk(factor(data,(captured(through(surveillance,(to(
measure(the(impact(and(contributory(factors(for(HCAI.((It(includes(the(following(three(published(
works:(
• Coello(et#al(2005((Appendix(3.1):(This(study(used(data(captured(by(the(SSI(surveillance(system(to(
determine(the(impact(of(surgical(site(infection((SSI)(on(the(costs(of(healthcare(and(risk(of(death(
adjusted(for(underlying(illness,(age(and(other(operation(related(risk(factors.((
• Ridgway(et#al(2005((Appendix(3.2):(This(analysis(used(multivariate(analysis(to(define(rates(and(
identify(significant(independent(risk(factors(for(SSI(following(hip(prosthesis(surgery.((
• Leong(et#al(2007((Appendix(3.3):(This(study(explored(the(impact(of(a(key(risk(factor(for(SSI,(the(
duration(of(operation(and(validated(our(methods(for(identifying(prolonged(operations(
associated(with(an(increased(risk(of(SSI.((
(
Chapter!4:(builds(on(these(findings(by(exploring(the(methodological(challenges(in(comparing(rates(of(
HCAI.((It(includes(the(following(three(published(works:(
• Wilson(et#al(2007((Appendix(4.1):(This(work(reflected(a(collaboration(with(European(colleagues(
to(explore(the(implications(of(variation(in(application(of(case(definitions,(case(mix(and(duration(
of(followAup(on(interAcountry(comparisons(rates(of(SSI.(((
• Wilson#et#al#2008((Appendix(4.2):(This(publication(describes(the(use(of(funnel(plots(to(provide(a(
novel(methodology(for(benchmarking(SSI(surveillance(data(and(identifying(hospitals(with(
outlying(rates(of(infection.((
• Wilson(et#al(2013((Appendix(4.3):(This(pragmatic(study(was(the(first(to(demonstrate(significant(
interAhospital(variation(in(the(application(of(postAdischarge(surveillance(methods(and(to(define(
the(impact(on(SSI(benchmarking(systems.(
(
(
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Chapter!5:(focuses(on(the(analysis(of(trends(emerging(from(national(BSI(surveillance(data(and(
includes(the(following(two(published(works:(
• Wilson(et#al(2010((Appendix(5.1):(Presents(an(analysis(of(trends(in(common(pathogens(causing(
bloodstream(infection(captured(by(the(national(laboratory(surveillance(system(which(used(a(
Poisson(regression(model(to(adjust(for(variation(in(case(ascertainment.(
• Wilson(et#al(2011((Appendix(5.2):(In(this(publication(the(Poisson(regression(methods(developed(
in(the(previous(study(were(applied(to(the(analysis(of(trends(in(sources(bloodstream(infections(
caused(by(meticillin(resistant(Staphylococcus#aureus((MRSA).(
(
The(final(two(chapters((Chapter(6(and(7)(provide(an(insight(into(my(personal(development(as(a(
competent(and(confident(researcher(and(how(I(can(further(develop(my(area(of(research((
!
1.4( The(published(works((
These(are(organised(into(six(appendices(each(corresponding(to(the(relevant(chapter(of(the(thesis:(
!
1.4.1! Primary!published!works!
1. Coello,(R.;(Charlett,(A.;(Wilson,(J.;(Ward,(V.;(Pearson,(A,;(Boriello,(P.((2005)(Adverse(impact(of(
surgical(site(infections(in(English(hospitals.(J.#Hosp.#Infect.#60:(93A103((Appendix(3.1)(
2. Ridgeway,(S.;(Wilson,(J.;(Charlett,(A.;(Kafatos,(G.;(Pearson,(A.;(Coello,(R.((2005)(Infection(of(the(
surgical(site(after(arthroplasty(of(the(hip.((J.#Bone#Joint#Surg.(87(6):(844A50((Appendix(3.2)(
3. Leong,(G.;(Wilson,(J.;(Charlett,(A.((2006)(Duration(of(operation(as(a(risk(factor(for(surgical(
site(infection:(comparison(of(English(and(US(data.(J#Hosp#Infect(63:(255A62.((Appendix(3.3)(
4. Wilson,(J.;(Suetens,(C.;(Ramboer,(I.;(Fabry.(J.((2007)(Hospitals(in(Europe(Link(for(Infection(
Control(through(Surveillance((HELICS).(InterAcountry(comparison(of(rates(of(surgical(site(
infection(–(opportunities(and(limitations.(J.#Hosp.#Infect.(65(S2):(165A70((Appendix(4.1)(
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5. Wilson,(J.;(Charlett,(A,;(Leong,(G.(et#al((2008)(Rates(of(surgical(site(infection(after(hip(
replacement(as(a(hospital(performance(indicator:(analysis(of(data(from(the(English(
mandatory(surveillance(system.(Infect.#Control#Hosp.#Epid.(19(3):(219A26((Appendix(4.2)(
6. Wilson,(J.;(Wloch,(C.;(Saei,(A.(et#al((2013)(InterAhospital(comparison(of(rates(of(surgical(site(
infection(following(caesarean(section(delivery:(evaluation(of(a(multicentre(surveillance(
study.(J.#Hosp.#Infect.(84:(44A51((Appendix(4.3)(
7. Wilson,(J.;(Elgohari,(S.;(Livermore,(D.(et#al((2010)(Trends(among(pathogens(reported(as(
causing(bacteraemia(in(England:(2004(–(2008.((Clinical#Microbiology#&#Infection.(17(3):(451A8(
(Appendix(5.1)(
8. Wilson,(J.;(Guy,(R.;(Elgohari,(S.(et#al((2011)(Trends(in(sources(of(meticillin(resistant(
Staphylococcus#aureus(bacteraemia:(data(from(the(National(mandatory(surveillance(of(MRSA(
bacteraemia(in(England,(2006(to(2009.(J#Hosp#Infect.(79:(211A217((Appendix(5.2)(
!
1.4.2! Secondary!published!work!
1. Cooke,( E.M.;(Coello,(R.;( Sedgwick,( J.;(Ward,(V.;(Wilson,( J.;(et#al( (2000)(A(national( surveillance(
scheme(for(hospitalAassociated(infections(in(England.((J.#Hosp.#Infect.(46:(1A3((Appendix(1.1)(
2. Glen,(A.;(Ward,(V.;(Wilson,( J.(et(al( (1997)(HospitalAacquired( infection:( surveillance(polices(and(
practice.(Public(Health(Laboratory(Service.((Appendix(2.1)(
3. Wilson,( J.( (2013)(Surgical( site( infection:( the(principles(and(practice(of(surveillance.(Part(1:(Key(
concepts(in(the(methodology(of(SSI(surveillance.(J#Infect#Prevent.(14:(6A12((Appendix(2.2)(
4. Wilson,( J.( (2013)( Surgical( site( infection:( the( principles( and( practice( of( surveillance.( Part( 2:(
analysing(and(interpreting.#J#Infect#Prevent.(17:(1A5((Appendix(2.3)(
5. McDougall,(C.;(Wilson,(J.;(Elgohari,(S.((2007)(A(review(of(compliance(with(the(national(protocols(
for( surveillance( of( surgical( site( infection.( Does( deviance( impact( on( the( quality( of( data( and(
detection(of(SSI?(Amer.#J.#Infect.#Control.##35:(271((Appendix(2.4)(
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6. Wilson,( J.;( Ward,( V.;( Coello,( R.( et# al( (2002)( A( user( evaluation( of( the( National( Nosocomial(
Infection( Surveillance( System:( surgical( site( infection( module.( J.# Hosp.# Infect.# 52:114A121(
(Appendix(2.5)(
7. Wilson,(A.P.R.;(Gibbons,( C.;( Reeves,( B.C.;(Hodgson,(B.;( Liu,(M.;( Plummer,(D.;( Krukowski,( Z.H.;(
Bruce,( J.;(Wilson,( J.;(Pearson,(A.( (2005).(Surgical(wound( infection(as(a(performance( indicator:(
agreement( of( common( definitions( of( wound( infection( in( 4773( patients.# BMJ( 329:( 720A25(
(Appendix(3.2)(
8. Wilson,(J.;(Saei,(A.;(Elgohari,(S.((2009)(The(application(of(small(area(estimate(models(to(measure(
the(effect(of(length(of(postAoperative(stay(on(observed(changes(in(rates(of(surgical(site(infection(
over(time.( (Poster(presentation.(Society(of(Healthcare(Epidemiologists(of(America.(April(2009.(
(Appendix!4.5)(
(
1.5( Demonstrating(the(requirements(of(a(PhD(by(publication(
The(overview(presented(in(this(submission(represents(a(coherent(programme(of(research,(linked(to(
my(work(in(analysing(data(captured(in(national(surveillance(systems(for(HCAI.((This(research(has(
been(informed(by(my(clinical(background(in(nursing(which(has(both(influenced(my(research(interests(
and(underpinned(my(interpretation(and(analysis(of(surveillance(data.(((
(It(demonstrates(how(my(work(has(influenced(the(delivery(of(surveillance(and(its(application(to(
identifying(differences(in(rates(of(HCAI(and(improving(health(outcomes.((It(has(also(enhanced(
understanding(of(risk(factors(that(affect(the(acquisition(of(HCAI.((Based(on(the(criteria(required(of(a(
PhD(by(submission(of(published(work(the(following(are(addressed(throughout(this(thesis:(
(
Conceptual!and!methodological!development!of!the!work:(I(appraise(these(aspects(in(the(
context(of(the(main(methods(and(findings(of(the(work.(
(
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Autobiographical!context:!My(involvement(in(the(conceptual(development(of(the(overall(
programme(of(research(and(specific(role(in(the(design,(methodology(and(execution(is(
explained(in(relation(to(each(published(work.((
(
Accounts!for!originality:!The(rationale(and(contribution(of(the(published(works(to(
knowledge(of(HCAI(and(surveillance(systems(are(explained(in(the(context(of(the(evidenceA
base(at(the(time(the(work(was(conducted.(((
(
Subsequent!contributions!to!the!subject:(the(originality(of(the(work(is(reappraised(in(
relation(to(contributions(to(the(subject(area(since(the(completion(of(the(research.(
(
Professional!development!as!a!research!practitioner:!Reflections(on(my(development(as(a(
researcher(and(how(undertaking(the(work(has(contributed(to(the(development(of(my(
knowledge(and(skills(in(undertaking(research.(
(
1.6(( Summary(of(chapter(
I(have(outlined(the(origin(of(the(programme(of(research(that(forms(the(basis(for(my(thesis;(the(
theoretical(principles(that(have(informed(it;(how(I(have(structured(the(thesis;(and(how(I(have(
demonstrated(the(requirements(of(a(PhD(by(publication.((The(following(chapter(will(describe(the(
emergence(of(surveillance(systems(for(HCAI(in(the(1960s,(the(key(methodological(concepts(that(have(
subsequently(underpinned(them(and(how(these(principles(have(informed(both(the(development(of(
national(surveillance(systems(in(England(and(my(role(within(this(research.(((
(
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(
The(development(of(national(surveillance(systems(in(England(
!
2.1( Introduction(@(the(evolution(of(healthcare(associated(infection(surveillance((
In!the!1960s!formal!structures!to!support!infection!control!in!hospitals!began!to!emerge!
with!the!appointment!of!specialist!staff!such!as!infection!control!nurses,!working!with!
microbiologists!or!hospital!epidemiologists.!!In!the!USA,!the!Centers!for!Disease!Control!
(CDC)!recommended!that!hospitals!conduct!surveillance!of!hospitalEacquired!infections!in!
order!to!obtain!epidemiological!data!on!which!to!base!effective!control!measures!(Langmuir!
1963;!Haley!et(al!1980a).!!Subsequently,!organised!programmes!of!infection!control!activity!
began!to!develop!which,!in!the!USA!commonly!included!surveillance!of!infection!acquired!in!
hospital.!!The!intention!of!this!surveillance!was!to!identify!all!nosocomial!infections!through!
the!review!of!laboratory!data!and!identification!of!patients!with!fever,!in!isolation!or!on!
antibiotics!with!data!mostly!captured!by!infection!control!nurses!(ICNs)!(Haley!&!Shachtman!
1980;!Abrutyn!and!Talbot!1987).!!Whilst!these!systems!were!comprehensive,!they!were!also!
highly!resource!intensive!and!generated!a!large!amount!of!data!that!was!not!always!useful!
to!drive!prevention!initiatives!(Glenister!et(al!1992;!Haley!1985a,!1985b).!!
!
2.1.1( The$Study$of$the$Efficacy$of$Nosocomial$Infection$Control$(SENIC):$Rising!costs!led!
to!the!benefits!of!these!resourceEintensive!surveillance!programmes!being!questioned!
(Haley!et(al!1980a,!1981,!1985a)!and!in!1980!CDC!initiated!a!large,!multicentre!study!to!
determine!both!the!magnitude!of!the!problem!of!HCAI!in!hospitals!and!the!extent!to!which!
the!surveillance!and!control!programme!approach!was!effective!in!reducing!the!risk!of!
infection.!!The!study!drew!on!a!sampling!frame!of!more!than!6000!hospitals!with!infection!
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control!programmes!of!varying!levels!of!intensity!as!defined!by!a!prior!countryEwide!survey!
(Haley!et(al!1980b).!!In!a!stratified!random!sample!of!338!of!6000!hospitals,!hospitalE
acquired!infections!were!identified!from!the!case!records!of!a!random!sample!of!500!
patients!before!and!after!infection!control!programmes!were!established!(Haley!et(al!
1980b).!!In!order!to!explore!the!independent!effect!of!varying!intensity!of!surveillance!and!
control!programmes!on!overall!rates!of!HCAI!and!rates!of!specific!types!of!HCAI,!a!
multivariable!logistic!regression!model!was!used.!!Such!models!correlate!the!dependant!or!
outcome!variable!(i.e.!infection)!with!more!than!one!explanatory!(predictor)!variable!at!the!
same!time,!enabling!the!effects!of!each!predictor!to!be!measured!whilst!accounting!for!the!
effect!of!all!the!other!predictors.!!This!was!important!in!order!to!distinguish!the!specific!
effect!of!individual!variables!since!many!were!likely!to!be!related!e.g.!length!of!hospital!stay!
and!severity!of!illness.!!Logistic!regression!was!used!because!the!model!was!estimating!a!
dichotomous!outcome!(infection!yes!or!no)!and!using!logit!of!proportion!as!the!outcome!
variable,!ensuring!that!meaningless!estimated!proportions!below!zero!or!above!one!were!
not!generated!(Bland!2000!p.321).!!Examples!of!this!type!of!modelling!are!contained!in!some!
of!the!publications!included!in!this!thesis!(Coello!et(al!2005;!Ridgeway!et(al!2005).!!Using!the!
logistic!regression!model!to!control!for!variation!in!characteristics!of!the!hospitals!and!their!
patients,!the!SENIC!study!demonstrated!that!organised!surveillance!was!an!essential!
component!of!an!effective!infection!control!programme.!Hospitals!with!both!surveillance!
and!organised!control!activities!reduced!infection!rates!by!32%,!whilst!in!hospitals!with!no!
infection!control!programme!the!rate!of!HCAI!increased!by!6%.!!Although!surveillance!was!
found!to!be!an!essential!component!of!the!programme!for!all!HCAI!types,!the!effect!was!
most!apparent!in!relation!to!surgical!infections,!pneumonia!and!urinary!tract!infection!
where!high!intensity!surveillance!was!associated!with!significant!reductions!in!rates!between!
to!two!data!capture!periods!of!1970!and!1975/6!(Haley!et(al!1985a).!!This!study!was!
therefore!critical!in!defining!the!essential!role!that!surveillance!played!in!effective!infection!
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control!programmes!and!it!inspired!the!formation!of!the!national!HCAI!surveillance!systems!
in!England,!which!have!underpinned!much!of!the!research!included!in!this!thesis!(section!
2.1.5).!!!
!
2.1.2( The$National$Nosocomial$Infection$Surveillance$system$(NNIS):(This!system!had!
been!established!by!CDC!in!the!1970s!to!provide!a!mechanism!for!collecting!and!analysing!
data!on!the!frequency!of!nosocomial!infections!in!US!hospitals!(Horan!et(al!1986).!!The!early!
NNIS!approach!reflected!the!CDC!advice!for!‘comprehensive!surveillance’!and!involved!51!
selected!hospitals!collecting!data!on!all!hospitalEacquired!infections!and!the!rate!for!the!
whole!hospital!being!calculated!using!the!number!of!patient!admissions!as!a!denominator.!!
However,!SENIC!demonstrated!that!surveillance!programmes!were!more!effective!if!they!
provided!meaningful!feedback!on!rates!of!specific!infections!to!relevant!clinicians.!!Indeed,!
as!the!SENIC!study!concluded!‘infection(control(problems(and(the(need(for(prevention(efforts(
were(not(apparent(to(physicians,(nurses(or(administrators(until(they(were(given(quantitative(
measures(of(the(problem(derived(from(surveillance(data’!(Haley!et(al!1985a).!!Thus!the!
concept!of!targeted!surveillance!emerged!in!the!late!1980s,!with!specific!surveillance!activity!
determined!by!local!priorities!and!recommended!to!be!objective!rather!than!process!driven!
(Haley!1985;!Haley!1995).!!NNIS!was!developed!accordingly!and!supported!surveillance!
under!three!‘components’!E!adult!and!pediatric!intensive!care!units,!high!risk!nursery!and!
surgical!patients!and!expanded!participation!to!300!hospitals!(Emori!et(al!1991,!National!
Nosocomial!Infection!Surveillance!(NNIS)!System!2004).!!The!standardized!protocols!
developed!for!capturing!this!surveillance!data!began!to!be!adopted!by!other!countries!as!
they!also!established!national!HCAI!surveillance!systems,!including!the!systems!that!
emerged!in!England!in!the!late!1990s.!!The!NNIS!surveillance!principles!underpin!the!surgical!
site!infection!(SSI)!data!described!in!this!thesis!and!are!explained!in!subsequent!sections!of!
this!chapter.!
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2.1.3( Development$of$surveillance$systems$in$the$United$Kingdom:$In!the!UK,!the!
collection!and!collation!of!infection!reports!from!microbiology!laboratories!at!a!national!
level!was!established!in!England!in!the!1940s.!!Initially,!these!reports!were!only!collected!
from!the!laboratories!that!were!part!of!the!Public!Health!Laboratory!Service!(PHLS)!network,!
but!in!the!1950s!the!system!was!extended!to!NHS!laboratories.!!For!the!first!50!years!the!
system!relied!on!manual,!paperEbased!reporting!to!the!PHLS.!!In!1975,!a!central!computer!
database!called!LabBase!was!established!and!laboratory!reports!on!microEorganisms!causing!
clinically!significant!infections!were!entered!manually!at!the!Centre!for!Disease!Surveillance!
&!Control!(CDSC),!which!was!established!at!the!Central!PHLS!in!1977!(Grant!and!Eke!1993).!!
Originally!these!included!pathogens!from!stools!and!urine;!then!in!1989!this!was!extended!
to!include!all!positive!blood!cultures!(Reacher!et(al!2000).!!In!1991!an!electronic!reporting!
system!was!introduced!which!was!subsequently!updated!to!a!unified!software!system!for!
England!and!Wales!called!‘CoSurv’.!!This!system!enabled!a!data!captured!locally!in!a!
laboratory!to!be!entered!into!a!computer!and!transmitted!as!a!structured!dataset!to!CDSC!
by!a!modem!link!(Grant!and!Eke!1993).!!Further!developments!in!the!1990s!enabled!
laboratories!to!extract!data!directly!from!their!laboratory!information!systems!to!be!
translated!into!the!CoSurv!data!format!required!by!CDSC.!!
!
2.1.4! Reporting(systems(for(laboratory(infections:((The!data!from!hospital!laboratory!
systems!was!used!by!CDSC!to!generate!both!weekly!and!serial!reports!which!were!published!
in!the!Communicable!Disease!Report!(CDR).!!The!numbers!included!in!these!laboratory!
reports!increased!by!a!factor!of!three!between!1975!and!1993!as!participation!in!the!
surveillance!system!increased!(Grant!and!Eke!1993).!!In!the!midE1990s!regional!
epidemiology!units!were!developed!to!support!analysis!and!reporting!of!the!laboratory!data.!!
Until!the!midE2000s!the!majority!of!data!was!submitted!manually,!but!a!project!to!
standardise!the!direct!electronic!transfer!of!data!from!laboratory!systems!resulted!in!over!
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90%!moving!over!to!electronic!data!transfer!by!2009.!!Although!the!surveillance!only!
captures!a!basic!dataset!on!episodes!linked!to!a!single!pathogen!and!does!not!distinguish!
isolates!associated!with!healthcare!from!those!associated!with!communityEacquired!
infection,!it!does!provide!invaluable!data!with!which!to!identify!trends!in!pathogens!causing!
infection.!!This!is!particular!the!case!with!blood!cultures,!since!the!laboratory!data!alone!is!
usually!indicative!of!a!systemic!infection.!!In!Chapter!5,!I!describe!an!analysis!of!trends!in!
pathogens!causing!bacteraemia!that!draws!on!this!laboratory!data!and!demonstrates!its!
value!in!determining!changes!in!epidemiology!at!a!population!level!(Wilson!et(al!2011;!
Appendix!5.1).!
!
2.1.5! Systems$for(surveillance$of$healthcare$associated$infections$in$England:!In!the!UK,!
infection!control!services!became!widely!established!in!hospitals!after!their!inception!in!the!
late!1960’s!and!by!1986!almost!90%!of!health!authorities!had!appointed!an!infection!control!
nurse!(Howard!1988).!!However,!unlike!in!the!USA!most!infection!control!programmes!in!the!
UK!did!not!include!comprehensive!surveillance!activity!but!focused!on!monitoring!for!
pathogens!associated!with!a!risk!of!transmission!e.g.!antimicrobial!resistant!organisms,!
staphylococcus!or!streptococcus!‘alert!organisms’.!!In!a!survey!of!30!infection!control!nurses!
by!Glenister!et(al!in!the!early!1990s,!87%!(26/30)!of!infection!control!teams!conducted!this!
type!of!‘alert!organisms’!surveillance!and!only!17%!(5/30)!produced!data!on!rates!of!
infection!and!where!this!was!the!case,!only!for!surgical!site!infection!(Glenister!et(al!1992).!
One!factor!that!may!have!contributed!to!this!difference!in!focus!was!the!involvement!of!
physicians!with!a!strong!interest!and!expertise!in!epidemiology!in!the!USA,!whereas!in!the!
UK!the!medical!microbiologist!(a!role!which!did!not!exist!in!the!USA)!was!more!likely!to!be!
part!of!the!infection!control!team!with!more!expertise!and!interest!in!microbiology!and!
control!measures!than!in!the!capture!and!interpretation!of!data.!!However,!the!publication!
of!SENIC!initiated!a!change!in!approach!to!surveillance!of!hospital!infection!in!the!UK!and!the!
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importance!of!surveillance!as!a!component!of!infection!control!programmes!in!the!UK!began!
to!feature!in!policy!documents!making!recommendations!about!hospital!infection!control!
(Department!of!Health!1995).!!In!addition,!when!the!NHS!and!Community!Care!Act!was!
published!in!1990,!it!signalled!the!emergence!of!an!‘internal!market’!in!the!NHS!associated!
with!competition!to!provide!services.!!This,!together!with!an!imperative!to!assure!quality,!
drove!the!need!for!data!to!assess!quality!and!measure!outcomes,!including!those!associated!
with!HCAI!(Soderlund!et(al(1997;!Department!of!Health!2003;!Commission!for!Healthcare!
Improvement!2003).!!!
!
2.1.6! Audit$of$infection$control$activity$project:!!After!the!results!of!the!SENIC!study!were!
published,!the!Department!of!Health!sought!to!advance!HCAI!surveillance!in!UK!hospitals.!!it!
therefore!funded!a!study!conducted!by!the!PHLS!to!explore!the!feasibility!of!undertaking!
surveillance!in!hospitals!in!the!UK!for!which!I!was!part!of!the!research!team.!!The!study!
involved!19!district!general!hospitals!in!England!and!Wales!and!found!a!rate!of!HCAI!2.7!per!
100!patients!episodes!(excluding!surgical!site!infections)!increasing!to!over!seven!for!
patients!with!an!invasive!device!(Glynn!et(al!1997;!Appendix!2.1).!!This!study!identified!
significant!variation!between!specialities!and!hospitals!in!risks!of!infection!that!were!not!
explained!by!caseEmix.!!One!of!the!key!recommendations!we!formulated!from!this!study!was!
the!need!to!address!the!apparent!variation!in!rates!of!infection!by!establishing!systems!for!
HCAI!surveillance!based!on!standard!protocols!and!data!capture!systems.!!This!
recommendation!subsequently!informed!the!development!of!national!systems!for!
surveillance!of!HCAI,!the!National!Nosocomial!Infection!Surveillance!System!(NINSS),!
established!in!England!in!the!late!1990s!(Cooke!el(al!2000;!Appendix!1.1).!!!
!
2.1.7! The$Nosocomial$Infection$National$Surveillance$System$(NINSS)$in$England:((The!
PHLS!formed!this!first!national!surveillance!system!in!1996!with!funding!from!the!
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Department!of!Health.!!It!aimed!to!both!facilitate!surveillance!of!HCAI!and!enable!
comparison!of!rates!between!institutions!in!order!to!inform!and!support!HCAI!prevention!
strategies!(Cooke#et#al#2000;(Appendix!1.1).!!Surveillance!was!subsequently!established!for!
three!HCAI:!!
• surgical!site!infection,!!
• catheterEassociated!urinary!tract!infection,!
• hospitalEacquired!bloodstream!infection.!!
!
The!aim!was!to!establish!a!voluntary!national!reporting!system!that!enables!hospitals!to!
compare!their!data!against!aggregated!annonymised!data!from!other!participating!hospitals.!
However,!whilst!external!benchmarks!can!be!a!powerful!driver!for!change!they!are!
acknowledged!to!require!considerable!effort!and!coEordination!to!develop!(Gaynes!et(al!
2001a;!Centers!for!Disease!Control!1991).!!As!part!of!the!multidisciplinary!team!that!
established!these!surveillance!systems!I!was!involved!in!establishing!the!key!principles!on!
which!they!were!based!to!assure,!as!far!as!possible,!the!validity!of!comparisons.!!These!
included!standardised!case!definitions,!active!case!finding!methods!and!analysis!that!
accounts!for!variation!in!case!mix.!!In!addition,!we!aimed!to!use!methods!that!could!reliably!
distinguish!outlying!rates!of!infection#(Cooke#et#al#2000;#Appendix!1.1).##The!methods!
chosen!were!adapted!from!those!used!by!the!CDC!NNIS!system!and!used!similar!datasets,!
but!focused!on!specific!types!of!infection!rather!than!specialist!services.!!We!also!devised!
new!methods!for!defining!infections,!capturing!and!reporting!data.!!There!was!also!a!focus!
on!publishing!benchmarking!data,!which!was!not!a!major!feature!of!other!national!
surveillance!systems!that!were!emerging!at!that!time!(Smyth!and!Emmerson!2000;!Emori!et(
al(1991;!Gastemeier!et(al!2008;!Haustein!et(al!2011).!!The!bloodstream!infection!surveillance!
initiated!by!NINNS!was!subsequently!replaced!in!2001!by!a!system!focused!on!bacteraemia!
caused!by!one!particular!pathogen,!methicillin!resistant!Staphylococcus(aureus!(MRSA).!!This!
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organism!was!causing!concern!at!this!time!because!it!was!resistant!to!the!first!line!
antimicrobial!agent!used!to!treat!staphylococcal!infections.!!Evidence!from!the!routine!
laboratory!surveillance!data!indicated!that!resistant!strains!had!become!widespread!in!the!
UK!and!that!the!incidence!of!invasive!infections!had!increased!rapidly!in!the!last!decade,!
with!attendant!implications!for!effective!treatment!of!these!serious!and!lifeEthreatening!
infections!(Duckworth!et(al!2002;!Shorr!2007).!!The!MRSA!surveillance!system!was!originally!
based!on!aggregate!quarterly!reports!of!cases,!but!became!a!patient!level,!webEbased!
reporting!system!called!the!MRSA!bacteraemia!Electronic!Surveillance!System!(MESS)!in!
October!2005.!!!
!
2.1.8! The!research!included!in!my!thesis!concerns!the!analysis,!interpretation!and!
application!of!data!from!three!of!these!national!surveillance!systems:!the!NINSS!surgical!site!
infection!surveillance!system!(SSISS),!bacteraemia!data!captured!by!the!routine!laboratory!
reporting!system!(LabBase)!and!the!MRSA!bacteraemia!surveillance!system.!!The!
methodology!underpinning!these!surveillance!systems,!including!the!metrics!generally!used,!
the!definition!of!cases!of!infection,!methods!of!case!finding!and!the!relevance!of!risk!factor!
data!in!surveillance!systems!will!be!outlined!in!section!2.2!to!provide!the!background!and!
context!for!the!research!presented!in!this!thesis.!
!
2.2 Methodologies(applied(to(the(surveillance(of(healthcare(associated(infections(
(
2.2.1 Metrics$for$calculating$rates$!
2.2.1.1( Surgical(site(infection:(The!conventional!method!of!measuring!SSI!is!the!cumulative!
incidence,!which!is!usually!expressed!as!the!number!of!SSIs!per!100!operations.!!This!is!more!
accurately!described!as!the!risk!of!SSI!but!is!commonly!referred!to!as!a!rate!of!SSI!(NNIS!
2004).!!!
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This!metric!is!calculated!as!follows:!
!
!
!
In!order!to!accurately!measure!risk,!cases!in!the!numerator!must!be!drawn!from!the!
population!included!in!the!denominator.!!Most!national!SSI!surveillance!systems!use!
methods!based!on!those!developed!in!the!1990s!for!the!National!Nosocomial!Infection!
Surveillance!(NNIS)!System!in!the!USA!and!which!were!built!on!the!findings!of!SENIC!(Emori!
et(al!1991).!!Surveillance!is!structured!to!calculate!this!metric!by!following!up!each!patient!
who!has!a!relevant!operation!prospectively!to!determine!if!they!develop!an!SSI.!!Since!the!
intrinsic!risk!of!SSI!is!not!the!same!for!all!types!of!operation!(being!strongly!influenced!by!the!
presence!of!microbial!flora!at!the!site!of!the!operation)!the!NNIS!system!distinguished!
categories!of!clinically!similar!procedures!that!are!likely!to!have!a!similar!intrinsic!risk!of!SSI!
(NNIS!2004).!!This!is!an!important!principle!in!order!to!report!meaningful!rates!of!SSI!to!
surgeons!and!clinical!teams!and!to!ensure!that!variations!in!rates!of!SSI!are!not!explained!by!
differences!in!the!intrinsic!risk!of!infection!associated!with!the!combination!of!procedures!
included!in!the!surveillance.!!
!
For!the!NINSS!SSI!surveillance!system!we!expressed!the!denominator!for!the!surveillance!by!
grouping!surgical!procedures!into!12!categories!based!on!a!defined!set!of!Office!of!
Population!Census!&!Statistics!(OPCS)!procedure!codes!which!are!the!standard!method!of!
coding!operations!in!the!UK.!!We!mapped!these!codes!to!the!categories!defined!by!the!NNIS!
system!in!the!USA!in!order!to!enable!comparison!with!data!from!other!surveillance!systems.!!
Such!comparisons!are!illustrated!in!Leong!et(al!2005!(Appendix!3.3)!where!we!explore!the!
duration!of!operation!as!a!predictor!of!SSI!(see!chapter!3;!section!3.4)!and!in!my!work!on!
interEcountry!comparison!of!rates!of!SSI!described!in!Wilson!et(al!2007!(Appendix!4.1)!in!
No.(SSI(in(a(defined(group(of(procedures
(X(100(
No.(operations(performed!#
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Chapter!4;!section!4.4.!In!selecting!NINNS!categories!we!considered!the!likely!costEbenefit!of!
conducting!the!surveillance!and!therefore!aimed!to!identify!procedures!where!the!
underlying!risk!of!SSI!was!either!reasonably!high!(e.g!bowel!surgery)!or!associated!with!
significant!morbidity!(e.g.!orthopaedic!surgery)!and!the!costs!of!surveillance!would!be!more!
likely!to!be!offset!by!its!impact!on!prevention!of!SSI.!!In!addition,!we!excluded!more!minor!
procedures!with!a!length!of!postEoperative!stay!of!less!than!three!days!since!it!can!take!
several!days!from!the!time!of!operation!for!symptoms!of!SSI!to!become!apparent!and!
methods!based!primarily!on!hospitalEbased!caseEfinding!would!therefore!not!detect!SSI!in!
patients!with!short!hospital!stays!(see!section!2.2.3).!!!
!
2.2.1.2! Bloodstream(infection:(Unlike!SSI,!any!patient!who!receives!healthcare!is!at!risk!of!
developing!a!healthcare!associated!bloodstream!infection!(BSI)!and!the!infection!may!also!
occur!outside!healthcare!settings,!arising!either!from!communityEacquired!infections!or!
healthcare!delivered!in!the!community!(Rojo!et(al!1999).!!Primary!BSI!are!infections!
associated!with!an!invasive!device!such!as!a!vascular!catheter,!and!are!always!considered!as!
healthcare!associated,!although!not!all!patients!with!such!devices!are!hospital!inpatients!
(Warren!et(al!2001).!!The!metrics!used!to!measure!risk!of!BSI!therefore!depend!on!the!
available!data,!purpose!of!the!measurement,!the!population!at!risk!and!whether!the!focus!
for!surveillance!is!primary,!secondary!or!all!BSI.!!The!denominator!used!to!measure!the!risk!
of!BSI!may!therefore!reflect!the!whole!population!(if!both!hospital!and!community!acquired!
infections!are!included)!or!only!the!population!in!hospital!during!the!period!under!study!(if!
focused!on!hospitalEacquired,!primary!BSI).!!Metrics!are!represented!as!follows:!!
$
Risk$(cumulative$incidence)$of$bacteraemia/BSI:$
!
No.(cases(bacteraemia/BSI((in(specified(time(period)(
((
No.(people(at(risk((in(population(from(which(cases(are(derived)(#
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Whilst!a!BSI!is!more!readily!identified!than!most!other!HCAI!because!it!is!primarily!a!
diagnosis!based!on!a!laboratory!result,!defining!BSI!that!are!associated!with!healthcare!and!
capturing!corresponding!denominator!data!is!much!more!problematic!because!healthcare!
may!not!be!delivered!in!a!hospital!setting.!!In!Chapter!5!(section!5.2),!my!publication!on!
trends!in!pathogens!causing!bacteraemia!presents!an!analysis!of!data!captured!by!the!
routine!laboratory!reporting!system!(LabBase)!(Wilson!et(al!2011;!Appendix!5.1).!!
!
Other!forms!of!BSI!surveillance!are!focused!on!bacteraemia!acquired!in!a!hospital!setting!
where!the!risk!of!acquiring!bacteraemia!is!dependant!on!the!number!of!days!spent!in!
hospital.!!In!surveillance!of!hospitalEacquired!BSI,!the!denominator!must!reflect!the!patient!
population!at!risk!and!account!for!length!of!hospital!stay.!!This!approach!was!used!by!the!
NNISS!hospitalEacquired!bacteraemia!surveillance!and!subsequently!by!the!MRSA!Electronic!
Surveillance!System!(MESS)!on!which!my!analyses!of!trends!in!sources!of!MRSA!bacteraemia!
presented!in!Chapter!5!(section!5.3)!are!based!(Wilson!et(al!2011;!Appendix!5.2).!!An!
example!of!this!type!of!metric!is!shown!below:!
!
Rate$(incidence$density)$of$hospitalLacquired$bacteraemia/BSI:$
!
!
!
!
Unlike!these!English!BSI!surveillance!systems!(LabBASE,!NINSS!and!MESS),!the!US!NNIS!
system!was!focused!only!on!the!surveillance!of!primary!BSI!in!intensive!care!units!and!did!
not!capture!population!level!data.!!In!this!situation,!a!more!appropriate!denominator!is!the!
number!of!days!of!exposure!to!the!devices!that!are!associated!with!primary!BSI!and!since!
most!are!associated!with!central!vascular!device,!the!total!number!of!days!with!one!or!more!
No.(new((bacteraemia/BSI(acquired(in(hospital((
(( ( X(1000(((
No.(patientNdays(in(population(
(sum(of(all(hospital(days(for(all(patients(during(the(surveillance(period)!#
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of!these!devices!for!the!period!under!surveillance!would!be!the!main!denominator!(Emori!et(
al!1991).!
!
2.2.2 Definitions$of$infection$
2.2.2.1( Surgical(site( infection:(The!ability!to!consistently! identify!SSI! in!operative!wounds! is!
recognised! as! an! essential! requirement! of! establishing! a! benchmarking! system,! however!
since! skin! is! normally! colonised! by! a! range! of!microEorganisms! that! could! cause! infection,!
wound!cultures!do!not!provide!a!reliable!indicator!of!infection.!!A!number!of!approaches!to!
defining!SSI!based!on!evidence!of!clinical!signs!and!symptoms!of!infection!have!been!used!for!
surveillance,!ranging!from!simply!the!presence!of!pus!in!the!wound!(Cruise!and!Foord!1973)!
which!may!miss! a! high! proportion! of! infections,! to!more! complex! scoring! criteria! such! as!
ASEPSIS! which,! whilst! detecting!more! cases,! are! difficult! to! apply! in! routine! data! capture!
systems!(Wilson!et(al,!1986).!!However,!most!SSI!surveillance!systems!use!definitions!based!
on! those! described! by! CDC! which! distinguish! infections! affecting! different! levels! of! the!
operative! site,! superficial! incisional,! deep! incisional! and! organ/space! (Horan! et( al! 1992;!
Horan!et(al!2008).!!This!definition!requires!the!presence!of!signs!and!symptoms!that!align!to!
a!specific!set!of!criteria!and!occur!within!30!days!of!the!operation!(or!one!year!if!nonEhuman!
material!is!left!permanently!in!the!operative!site!(Horan!et(al!1992;!Horan!and!Emori!1997).!!
A! key! challenge! associated! with! case! definitions! is! ensuring! the! criteria! are! sufficiently!
objective!to!maximise!interErater!reliability.! !Objective!criteria!are!more!difficult!to!apply!to!
superficial!SSI!where!symptoms!can!be!nonEspecific!and!open!to!variation! in! interpretation!
by! clinicians! and!microbiological! cultures! from! the! wound!may! reflect! colonisation! rather!
than!infection.!!In!developing!the!NINNS!methodology!we!chose!address!this!subjectivity!by!
amending!the!CDC!definition!to!require!specific!evidence!of!at!least!two!clinical!signs!such!as!
inflammation! and! localised! pain,! rather! than! only! a! clinician’s! diagnosis! for! superficial!
incisional! SSI! (Health! Protection! Agency! (HPA)! 2004).! ! This! had! implications! for! making!
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comparisons! with! data! captured! by! other! SSI! surveillance! systems! and! this! subject! was!
explored!in!my!work!on!the!analysis!of!surveillance!data!collected!by!a!network!of!European!
hospitals! (Hospitals! in!Europe!Linked! in! Infection!Control! though!Surveillance)!and!which! is!
described!in!Chapter!4!of!this!thesis!(Wilson!et(al!2007;!Appendix!4.1).!
!
2.2.2.2! Case(definitions(for(bloodstream(infection:(When!HCAI!surveillance!systems!emerged!
in! the! USA! in! the! 1980s,! cases! based! on! microorganisms! recovered! from! blood! were!
described! as! bacteraemias! and! until! 1986,! the!NNIS! system!was! focused! on! hospitalEwide!
HCAI!surveillance!which!included!surveillance!for!all!cases!of!bacteremia!(Haley!et(al!1985b).!!
Subsequently,!the!methodology!was!changed!to!focus!on!specific!groups!of!patients!at!high!
risk!of!HCAI,!including!intensive!care!units!and!highErisk!nurseries.!!As!a!result,!more!precise!
definitions! for! HCAI! were! developed! that! focused! on! bacteraemia! associated! with! central!
vascular! devices! that! were! a! major! risk! of! HCAI! in! these! settings! and! termed! primary! or!
catheterErelated!bloodstream! infection! (CREBSI)! (Garner!et(al!1988;!Emori!et(al!1991).! !The!
NNIS!system!thus!excluded!BSI!from!which!another!source!of! infection!caused!by!the!same!
organisms! had! been! identified! and! focused! only! cases! occurring! in! patients!with! a! central!
vascular!catheter.! !Other!surveillance!systems! in!Europe!continued! to! include!all!BSI! in! the!
surveillance,!creating!more!specific!criteria!to!define!those!where!an! intravascular!catheter!
was! the! source! (Hospitals! in! Europe! Link! in! Infection! Control! though! Surveillance! (HELICS)!
2004b).!!
!
In!the!UK,!BSI!surveillance!had!been!established!as!part!of!the!PHLS!laboratory!surveillance!
system,!but!this!was!‘microorganism’!rather!than!infection!focused!and!therefore!referred!to!
as!‘bacteraemia!surveillance’.!!Whilst!laboratories!would!be!required!to!report!‘clinically!
significant’!isolates!from!blood,!this!was!not!based!on!defined!criteria!(HPA!2008b).!!Thus!
whilst!the!laboratory–based!surveillance!had!the!advantage!of!capturing!data!on!a!broad!
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range!of!pathogens!recovered!from!blood,!in!the!absence!of!precise!case!definitions!was!less!
useful!for!comparisons!between!individual!centres.!!These!issues!are!demonstrated!in!my!
publication!on!the!trends!in!pathogens!causing!BSI!described!in!Chapter!5,!section!5.2!!
(Wilson!et(al!2011;!Appendix!5.1).!!The!NINNS!system!in!England!in!part!addressed!this!issue!
by!establishing!a!surveillance!module!for!hospitalEacquired!bacteraemia!that!aimed!to!
monitor!trends!in!hospitalEacquired!infections!(Coello!et(al!2003).!!This!surveillance!was!
based!on!the!application!of!specific!criteria!to!define!both!that!the!infection!was!acquired!in!
hospital,!and!whether!it!was!specifically!associated!with!an!intravascular!device!(e.g.!same!
organisms!isolated!from!blood!and!IV!line!or!symptoms!resolve!once!line!is!removed).!!When!
this!was!replaced!by!MESS,!surveillance!data!was!collected!on!all!cases!of!bacteraemia!due!
to!MRSA,!regardless!of!whether!they!were!hospital!or!community!acquired!and!whether!
they!were!accompanied!by!clinical!signs!of!infection.!!This!surveillance!used!crude!criteria!for!
defining!whether!the!MRSA!bacteremia!was!hospital!acquired,!based!on!the!point!during!
admission!the!blood!was!taken!and!used!this!distinction!to!report!cases!of!hospital!and!
communityEacquired!infection.!!This!method!has!limitations!because!many!patients!
admitted!to!hospital!with!signs!of!infection!have!acquired!their!bacteremia!as!a!result!of!a!
previous!intervention!or!onEgoing!hospital!care!and!should!therefore!for!be!classified!as!
hospital!rather!than!community!acquired!cases.!!These!issues!are!illustrated!in!Wilson!et(al!
2011!(Appendix!5.2)!on!the!analysis!of!trends!in!sources!of!MRSA!bacteraemia!presented!in!
Chapter!5,!section!5.3.!!
$
2.2.3 Case(finding(methodology(for(Surgical(site(infection!
The!methodology!for!the!surveillance!of!SSI!was!developed!with!advice!from!a!
multidisciplinary!group!of!experts!in!surveillance,!infection!control!and!surgery.!!It!centred!on!
the!recruitment!of!patients!undergoing!an!operation!in!one!or!more!of!the!defined!
categories!of!surgery!and!active,!prospective!surveillance!during!the!postEoperative!inpatient!
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stay!for!SSI!that!met!the!case!definitions.!!Whilst!the!NNIS!system!in!the!USA!required!
participating!hospitals!to!collect!data!for!minimum!oneEmonth!periods,!we!made!the!
decision!to!extend!this!to!threeEmonth!surveillance!periods!for!the!NINSS!protocols!in!order!
that!rates!could!be!estimated!from!a!larger!dataset!at!each!participating!hospital.!!This!
reflected!a!pragmatic!balance!between!improving!precision!to!support!valid!comparison,!the!
need!to!enable!rapid!feedback!of!results!to!maximise!their!impact!and!the!resources!
available!to!NHS!hospitals!to!undertake!surveillance!on!a!continuous!basis!(Cooke!et(al!2000;!
Appendix!1.1).!!!
!
2.2.3.1! The!protocols!developed!by!many!national!surveillance!systems,!including!NNIS,!
focus!mostly!on!case!definitions!of!infection!and!not!the!methods!applied!to!detect!them!
(Coello!et(al!2001;!Gastmeier!et(al!2008).!!However,!the!efficacy!of!methods!to!detect!SSIs!
have!a!significant!impact!on!the!sensitivity!of!case!finding.!!Prospective!methods!will!find!
more!cases!of!infection!than!retrospective!methods!that!rely!on!access!to!accurate!
documentation!(Perl!1997).!!Similarly,!active!surveillance!where!trained,!designated!staff!are!
responsible!for!systematic!review!of!patients!to!identify!cases!of!infection!are!more!sensitive!
than!passive!methods!where!infections!are!reported!by!staff!who!do!not!have!designated!
responsibility!for!the!surveillance!programme!(Perl!1997).!However,!even!active!methods!of!
surveillance!have!been!demonstrated!to!have!different!sensitivities!of!case!finding!
depending!on!the!data!sources!queried!(Glenister!et(al!1993).!Since!the!primary!aim!of!NINSS!
was!to!support!valid!comparisons!of!rates,!assuring!sensitive!methods!of!case!finding!and!
minimising!the!risk!of!selection!and!measurement!bias!were!key!priorities.!!The!methods!
chosen!for!the!NINSS!SSI!surveillance!were!informed!by!the!work!of!Glenister!et(al!(1993)!
who!found!that!the!most!sensitive!method!of!detecting!HCAI!was!using!a!systematic!
combination!of!followEup!of!laboratory!results,!liaison!with!ward!staff!and!review!of!case!
notes.!!This!method!was!found!to!detect!76%!of!HCAI!compared!to!the!36%!identified!when!
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surveillance!was!based!on!the!telephone!followEup!of!laboratory!reports!(Glenister!et(al!
1993).!!The!implications!of!variation!in!case!finding!methodology!on!the!comparison!of!rates!
of!SSI!are!explored!in!my!publications!on!interEcountry!comparisons!(Wilson!et(al!2007;!
Appendix!4.1)!and!using!rates!of!SSI!as!a!performance!indicator!(Wilson!et(al!2008;!Appendix!
4.2)!in!Chapters!4!(sections!4.2!and!4.3).!
!
2.2.3.2 PostNdischarge(surveillance:(Infection!introduced!at!the!operative!site!during!a!
surgical!procedure!can!take!several!days!to!become!apparent!and!signs!of!infection!may!not!
develop!until!after!the!patient!has!been!discharged!from!hospital.!!Initially,!NINSS!
surveillance!methods!were!based!on!inpatient!surveillance!and!although!hospitals!were!able!
to!report!SSI!detected!after!discharge,!this!data!capture!was!voluntary,!not!based!on!any!
defined!methods!and!SSI!identified!post!discharge!were!not!included!in!the!main!analysis!of!
rates!of!SSI.!!This!approach!was!driven!by!the!requirement!for!the!surveillance!to!support!
valid!comparisons!between!hospitals,!and!whilst!specific!methods!could!be!proscribed!to!
support!consistent!case!finding!among!inpatients!this!was!acknowledged!to!be!much!more!
difficult,!and!resource!intensive,!once!the!patient!had!left!the!hospital!(Manian!et(al!1997,!
Petherick!et(al!2006).!!Benchmarking!was!therefore!based!only!on!the!proportion!of!SSI!that!
were!detected!during!the!inpatient!stay!(Cooke!et(al!2000;!Appendix!1.1).!!However,!we!
observed!that!developments!in!the!delivery!of!healthcare!in!the!2000’s!were!associated!with!
a!marked!decline!in!length!of!postEoperative!stay!in!hospital!for!some!categories!of!surgical!
procedure,!notably!elective!orthopaedic!surgery.!For!example,!in!prosthetic!joint!
replacement!the!length!of!stay!had!changed!from!nine!days!to!five!days!and!in!large!bowel!
surgery!from!12!to!eight!days!(Wilson!2013!a!and!b;!Appendix!2.2!and!2.3).!!Thus,!since!this!
surveillance!system!was!based!only!on!SSI!detected!during!the!inpatient!stay!it!would!miss!a!
large!proportion!of!cases!if!the!length!of!stay!in!hospital!declined.!Whilst!some!national!
surveillance!systems!included!SSI!detected!by!postEdischarge!surveillance!there!was!limited!
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evidence!for!the!reliability!of!the!methods!(Taylor!et(al!2003;!Petherick!et(al!2006;!McNeish!
et(al!2007).!!A!key!consideration!in!defining!methods!of!PDS!for!SSISS!was!the!resources!it!
required!(Mitt!et(al!2005).!!We!already!had!evidence!that!at!least!17%!of!hospitals!
participating!in!SISS!were!not!resourcing!active!inpatient!surveillance!for!SSI,!and!adding!a!
resourceEintensive!method!of!PDS!would!exacerbate!this!problem!(McDougall!et(al!2007;!
Appendix!2.4).##Therefore,!in!July!2008,!we!introduced!a!defined!methodology!for!postE
discharge!surveillance!that!included!both!voluntary!and!compulsory!elements!(see!Table!2.1).!!
Only!SSI!detected!on!readmission!to!hospital!were!included!with!the!inpatient!detected!SSI!
for!benchmarking!as!these!methods!were!considered!to!be!feasible!for!all!hospitals!to!
implement!and!least!likely!to!introduce!a!major!case!ascertainment!effect.!!Supplementary!
rates!based!on!all!SSI!detected!were!reported!separately!(HPA!2009).!!My!work!on!validating!
these!postEdischarge!surveillance!methods!and!exploring!their!efficacy!as!a!surveillance!
method!for!SSI!following!caesarean!section!delivery!was!published!in!Wilson!et(al!2013!
(Appendix!4.3)!and!presented!in!Chapter!4!(section!4.4).!!!
(
2.2.4 Case(finding(methods(for(blood(stream(infection!
Laboratory!based!surveillance!is!the!cornerstone!of!BSI!surveillance!since,!by!definition,!a!
positive!culture!of!blood!is!fundamental!to!the!characterisation!of!the!infection.!!The!
prospective!followEup!of!positive!blood!cultures!enables!data!to!be!collected!on!clinical!signs!
and!symptoms!and!sources!of!infection!and!to!more!specifically!define!the!BSI!as!catheter!
related.!!CaseEfinding!systems!that!only!include!cases!with!a!positive!blood!culture!miss!cases!
of!‘clinical!sepsis’,!where!the!patient!has!the!signs!and!symptoms!of!systemic!infection!but!in!
the!absence!of!positive!blood!cultures!(Horan!et(al!2008).!!Systems!such!as!the!MESS!and!
NINSS!captured!data!on!cases!of!both!primary!and!secondary!BSI.! !
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Table(2.1:(Methods(of(PDS(incorporated(into(SSISS(in(2008(
(
1.! Follow@up(of(patients(during(the(inpatient(stay((required)!
From! the! day! after! surgery! until! the! patient! is! discharged! from! hospital! designated! staff! trained! to! undertake! the!
surveillance!should!actively!and!systematically!monitor!each!patient!for!signs!of!infection!using!the!following!methods:!
a)!! Liaise!with!ward!staff!and!review!medical!and!nursing!records,!temperature!and!treatment!charts!at(least(three(
times(a(week(to!identify!signs!and!symptoms!that!may!indicate!an!SSI.!
b)! Regularly!review!microbiology!reports!to!find!any!positive!surgical!site!cultures!from!patients!in!the!study!
population!and!check!why!the!cultures!were!taken!and!if!there!are!clinical!signs!of!infection.!
These$infections$will$be$included$with$the$SSI$detected$during$the$admission$when$calculating$rates$of$SSI.(
$
2.!!!Detecting(SSI(in(patient(readmitted(to(hospital((required)!
Systems!must!be! in!place! to! identify!patients! included! in! the!surveillance! that!are!subsequently! readmitted!with!SSI.!!
These!must!meet!the!criteria!for!SSI!and!be!reported!as!‘SSI!detected!on!readmission’.!!These!are!likely!to!include!the!
more!severe!deep!and!organ/space!SSI.!!
These$infections$will$be$included$with$the$SSI$detected$during$the$admission$when$calculating$rates$of$SSI.$
$
3.!!!!SSI(detected(by(other(post(discharge(follow(up((optional)!
SSI!may!be!detected!and!confirmed!as!meeting!the!definition!of!SSI!by!the!following!methods:!
a)! Patients!should!be!encouraged!to!contact!a!key!person!at!the!hospital!if!they!have!concerns!about!their!wound!
and!arrangements!made!to!return!to!the!hospital!for!the!wound!to!be!reviewed!and!SSI!that!meet!the!definitions!
of!SSI!reported.!!Provision!of!a!‘drop!in’!post!operative!clinic!for!patients!with!problem!with!their!wounds!could!be!
considered!to!enhance!the!surveillance.!
b)! Staff!trained!in!applying!the!definitions!identify!SSI!in!patients!included!in!the!surveillance!who!return!to!an!
outpatient!clinic!appointment.!!These!SSI!are!more!likely!to!be!detected!if!active!surveillance!systems!are!
established,!for!example!designated!staff!are!responsible!for!actively!monitoring!patients!attending!outpatient!
departments!to!detect!SSI!and!collect!the!relevant!data.!
c)! CommunityEbased!healthcare!staff!trained!in!applying!the!definitions!report!SSI!identified!when!the!patients!
visits/is!visited!for!treatment.!!
These$surveillance$methods$will$provide$more$complete$data$on$SSI$that$occur$postLdischarge$and$can$be$confirmed$
as$meeting$the$definition$of$SSI.$$However,$since$consistent$followLup$and$reporting$using$these$methods$is$unlikely$
across$all$participating$hospitals,$the$SSI$identified$will$not$be$included$with$those$detected$in$
inpatients/readmissions$when$reporting$comparative$rates$of$SSI.$
!
4.!!!SSI(reported(by(Patient(Wound(Surveillance(Questionnaire((optional)!
To!obtain!more!complete!data!on!SSI!that!develop!postEdischarge,!patients!should!be!asked!to!report!problems!with!
the!healing!of!their!wound!30!days!after!the!operation!using!one!of!the!following!methods:!!
a)! On!discharge!patients!should!be!given!a!copy!of!the!Wound!Surveillance!Questionnaire!and!the!details!of!
designated!staff!to!contact!if!they!are!readmitted,!or!an!SSI!is!suspected.!The!30th!postEop!date!and!patient!details!
must!be!written!on!the!questionnaire!and!a!pre!paid!addressed!envelope!should!be!provided!to!encourage!return.!!
Patients!who!do!not!return!the!questionnaire!should!be!followedEup!by!letter!or!telephone.!If(the(responses(in(the(
questionnaire(are(indicative(of(an(SSI(the(patient(should(be(contacted(and(the(symptoms(confirmed.(!
b)! Designated!staff!telephone!patients!on!or!soon!after!their!30th!postEoperative!day!and!ask!them!the!set!of!
questions!on!the!Wound!Surveillance!Questionnaire.!!Patients!will!need!to!be!informed!on!discharge!that!they!will!
be!contacted!one!month!following!their!operation!to!find!out!if!their!wound!has!healed!satisfactorily.!
! If(the(patient(indicates(that(a(healthcare(professional(e.g.(GP,(practice/district(nurse,(have(examined(the(wound(
they(should(be(contacted(and(a(diagnosis(of(SSI(confirmed.(If(an(SSI(reported(by(the(patient(has(also(been(identified(
and(confirmed(by(another(method(only(the(confirmed(SSI(should(be(reported(to(avoid(counting(SSIs(more(than(
once.((!
Rates$based$on$patient$reported$SSI$will$be$analysed$separately$as$it$is$not$possible$to$determine$the$type$of$SSI$or$
confirm$that$they$meet$the$definition$of$SSI$
$
!
!
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2.2.4.1!The!NINSS!bacteraemia!surveillance!involved!a!relatively!sensitive!method!of!case!
finding!using!a!laboratory!blood!culture!result!as!a!trigger,!but!incorporating!active!
surveillance!methods!to!identify!infections!that!meet!the!case!definition!(Coello!et(al!2003;!
Glenister!et(al!1993).!!However,!the!passive!surveillance!methods!used!by!the!voluntary!PHLS!
laboratory!system!to!detect!cases!of!bacteraemia!illustrates!the!problem!of!incomplete!case!
ascertainment!that!such!systems!are!vulnerable!to.!!For!example,!the!introduction!of!
mandatory!surveillance!of!MRSA!bacteraemia,!which!employed!active!surveillance!methods,!
identified!40%!more!cases!that!the!corresponding!voluntary!system!(Pearson!2009).!!
Therefore,!in!passive!surveillance!systems,!changes!in!trends!of!cases!may!are!more!complex!
to!interpret!since!they!may!reflect!changes!in!case!ascertainment!rather!than!true!changes!in!
number!events.!!This!is!discussed!in!relation!to!the!trend!analyses!of!bacteraemia!that!forms!
part!of!this!thesis!and!are!presented!in!Wilson!et(al!2011!(Appendix!5.1)!in!Chapter!5;!
sections!5.2!and!5.3.!
!
2.2.5 Risk$factors$for$SSI$
The!risk!of!a!patient!developing!an!infection!of!the!tissues!involved!in!an!operative!procedure!
depends!on!a!combination!of!factors!but!in!particular!the!number!of!microEorganisms!
present!in!or!introduced!into!the!operative!site!during!the!procedure!and!the!efficacy!of!the!
host’s!immune!defences!in!eliminating!any!left!at!the!site!after!the!wound!is!closed!(National!
Collaborating!Centre!for!Women’s!and!Children’s!Health!(NCCWCH)!2008;!Mangram!et(al!
1999).!!Variation!in!these!factors!among!patients!undergoing!surgery!may!have!a!significant!
effect!on!the!risk!of!SSI.!!Methods!of!adjusting!rates!of!infection!for!intrinsic!variation!in!the!
population!at!risk!have!therefore!been!developed!to!account!for!this!variation!and!support!
valid!companions!between!centres!or!within!centres!over!time!(Gaynes!et(al!2001;!Emori!et(
al!1991).!!Pathogens!that!cause!SSI!may!be!derived!from!the!patient’s!own!microbial!flora!on!
the!skin!and!in!the!body!or!from!the!skin!or!mucous!membranes!of!operating!personnel,!or!
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from!the!operating!room!environment!(including!air),!and!the!instruments!and!tools!used!
during!the!procedure!(Barrie!et(al!1992,!Hoffman!et(al!2002,!Mangram!et(al!2009).!!
Occasionally,!microEorganisms!from!a!distant!infection!in!the!body!can!establish!a!SSI!by!
attaching!to!prosthesis!or!other!implant!left!in!the!operative!site!(David!and!Vrahas,!2000).!!
Procedures!that!involve!parts!of!the!body!with!a!dense!normal!flora!such!as!the!bowel!are!
associated!with!the!highest!risk!of!SSI!as!these!organisms!can!remain!in!exposed!tissues!
where!they!are!able!to!cause!infection.!!Other!tissues,!such!as!bone!are!sterile!and!therefore!
microorganisms!are!much!less!likely!to!contaminate!the!operative!site.!!A!classification!
system!to!distinguish!risk!of!SSI!associated!with!the!microbial!burden!encountered!in!
different!tissues,!together!with!pre!and!intraEoperative!events!(such!as!trauma!and!presence!
of!infection)!was!developed!by!the!National!Research!Council!(NRC!1964)!in!the!USA!in!order!
to!conduct!research!studies!on!the!use!of!ultraviolet!light!to!prevent!surgical!infection.!The!
wound!classification!system!became!the!standard!approach!to!adjusting!for!intrinsic!risk!of!
SSI!in!the!American!NNIS!system!and!other!in!the!early!studies!on!SSI!surveillance!(Cruse!and!
Foord!1973).!!However,!the!wound!classification!does!not!take!account!of!patient!related!
factors!that!might!decrease!the!efficacy!of!the!general!immune!response!(e.g.!age,!diabetes,!
immune!suppression,!malnutrition)!and!local!immune!response!(e.g.!damage!to!tissue,!fluid!
collection,!foreign!bodies)!(Mangram!et(al(1999;!NCCWCH!2008).!!(
(
2.2.5.1((The(NNIS(Risk(Index:((In!the!SENIC!study,!logistic!regression!techniques!were!used!to!
identify!significant!independent!risk!factors!for!SSI!and!a!combination!of!four!factors!likely!to!
reflect!intrinsic!risk!of!SSI!(wound!classification,!underlying!diagnosis,!duration!of!operation,!
abdominal!surgery)!were!found!to!predict!the!risk!of!SSI!twice!as!well!as!the!simple!wound!
classification!(Haley!et!al!1985b).!!Whilst!this!was!an!important!development,!the!collection!
of!complex!data!from!patient!records!was!resource!intensive!and!difficult!to!implement!for!a!
routine!surveillance!system.!!A!subsequent!development!of!this!analysis!refined!the!number!
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of!factors!included!in!this!risk!index,!combining!three!variables!that!were!routinely!collected!
into!a!risk!index!score.!!This!scoring!system!was!found!to!be!a!significantly!better!predictor!of!
SSI!risk!than!the!traditional!wound!classification!system!and!to!perform!well!across!a!broad!
range!of!operative!procedures!(Culver!et(al!1991).!The!score!ranges!from!0!to!3!and!is!
derived!from!the!number!of!risk!factors!present!among!the!following:!!
1) The!NRC!wound!classification!of!contaminated!or!dirty!denoting!microbial!contamination!
in!the!wound!associated!with!the!specific!site!of!surgery!(e.g.!bowel)!or!conditions!in!the!
surgical!site!(e.g.!preEexisting!infection).!!
2) The!preEoperative!American!Society!of!Anesthesiologists’!classification!of!physical!status!
is!a!system!used!to!assess!the!fitness!of!patients!prior!to!surgery.!!A!score!of!three!or!
more!denotes!patients!with!a!severe!systemic!disease!and!is!used!in!the!risk!index!as!an!
indicator!of!underlying!comorbidities!that!are!likely!to!increase!susceptibility!to!infection.!!
3) !An!operation!lasting!over!T!hours!(time!at!the!75th!percentile!of!duration!of!operation!
for!a!given!type!of!surgery!rounded!up!to!the!nearest!hour) and!is!intended!to!reflect!
complex!surgery!through!defining!unusually!long!procedures.!
!
This!Risk!Index!became!the!standard!approach!to!risk!adjustment!of!rates!for!intrinsic!risk!of!
SSI!and!was!adopted!by!the!majority!of!national!surveillance!systems.!!By!capturing!patient!
level!data!on!both!denominator!and!numerator!the!index!can!be!used!to!determine!rates!of!
SSI!for!specific!risk!groups,!and!the!effect!that!variation!in!distribution!of!risk!groups!has!on!
observed!differences!in!rates!between!centres.!!Whilst!the!risk!index!represents!a!relatively!
simple!approach!to!adjustment,!it!does!appear!to!discriminate!differences!in!risk!of!SSI!
(Figure!2.1)!and,!whilst!not!explaining!all!variation!in!risk,!it!is!a!better!indicator!of!risk!than!
wound!classification!(Culver!et(al!1991,!Freidman!et(al!2007).!!(
(
(
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Figure(2.1:(Example(of(rates(of(SSI(distributed(by(NNIS(Risk(Group(in(large(bowel(surgery.!
Source:!Surgical!Site!Infection!Surveillance!Service,!Health!Protection!Agency!
#
In!the!publications!on!rates!of!SSI!following!hip!prosthesis!and!the!duration!of!operation!as!a!
predictor!of!SSI!presented!in!Chapter!3!(section!3.3!and!3.4)!I!explore!the!influence!of!both!
the!components!of!the!NNIS!risk!index!and!some!of!these!other!risk!factors!(Ridgeway!et(al!
2005;!Appendix!3.2,!Leong!et(al!2005;!Appendix!3.3).!
$
2.2.6 Risk$factors$for$bloodstream$infection$
As!discussed!in!section!1.2.1!many!BSI!are!a!secondary!infection!related!to!a!focus!in!another!
tissue!or!organ,!the!risk!factors!that!contribute!to!their!occurrence!therefore!depend!on!the!
risk!factors!for!the!source!infection.!!Rojo!et(al!!used!a!multivariate!model!to!identify!
significant!independent!predictors!of!hospitalEacquired!BSI.!!These!were!found!to!include!
intravascular!catheterisation,!invasive!procedures,!malignancy,!indwelling!devices,!stay!in!
ICU!or!surgical!department!and!length!of!hospital!stay!(Rojo!et(al(1999).!!!!
!
!
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2.2.6.1! !In!the!case!of!MRSA,!the!epidemiology!of!BSI!in!the!UK!has!been!strongly!influenced!
by!the!spread!of!two!epidemic!clones!(EMRSA15!and!EMRSA16)!in!the!1990s!which!were!
carried!on!the!skin!of!affected!patients!and!able!to!access!devices!or!other!breaches!in!
normal!defence!mechanisms!to!cause!many!different!types!of!infection!including!primary!
and!secondary!BSI!(Johnson!et(al!2001;!2005).!!Prevalence!of!MRSA!carriage!and!other!
factors!such!as!underlying!illness!or!invasive!procedure!are!important!determinants!of!the!
risk!of!MRSA!BSI!(O’Grady!et(al!2011).!!My!paper!presented!in!chapter!5!(section!5.3)!on!
trends!in!sources!of!MRSA!bacteraemia!explores!these!factors!in!data!captured!by!the!MRSA!
electronic!surveillance!system!(Wilson!et(al!2011;!Appendix!5.2).!!
!
2.2.6.2!Primary!BSI!are!attributed!to!an!intravascular!device!which!provides!a!direct!route!of!
access!into!the!bloodstream.!!Any!microEorganism!can!enter!the!device!either!along!the!
external!surface!of!the!catheter!or!via!the!lumen!in!intravenous!fluids!or!contamination!of!
the!internal!surfaces!of!the!device!(O’Grady!et(al!2011).!!However,!some!microEorganisms,!
notably!the!common!skin!commensal!Staphylococcus(epidemidis,!are!able!to!form!biofilms!
on!the!surface!of!catheters!which!give!them!a!propensity!to!a!cause!BSI!(Raad!et(al!1998).!!
The!risk!of!BSI!varies!according!to!the!type!of!device,!with!the!greatest!risk!associated!with!
devices!placed!into!central!arteries!or!veins!(Raad!et(al!1998,!Rojo!et(al!1999).!!Since!these!
infections!are!dependant!on!the!presence!of!the!device,!each!day!that!it!is!in!place!increases!
the!risk!of!infection!(O’Grady!et(al!2011).!!The!primary!approach!to!risk!adjustment!in!the!
surveillance!of!healthcare!associated!BSI!is!therefore!accounting!for!the!duration!of!central!
intravenous!devices!(see!section!3.8.6).!!
!
2.3 Data(analysis(and(reporting(HCAI(surveillance(data(
The!timely!analysis!and!reporting!of!rates!to!those!able!to!take!action!in!response!to!the!
surveillance!data!is!an!essential!component!of!effective!surveillance!systems!(Gaynes!et(al!
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2001a).!!However,!there!are!significant!differences!in!approach!to!data!analysis!and!reporting!
of!data!from!SSI!and!BSI!data!capture!systems,!driven!both!by!the!differences!in!the!structure!
of!the!data!captured!that!limits!the!analyses!available,!but!also!by!the!primary!aim!of!the!
surveillance!systems.!(
!
2.3.1$ Analysis$and$reporting$of$SSI$data!!
Since!a!key!aim!of!the!SSI!surveillance!system!was!to!provide!data!that!could!be!used!to!
target!infection!prevention!activity!though!identifying!hospitals!with!outlying!rates!of!SSI,!
robust!methods!of!comparing!or!benchmarking!rates!of!SSI!with!other!participating!hospitals!
were!required.!!However,!this!presented!a!number!of!statistical!and!practical!problems.!At!
the!inception!of!the!surveillance!scheme,!the!cumulative!incidence!was!chosen!as!the!
measure!of!SSI!risk!because!it!was!widely!accepted!and!if!expressed!as!‘%!operations!with!
SSI’!would!be!readily!understood!by!nonEexperts.!!However,!difficulties!with!this!metric!arise!
because!symptoms!of!SSI!do!not!necessarily!develop!immediately!after!the!procedure!and!
the!case!definitions!allow!for!infections!linked!to!the!operation!to!occur!up!to!30!days!after!
the!procedure!(one!year!if!an!implant!remains!at!the!operative!site).!!Thus,!unless!patients!
are!actively!monitored!for!SSI!for!the!entire!period!at!which!they!are!at!risk!of!developing!SSI,!
the!number!of!cases!detected!will!depend!on!the!period!of!active!followEup!postEoperation.!!
When!SSISS!was!established,!the!methodology!was!focused!on!inEpatient!surveillance!with!
the!option!to!report!SSI!detected!postEdischarge!although!most!hospitals!did!not!establish!
active!systems!for!postEdischarge!followEup.!!Therefore,!for!comparison!of!rates!over!time!or!
between!hospitals!the!numerator!was!based!only!on!those!SSI!detected!in!inpatients!since!
postEdischarge!case!finding!was!recognised!to!be!less!reliable!and!not!conducted!by!all!
hospitals!(HPA!2004).!!It!was!acknowledged!that!the!inpatient!cumulative!incidence!would!
not!capture!the!total!risk!of!SSI!but!since!procedures!selected!for!inclusion!had!several!days!
of!postoperative!stay!the!inpatient!surveillance!would!detect!a!reasonable!proportion!of!SSI.!!
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However,!as!described!in!section!2.3.3.2,!once!the!length!of!postEoperative!days!began!to!
decline!in!the!2000s!we!began!to!explore!other!approaches!to!capturing!data!on!SSI!after!
discharge!and!adjusting!rates!for!length!of!postEoperative!stay.!!My!work!on!developing!
novel!approaches!to!adjusting!for!length!of!followEup!using!the!incidence!density!of!SSI!are!
presented!in!Chapter!4,!section!4.3!(Wilson!et(al!2008;!Appendix!4.2).!!In!the!subsequent!
development!of!the!surveillance!methods!to!include!both!voluntary!and!compulsory!
elements!of!PDS,!we!were!particularly!concerned!to!minimise!the!effect!of!case!
ascertainment!on!interEhospital!comparisons.!!In!the!study!on!the!efficacy!of!these!PDS!
methods!in!detecting!SSI!following!caesarean!section!I!explored!their!reliability!in!identifying!
cases!of!SSI!and!the!implications!of!rates!based!on!PDS!for!the!validity!of!benchmarking!
hospitals!(Wilson!et(al!2013;!Appendix!4.3).!!
!
2.3.1.1(Adjusting(SSI(rates(for(caseNmix:(Standardisation!is!used!as!a!relatively!simple!
approach!to!comparing!a!study!dataset!with!a!reference!or!standard!dataset!whilst!
accounting!for!differences!in!population!structure.!In!SSI!surveillance!data!indirect!
standardisation!is!the!preferred!method!since!some!risk!groups!have!few!events.!!It!
generates!a!standardised!infection!ratio!(SIR)!by!calculating!the!expected!number!of!SSI!in!
each!risk!group!using!the!infection!rates!of!the!corresponding!reference!groups,!and!dividing!
the!number!of!SSI!observed!in!the!surveillance!by!the!number!expected.!!A!SIR!that!is!greater!
than!one!indicates!a!higher!rate!of!SSI!than!the!reference!rate!and!if!less!than!one,!a!lower!
rate.!!This!approach!was!used!by!NNIS!in!combination!with!a!Fisher’s!exact!test!for!small!
samples!sizes!to!test!whether!the!SIR!for!an!individual!hospital!differs!significantly!from!one!
which!would!suggest!the!infection!rate!is!unusually!high!or!low!infection!rate!(Gaynes!et(al!
2001b).!!Other!surveillance!systems!have!recommended!more!sophisticated!methods!of!
adjustment!by!including!additional!risk!factors!in!the!SIR!using!a!multiple!regression!model!to!
improve!its!ability!to!discriminate!risk!of!SSI!(Rioux!et(al!2006;!Geubbels!et(al!2006b;!
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Friedman!et(al!2007).!!!In!the!English!national!surveillance!system,!we!considered!
standardisation!as!a!mechanism!for!identifying!hospitals!with!outlying!rates!of!SSI!but!faced!
the!practical!problem!of!incomplete!data!on!risk!factors.!!Many!hospitals!found!it!difficult!to!
capture!data!on!the!ASA!score!in!particular,!as!it!was!not!always!clearly!documented!by!the!
anaesthetist.!!The!ASA!score!was!an!important!risk!factor!as!it!was!a!proxy!of!underlying!
comorbidities!(Culver!et(al!1991).!!Thus!with!this!data!item!missing!on!approximately!a!third!
of!records!overall!and!with!wide!interEhospital!variation!in!the!proportion!of!records!with!a!
missing!ASA!score,!it!was!not!possible!to!generate!a!robust!SIR.!!Excluding!records!with!
missing!ASA!scores!would!have!increased!the!imprecision!of!the!estimated!rate,!especially!
where!a!high!proportion!of!records!for!a!hospital!had!missing!risk!factor!data.!!In!practice,!a!
separate!analysis!I!undertook!on!vascular!surgery!data!from!41!hospitals!suggested!that!
where!rates!were!adjusted!for!risk!factors,!the!crude!and!adjusted!rate!were!very!similar!in!
the!majority!of!cases!(Wilson!2002).!!This!same!finding!was!also!reported!by!Brant!et(al!in!an!
analysis!of!data!from!the!German!SSI!surveillance!system!(Brandt!et(al!2004;!Brummer!et(al!
2008).!!This!is!not!surprising!as!in!a!health!service!that!is!free!at!the!pointEofEaccess!such!as!
the!NHS,!the!operations!performed!and!patient!caseEmix!is!likely!to!be!broadly!similar!in!
most!hospitals!(Wilson!2002).!!Therefore!the!approach!we!took!in!SSISS!was!to!stratify!the!
rates!of!SSI!by!risk!index!group,!enabling!the!distribution!of!risk!factors!to!be!considered!as!a!
possible!factor!in!explaining!high!rates!of!SSI!but!without!calculating!an!SIR.!!
!
2.3.1.2( Identifying(outlying(rates(of(SSI:(Rather!than!a!simple!‘league!table’!of!performance!
by!rate!of!SSI,!we!used!box!and!whisker!plots!as!a!means!of!identifying!outlying!rates!of!SSI!
(Wilson!et(al!2008).!!These!placed!each!hospital!rate!of!SSI!in!a!distribution!of!all!rates!within!
a!specific!category!of!surgical!procedures!and!illustrated!the!rate!of!infection!at!the!10th,!25th,!
50th!and!75th!percentiles!using!the!box!and!whisker!(Figure!2.2).!!Whilst!this!approach!had!the!
advantage!of!being!relatively!simple!and!easily!understood,!it!was!based!on!crude,!
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unadjusted!rates!that!meant!that!high!rates!could!have!been!explained!by!case!mix.!!A!
second!problem!when!comparing!rates!of!SSI!between!hospitals!is!that!many!of!those!
contributing!data!performed!fewer!than!100!operations!in!a!given!category,!even!in!the!
required!threeEmonth!surveillance!period.!This!meant!that!the!precision!of!the!rate!
estimated!from!the!sample!of!procedures!would!vary!with!the!number!of!procedures!
included,!and!that!the!confidence!intervals!within!which!the!true!rate!could!lie!would!be!
wide!where!the!number!of!procedures!was!small.!!
(
Figure(2.2:(Example(of(a(box(and(whisker(plot(used(to(identify(hospitals(with(outlying(rates(
of(SSI(in(each(category(of(surgical(procedure.((Source:(Health(Protection(Agency,(2006(
!
In!order!to!avoid!identifying!hospitals!with!highly!imprecise!rates!of!SSI!as!outliers!we!only!
included!their!rate!if!based!on!more!than!50!operations!and!used!rates!above!the!90th!
#
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percentile!as!the!marker!for!an!unusually!high!rate!that!required!investigation.!!Hospitals!
that!fell!into!this!part!of!the!distribution!were!advised!of!their!high!rate!and!recommended!
to!investigate!possible!underlying!factors.!!The!subsequent!work!I!undertook!to!develop!a!
method!of!identifying!outliers!that!also!took!account!of!the!precision!of!the!estimate!is!
described!in!Chapter!4!of!this!thesis!(Wilson(et(al(2008;!Appendix!4.2).!!!!
!
2.3.2 Analysis$of$data$on$bloodstream$infections$
The!approach!to!calculating!and!comparing!rates!of!bloodstream!infection!is!dependant!of!
the!population!included!in!surveillance!and!the!criteria!used!to!define!cases!of!infection.!!In!
the!PHLS/HPA!laboratoryEbased!surveillance!of!bacteraemia!rates!are!commonly!reported!by!
100!000!population,!since!the!infections!reported!by!this!routine!surveillance!system!do!not!
discriminate!those!acquired!as!a!result!of!healthcare!and!cases!are!not!linked!to!specific!
hospitals!(Anon!2001).!!Other!surveillance!systems!that!distinguish!cases!of!BSI!acquired!in!
hospital!use!a!denominator!that!reflects!this!population,!for!example!the!number!of!patients!
admitted!or!the!total!number!of!‘patientEdays’!during!a!defined!time!period,!to!respectively!
calculate!a!cumulative!incidence!or!incidence!density!(Horan!et(al!1986;!Seutens!et(al!2007).!!
The!NINNS!hospitalEacquired!bacteraemia!surveillance!in!the!UK,!derived!the!denominator!
for!patients!at!risk!of!bacteraemia!from!data!supplied!by!each!hospital!on!admissions!and!
discharges!for!patients!during!the!relevant!surveillance!period!(Coello!et(al!2003).!!In!the!
subsequent!MESS!system,!a!less!resource!intensive!approach!was!taken!with!the!
denominator!estimated!for!a!hospital!population!by!using!routinely!collected!data!on!!
‘occupied!bedEdays’!(KH03).!!These!were!aggregated!to!provide!the!denominator!for!the!
relevant!surveillance!reporting!period,!although!delay!in!reporting!meant!that!for!practical!
purposes!the!denominator!was!estimated!from!historic!periods,!with!rates!expressed!as!the!
number!of!cases!by!10!000!bed!days.!!This!KH03!data!is!part!of!the!central!return!of!data!
that!all!NHS!hospitals!are!required!to!report!and!reflects!the!number!of!beds!that!have!been!
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occupied!overnight!by!a!patient!during!each!quarterly!period!(HPA!2008b).!This!measure!is!
more!accurate!than!the!number!of!beds!available!in!the!hospital!as!it!reflects!the!number!of!
days!that!beds!that!are!occupied!by!a!patient!and!hence!exposed!to!a!risk!of!BSI.!!The!metric!
used!in!the!MESS!system!to!calculate!the!rate!of!MRSA!bacteraemia!is!as!follows:!
!
(
(
(
2.3.2.1( Risk(adjustment(of(BSI(rates:(An!aggregate!denominator!such!as!KH03!cannot!be!
used!to!stratify!the!risk!of!infection!by!different!patient!groups!as!they!may!have!very!
different!intrinsic!risk!of!BSI.!!This!requires!more!detailed!data!on!the!number!of!patient!days!
in!a!specific!speciality!of!care!e.g.!medicine!or!surgery!(Figure!2.3).!This!figure!illustrates!that!
the!risk!of!BSI!is!greatest!in!intensive!care!units!and!many!national!surveillance!systems!have!
therefore!focussed!efforts!on!these!settings!(NNIS!2004;!Seutens!2007).!From!1990,!NNIS!
defined!two!intensive!care!settings!for!surveillance:!intensive!care!units!and!highErisk!
nurseries!(neonatal!intensive!care!unit)!(Emori!et(al!1991;!Emori!and!Gaynes!1993).!!In!both!
settings,!the!surveillance!of!BSIs!was!based!only!on!primary!BSIs!where!a!central!venous!
catheter!(CVC)!has!been!attributed!as!the!source!of!infection.!!
!
2.3.2.2! These!catheterErelated!BSI!(CREBSI)!represent!a!significant!burden!of!HCAI!and!
associated!morbidity!and!mortality!in!ICUs!and!considered!amenable!to!prevention!through!
improved!infection!control!practice!(Jarvis!1996;!Pronovost!et(al!2006;!Loveday!et(al!2014;!
O’Grady!et(al!2011).!!Since!only!patients!with!a!CVC!could!acquire!a!CREBSI!and!the!risk!of!
infection!increases!for!each!day!the!catheter!is!in!place,!this!should!be!reflected!in!the!
denominator!used!to!calculate!the!risk!of!infection!(Coello!et(al(2003,!Suetens!et(al!2007).!!
!
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Source:!Public!Health!Laboratory!Service!2003.!
!
By!capturing!data!on!the!total!number!of!days!with!the!device!for!all!patients!in!the!period!
under!surveillance,!deviceEdays!can!be!incorporated!into!the!denominator!and!used!to!adjust!
rates!for!the!length!of!exposure!to!a!CVC,!generally!presented!as!a!rate!of: 
(
!
!
!
However,!in!practice!capturing!data!on!deviceEdays!is!laborious!and!whilst!deviceEdays!could!
be!captured!for!intensive!care!units!in!the!NINSS!bacteraemia!surveillance,!currently!there!
are!no!national!surveillance!systems!in!England!that!report!rate!of!BSI!by!deviceEdays.!
(
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2.4 Development(and(evaluation(of(the(national(SSI(surveillance(systems((
The!methodology!and!data!capture!systems!for!12!categories!of!surgical!procedure!were!
tested!in!a!pilot!study!conducted!over!an!8Eweek!period!in!1997!in!35!hospitals.!!
Amendments!were!subsequently!made!to!facilitate!reporting!of!SSI!detected!after!discharge.!!
Although!these!SSI!were!not!included!in!the!calculation!of!comparative!rates!of!SSI!because!
postEdischarge!surveillance!was!considered!too!resource!intensive!to!mandate!as!part!of!the!
surveillance!methodology,!they!did!provide!hospitals!with!local!data!on!postEdischarge!
infections!and!ultimately!provided!the!mechanism!to!support!more!fundamental!changes!to!
the!reporting!system!in!2008!when!postEdischarge!surveillance!was!incorporated!into!the!
methodology!(see!Chapter!4,!section!4.4).!!A!survey!of!users!of!the!SSI!surveillance!system!
that!I!conducted!three!years!later!demonstrated!the!importance!of!comparative!rates!to!user!
of!the!service,!with!87%!of!the!113!hospitals!that!responded!to!the!survey!indicating!that!
standard!surveillance!methods!and!comparisons!with!national!data!as!key!reasons!for!their!
participation!(Wilson!et(al(2002;(Appendix!2.5).!!The!survey!also!provided!evidence!that!the!
surveillance!contributed!to!increasing!awareness!of!infection!control!issues!with!57%!of!
hospitals!reporting!taking!action!in!response!to!the!results!of!surveillance.!!In!addition,!it!also!
gave!an!indication!of!the!lack!of!skills!within!infection!control!teams!in!terms!of!interpreting!
and!using!surveillance!data,!with!the!majority!(87%)!of!respondents!indicating!that!they!
would!like!more!training.!!This!was!perhaps!a!reflection!of!the!historic!lack!of!emphasis!on!
surveillance!within!infection!control!programmes!in!the!UK!(Glenister!et(al!1993).!!
(
2.5 Conclusions(to(chapter(
The!methodologies!that!I!have!outlined!in!this!chapter!underpin!my!research!related!to!
surveillance!of!HCAI!and!further!evidenced!in!the!following!chapters.!!My!research!begins!
with!analyses!of!SSI!surveillance,!which!because!it!captured!a!full!dataset!on!both!the!
numerator!and!denominator,!can!be!used!to!compare!risk!factors!and!outcomes!in!those!
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patients!that!develop!SSI!and!those!that!do!not.!!In!Chapter!3,!I!present!three!publications!
that!focus!on!the!analysis!of!this!SSI!data;!the!first!examines!the!effect!of!SSI!on!length!of!
postEoperative!stay!and!mortality!(Coello!et(al!2005;!Appendix!3.1),!the!second!explores!the!
risk!factors!that!predicted!the!risk!of!SSI!in!hip!replacement!surgery!(Ridgeway!et(al!2005;!
Appendix!3.2)!and!the!third!evaluated!the!relationship!between!risk!of!SSI!and!duration!of!
operation!(Leong!et!al!2006;!Appendix!3.3).!!This!research!has!been!influential!in!both!
defining!the!importance!of!SSI!as!an!infection!and!in!developing!the!methods!of!capturing!
and!analysing!surveillance!data!to!ensure!that!rates!could!be!appropriately!riskEadjusted.!!
This!experience!led!to!my!subsequent!research,!presented!In!Chapter!4,!which!explored!the!
methodology!required!to!support!robust!comparison!of!rates!of!SSI!both!between!countries!
(Wilson!et(al!2007;!Appendix!4.1)!and!between!hospitals!in!England!(Wilson!et(al!2008;!
Appendix!4.2).!!The!introduction!of!standard!methods!of!postEdischarge!surveillance!to!the!
SSISS!methodology!in!2008,!led!me!to!evaluate!the!impact!of!postEdischarge!surveillance!on!
rates!of!SSI!and!their!implication!for!benchmarking!(Wilson!et(al!2013;!Appendix!4.3).!!Finally,!
I!applied!my!knowledge!of!both!surveillance!and!HCAI!to!the!analysis!and!interpretation!of!
data!on!bloodstream!infections.!!The!two!publications!in!Chapter!5!illustrate!how!I!identified!
emerging!trends!in!pathogens!causing!bloodstream!infection!at!a!population!level!and!
explored!potential!causal!factors!for!MRSA!infections!(Wilson!et(al!2011;!Appendix!5.1,!
Wilson!et(al!2011;!Appendix!5.2).!
!
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CHAPTER 3 
 
Investigation of the impact of surgical site infection and the influence of risk 
factors on rates 
 
3.1 Introduction 
As demonstrated in the overview of healthcare associated infection (HCAI) surveillance in Chapter 2, 
the approach adopted by the Nosocomial Infection National Surveillance System (NINSS) for the 
surveillance of surgical site infection (SSI) was based on capturing a core set of data for all patients 
who undergo a relevant operation and then following them prospectively to identify those that 
develop SSI.  These methods provide the opportunity to use cohort study designs to explore the 
relationship between risk factors (exposures) in the population of patients undergoing the operation 
and the occurrence of disease, in this case SSI.  Similarly, the large national datasets with 
demographic data captured on all patients makes it possible to undertake novel analyses of both the 
risk of SSI and the adverse consequences associated with it.  These analyses are important in order 
to target and support preventative strategies, but also to ensure that the methods used for 
surveillance provide comparable data and take account of risk factors that might explain variation 
between hospitals (Gaynes et al 2001b).   
 
This chapter presents three papers on different aspects of risks and risk factors associated with SSI 
that were published between 2005 and 2007.  Section 3.2 describes the investigation of the costs of 
healthcare and mortality associated with SSI (Coello et al 2005; Appendix 3.1).  This work built on an 
earlier Public Health Laboratory Service study, which had defined the overall costs of healthcare 
associated infection (Plowman et al 1999), and was the first time that such a detailed evaluation of 
the specific impact of SSI had been published.  Section 3.3 explored risk factors for SSI following hip 
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prosthesis surgery (Ridgeway et al 2005; Appendix 3.2).  This work was important to inform both 
prevention strategies and the risk adjustment methodology for data captured by surveillance.  
Section 3.4 continues with this theme of risk factor analysis by using a novel approach to explore the 
relationship between the duration of operation and the risk of SSI (Leong et al 2007; Appendix 3.3).   
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3.2 Published Work 1: The adverse impact of surgical site infections 
Coello, R., Charlett, A., Wilson, J., Ward, V., Pearson, A., Boriello, P. (2005) Adverse impact of 
surgical site infections in English hospitals. Journal Hospital Infection. 60: 93-103). (Appendix 
3.1) 
 
3.2.1 Background 
HCAI are considered to be associated with considerable financial costs to healthcare services in 
particular and society in general, and risks to the patient in terms of disability, morbidity and 
mortality (Perencevich et al 2007).  SENIC provided the initial data on the potential for prevention of 
HCAI (Haley et al 1985a) and a subsequent review by Harbarth et al (2003) suggested that up to 70% 
of HCAI could be preventable, although the potential for reduction was dependent on the type of 
infection and the baseline rate.  However, infection prevention activities also consume resources 
especially if they include broad-based surveillance programmes that require considerable effort to 
capture, analyse and report data (Reilly et al 2001, Jarvis 1996, Glenister et al 1993) or require long-
term education and monitoring systems (Halton et al 2010).  Valid estimates of the costs of HCAI are 
critical to understanding the cost-benefit of infection control activity and encouraging investment in 
effective infection prevention strategies (Perencevich et al 2007; Graves and McGowan 2008).  
Although mortality due to HCAI is not directly associated with hospital costs, placing a value on 
human life is also an important aspect of properly costing the adverse outcome and evaluating the 
benefit of prevention strategies, regardless of who incurs the cost or receives the benefit (Graves et 
al 2007).  If mortality is not considered then the full economic effect of an infection or intervention 
will be underestimated.  This paper describes the analysis of data captured for the Surgical Site 
Infection Surveillance System (SSISS) in England between 1997 and 2001 that aimed to measure the 
adverse effects of SSI in terms of both its effect on mortality and additional costs associated with 
treatment. 
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3.2.2. Conceptual and methodological development 
The main cost associated with an HCAI is additional stay in hospital (Graves et al 2010).  Although up 
to 85% of these costs are fixed because they reflect buildings, equipment, administrative systems 
and salaried staff that cannot be eliminated in the short–term, in economic terms the additional 
bed-days associated with HCAI reflect ‘opportunity costs’ because they could be used to treat more 
patients (Graves et al 2010; Perencevich et al 2007).  Thus, key to defining the costs of HCAI, and 
hence the cost-benefit of potential prevention strategies, is the number of additional bed days 
directly attributable to an HCAI and the economic value of those bed-days (Graves et al 2010). 
 
3.2.2.1 Approaches to measuring costs and morbidity: Measuring morbidity or costs associated 
with HCAI is associated has a number of methodological problems and must take account of other 
factors that influence hospital stay such as the underlying illness and other comorbidities.  There are 
two main approaches to estimating extra length of hospital stay and costs or mortality/morbidity 
due to HCAI.  Firstly, physician assessment – where a doctor reviews cases to distinguish resources 
used in the treatment of the primary diagnosis from those used to treat HCAI (Haley et al 1980c; 
Fukuda et al 2011).  Secondly, matched comparisons of cohorts or cases, where patients who 
acquire an HCAI are matched to patients with similar attributes but who do not develop an HCAI to 
determine differences in outcome or resource use.  The second approach is much simpler and less 
resource intensive, but suffers from several potential biases which are difficult to address.  In 
particular, patients who stay in hospital for longer tend to have underlying comorbidities that can 
explain both increased morbidity and prolonged stay but at the same time also increase the risk of 
HCAI.  Matching therefore needs to include these variables if confounding is to be avoided (Graves 
2007).  However, attempting to eliminate this bias by increasing the number of variables used to 
match the cases and controls is likely to result in more cases being eliminated and they no longer 
become representative of patients with HCAI.  A better approach is to control for such endogenous 
variable confounding in the analysis than in the study design using statistical regression analysis with 
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a cohort of patients to avoid selection bias completely and reduce the risk of bias from comorbidities 
(Graves et al 2007, Graves et al 2010).  In our analysis of costs of SSI we had access to data on a 
cohort of patients from hospitals contributing data to the SSI surveillance system, some of who 
developed SSI, including basic operation and patient risk factors for all procedures.  Our approach 
was therefore to measure costs associated with SSI by determining the difference in length of stay in 
hospital after the procedure, and control for the confounding effects of severity of illness on length 
of stay and SSI though by using a logistic regression analysis (see section 2.1.1).  Since the 
surveillance system did not directly capture data on costs we derived the mean costs of a hospital-
day from the study on the socio-economic burden of hospital-acquired infection (Plowman et al 
1999).  This study had captured data on 4000 patients admitted to selected specialties of a district 
general hospital, identified those that developed infection and recorded the daily resource use for 
both infected and uninfected patients.  Linear regression modeling was then used to estimate how 
much resource use could be explained by hospital acquired infections by controlling for age, sex, 
admission specialty, diagnosis, number of comorbidities and admission type (Plowman et al 2001).  
This data was contemporary and based on costs at an NHS hospital in England and therefore could 
be reasonably applied to our cost estimations for SSI.   
 
3.2.3 Summary of main methods and findings 
By 2004, the national SSI surveillance system had been in operation for 5 years and had accumulated 
a large dataset.  Data on more than 67 000 operations and 2832 SSI from nine categories of surgery 
submitted by 140 hospitals participating in the SSI surveillance were included the analysis of the 
impact of SSI.  We excluded categories where the number of procedures were small and hospitals 
with data on less than 11 procedures.  The first part of the analysis presented in this paper described 
the rate of SSI in each of the categories of surgery.  This was an important milestone since it 
represented the first time data on the risk of SSI associated with a range of surgery conducted in 
England had been published.  It demonstrated the wide variation in risk of SSI between categories as 
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would be expected due to differences in intrinsic risk associated with different types of procedure, 
largely influenced by variation in microbial contamination encountered at the operative site 
(National Collaborating Centre for Women’s and Children Health (NCCWCH) 2008; Mangram et al 
1999).  We also demonstrated a significant linear trend in incidence of SSI with increasing risk index 
group in all categories apart from knee prosthesis, again for the first time in an English surveillance 
dataset.  This endorsed the value of the risk index as a predictor of risk of SSI, an important step in 
the context of scepticism among surgeons as to the validly of such risk adjustment especially since 
one of the parameters – ASA score – was a subjective measurement and may have been prone to 
variation in how it was applied (Aronson et al 2003).   
 
3.2.3.1 Estimating the length of hospital stay: Key variables captured by the surveillance were the 
date and reason for the surveillance being discontinued (discharge, transfer or death).  For 
categories of surgery without implants (non-human material left permanently in the operative site) 
the surveillance could be undertaken for a maximum of 30 days, but this period could be extended 
to 120 days where the surgery involved an implant (Horan et al 1992; 1997).  The length of hospital 
stay from the date of operation to the date of discharge or death was used to determine 
attributable cost associated with SSI and estimates of mortality were based on patients who died 
during the in-patient follow-up period.  The analysis showed that the crude LOS was longer for 
patients with SSI in all categories (ranging from 9 to 51 days).  However, it was necessary to adjust 
these values for bias associated with missing follow-up data and the potential confounding effect of 
severity of illness on LOS.   
 
a) Missing follow-up data: Since surveillance was only required during the inpatient stay the majority 
of patients would be discharged before the end of the surveillance period.  However, if patients 
remained in hospital beyond 30 days then follow-up would be discontinued and therefore data on 
length of stay and outcome would be missing.  The proportion of records affected by this missing 
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data varied between categories, from 30.4% in limb amputation to 0.3% in abdominal hysterectomy, 
reflecting differences in the care requirements and demographics of patients undergoing these 
procedures.  In order to include these patients in the analysis our approach was to use a censored 
normal regression model, which adjusted for the bias that might occur due to this missing data 
(Schnedler et al 2005).  The length of stay (LOS) was estimated for all SSI and also for superficial and 
deep/organ-space infections.  The dependent variable included in the regression was the natural log 
of number of days of post-operative stay, with the SSI and type of SSI (superficial, deep or 
organ/space) as explanatory variables.  The model then estimated the mean LOS for patients with 
and without SSI.  We used the geometric mean rather than the arithmetic mean because this 
indicates the central tendency of the distribution and therefore it provides a more robust estimate 
of the mean where there is a wide range in values as was the case for LOS (Bland 2000 p.113).  
 
b) Adjusting length of stay for confounding variables: In order to adjust for the confounding between 
LOS and underlying comorbidities the following indicators of case-mix captured in the surveillance 
dataset were used as additional explanatory variables in the model.  These were: 
 Age 
 Sex 
 Pre-operative stay in hospital (which is indicative of more severe underlying illness) 
 Risk Index factors (ASA score, wound classification, duration of operation) 
 Elective/emergency surgery 
 Multiple procedures through the same incision (indicative of multiple underlying problems 
and complexity of surgery) 
 Implant present 
 Operations due to trauma.  
 
This adjustment reduced the LOS attributable to SSI from between three days after abdominal 
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hysterectomy to 21 days following limb amputation.  However, apart from two categories 
(abdominal hysterectomy and large bowel surgery) the adjusted LOS was still double that of patients 
with SSI (see Table 1). The primary analysis included all SSI types but since it could be expected that 
patients with superficial SSI would not require significant additional hospital treatment we also 
explored the effect of the more severe (deep and organ/space) infections on LOS.   This 
demonstrated that they had longer adjusted LOS than superficial SSI for all categories except limb 
amputation, although since the severe SSI accounted for only one third of all SSI, the confidence 
intervals were fairly wide.  For hip and knee prosthesis and abdominal hysterectomy the LOS 
associated with deep and organ/space SSI was between 2.4 and 2.6 times longer than patients who 
did not develop SSI. 
 
3.2.3.2 Estimating costs: We used the costs determined by Plowman et al to estimate the costs for 
this analysis (Plowman et al 2001).  This study provided estimates of the average cost to a hospital of 
an SSI and the average adjusted LOS attributable to SSI.  For the purposes of our analysis we divided 
the Plowman estimates of the number of extra days of LOS attributable to SSI by the mean hospital 
costs to generate a value for a bed-day of £224.50.  We then revised this figure for inflation during 
the intervening years based on the Annual Health and Social Care Inflation values, to £290.60 per 
extra bed-day spent in hospital due to SSI.  This estimated daily cost was then applied to the 
additional days LOS for SSI for each category of surgery and type of SSI generated in the regression 
model described in 3.2.3.1.  We found that for all SSI these costs ranged from £959 for abdominal 
hysterectomy to £6103 for limb amputation; for deep and organ/space alone the costs ranged from 
£1947 for abdominal hysterectomy to £6422 for coronary artery bypass graft (Table 3.1).   
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Table 3.1: Post-operative mean* length of stay (LOS) for patients with and without surgical site infection 
(SSI), and adjusted+ extra LOS and cost♯  of hospitalisation for patient with SSI by surgical procedure. 
 
 
3.2.3.3 Estimating mortality: The estimated risk of death was based on whether the patient was 
alive when follow-up was discontinued.  A multivariable logistic regression analysis was then used to 
estimate the odds ratio of death for patients with or without SSI, adjusted for the same explanatory 
variables used in the LOS analysis to control for confounding between comorbidities and SSI that 
might affect mortality.  A logistic regression model is appropriate for use with dichotomous outcome 
variable (mortality) with SSI and the other risk factors as predictor variables.  The magnitude of the 
effect of SSI as a predictor of death (adjusted for the other factors) was expressed as an odds ratio 
with associated confidence intervals.  This approach would only provide a minimum estimate of 
mortality as the surveillance did not capture data on mortality after discharge or the end of follow-
up.  For all types of SSI, this analysis found that the crude mortality was higher for patients with SSI 
in all categories but after controlling for the other factors that may have influenced mortality, there 
was only a statistically significant association between SSI and mortality in hip prosthesis with an 
odds ratio of 1.8 (95%CI 1.3-2.7).  However, for the deep and organ/space SSI, the association 
between mortality and SSI was statistically significant in three categories, with the odds of death 
varying from 6.8 (95%CI 3.0-15.4) in vascular surgery to 1.8 in large bowel surgery (95%CI 1.1-3.2) 
and 2.5 in hip prosthesis (95%CI 1.3-4.5).  In some categories the small number of these more severe 
SSI meant that although the OR was high the confidence intervals were wide and therefore the 
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estimates of increased odds of death associated with the SSIs may reflect chance variation rather 
than a true effect.   
 
3.2.4 Conclusions 
The variables used for risk adjustment in this analysis were captured routinely as part of the 
surveillance dataset.  This magnitude of data would be difficult and expensive to collect as part of a 
research study hence it provided an important opportunity to explore the impact of SSI across a 
range of types of surgery that would not be possible in a single centre study.  However, whilst this 
dataset had the advantage of including a sufficiently large number of records to support measuring 
the independent effect of predictors, unlike research-based datasets it did not include 
comprehensive data on potential risk factors.  Thus, whilst we were able to adjust estimates of 
effect of SSI on length of stay and mortality using key variables that reflect underlying illness (ASA 
score, preoperative LOS, gender), susceptibility to SSI (risk index factors, age, operation data) and 
risk of mortality (ASA score, age, gender), this adjustment may not have included other important 
confounders.  In particular the ASA score, whilst an apparently good predictor of risk of SSI, provides 
a relatively crude measure on a 5-point scale of underlying illness and has been associated with poor 
inter-rater reliability (Mak et al 2002; Aronson et al 2003;).  If ASA score only partly measured the 
severity of underlying illness and its effect on LOS and mortality, then the adjustment could inflate 
the estimates of effect.  
 
3.2.4.1 A particular problem with the SSI surveillance data captured for the English surveillance 
system was the lack of data on SSI that occurred after discharge from hospital.   Thus whilst we were 
able to include variables captured in the dataset in the regression model to adjust for confounding 
between LOS, mortality and SSI we were not able to include the effect of SSI that occurred after 
discharge.  Indeed our estimates may have been biased by the increased detection of SSI in those 
patients with extended LOS.  Since follow-up was not continued after discharge we were also not 
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able to consider the costs and mortality associated with subsequent admissions, treatments or 
operations or the costs of treatment in primary care or of death after discharge (Plowman et al 
2001). However, one advantage of conducting this study on data captured in the late 1990s to early 
2000s was that the length of post-operative stay in England at this time was relatively long thus 
minimizing, although probably not eliminating, this bias (Wilson 2013).  Other studies based on a 
matched cases design, have measured the longer-term costs related to readmission and long-term 
treatment and suggest that inpatient costs may significantly underestimate true costs (Whitehouse 
et al 2002; Kirkland et al 1999). Whitehouse et al (2002) estimated that an SSI after orthopaedic 
surgery increased the costs by four times as a result of repeat hospitalisation and operations.  
Kirkland et al (1999) found that an SSI following general and orthopaedic surgery increased the 
length of hospital stay by 6.5 days, had a significant impact on the risk of death, ICU admission and 
readmission and their associated costs. Thus our analysis probably represented a significant 
underestimate of the costs and mortality associated with SSI.  
 
3.2.4.3 My contribution to this research 
This paper represented the first major analysis of data captured by the national SSI surveillance 
system in which I played a major part in the design of the underpinning dataset and data capture 
systems, and in validating and quality assuring data.  I used this expert knowledge to inform the 
development of the methods for this analysis and subsequently for the interpretation of the results, 
particularly in the context of limitations of the data and comparison of rates with other surveillance 
systems.  
 
 3.2.5 Contribution of this study to contemporary knowledge 
This study represented the first analysis and publication of data on the incidence of SSI nine 
categories of surgery in the UK based on a large set of procedures from 140 hospitals.  It provided 
indispensable data on the impact of SSI for hospitals to use in both explaining the importance of 
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measures to prevent SSI and in justifying their costs and the resources required to conduct 
surveillance.  It has subsequently been cited by more than 200 other authors and the risk adjusted 
estimates of adverse effects of SSI have been used by other studies to calculate the costs of SSI or 
estimate the efficacy of prevention measures (Brandt et al 2006; NCCWCH 2008; Pinkney et al 2011; 
Boltz et al 2011; Myles et al 2011; Andersson et al 2012).  The estimates were also used in the 
National Institute for Health and Care Excellence (NICE) guideline on the prevention of SSI as the 
data informing all the economic analyses of cost effectiveness (NCCWCH 2008).  
 
3.2.5.1 The SSI surveillance system that we established in England and on which these analyses 
were based, was one of the largest outside the USA since the National Nosocomial Infection 
Surveillance (NNIS) system in the USA was limited to around 300 hospitals at this time.  Although our 
surveillance system was based on that used by NNIS, the differences in case definitions and the 
defined case-finding methodology may have contributed to the higher rates of SSI that we found in 
the English dataset compared to the NNIS data (NNIS 2002).  We found the English rates to be 
similar to those reported by the Dutch national surveillance system.  However, a subsequent analysis 
that I undertook a few years later (see section 4.2) illustrated the problems of making inter-country 
comparisons because of the impact of differences in protocol and healthcare delivery systems, in 
particular the interpretation of case definition and intensity of post-discharge surveillance (Geubbels 
et al 2000; Wilson et al 2007, Appendix 4.1).  The evaluation of the risk index was also important in 
terms of confirming its ability, previously only validated with US data, to predict the risk of SSI across 
most surgical categories in the English data and provide a statically significant measure of increasing 
trend.  This supported the continued use of the risk index as the method of stratification for risk of 
SSI in the NINNS surveillance system.   
 
3.2.5.2 The analysis of LOS and associated costs that we published in this study was ground-
breaking because at that time the few studies that had investigated the costs and mortality 
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associated with SSI were small scale and used a matched design with the attendant biases described 
previously (section 3.2.2.1) (Boyce et al 1990; Coello et al 1993; Hollenbeak et al 2002; Kirkland et al 
1999; 2000; Reilly et al 2001).   Two studies, conducted in the USA by Hollenbeak and colleagues on 
cardiac and liver transplant surgery, applied linear regression methods to determine attributable 
costs of SSI, although these were also small scale and focused on hospital resource utilisation 
(Hollenbeak et al 2000; 2001).  An analysis of mortality data captured by the French national SSI 
surveillance system (INCISCO) did not specifically explore the association between SSI and death in 
different types of surgery, but found a case fatality rate associated with SSI of 4.5% and estimated 
that 38% of the cases were directly attributable to the SSI (Astagneau et al 2001).  Plowman et al 
(2001) was a landmark study because it captured data in the entire hospital, prospectively and used 
logistic regression analysis to adjust for confounding between comorbidities and outcome.  Whilst 
Plowman et al identified that overall an SSI nearly doubled the length of hospital stay and was 
associated with a cost of £1594, the numbers of these HCAI included in the analysis was too small 
(38) to derive procedure-based estimates (Plowman et al 2001).  Thus the estimates we made in this 
analysis identified for the first time the effect of SSI on length of hospital stay and mortality using a 
methodology that adjusted for confounding factors. In addition, the large national dataset based on 
four years of data from 140 hospitals enabled us to calculate the adjusted risk associated with SSI for 
nine categories. The accuracy of the estimates has been supported by a recent review which 
confirmed our findings that an SSI doubles the length of post-operative stay (Broax et al 2009). 
 
3.2.5.3 The costs of HCAI were a topical issue at this time, and featured in the second National Audit 
Office report on progress in relation to the prevention of HCAI that was published in July 2004 
(National Audit Office (NAO) 2004).  Whilst participation in the NINIS SSI surveillance had increased 
steadily in the four years since its inception, it was recognised to be resource intensive as, unlike 
other types of surveillance, it required active case finding though ward visits and assessment of 
clinical symptoms rather than review of laboratory data (Wilson et al 2002; Appendix 2.5).  Thus this 
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study provided clear evidence based on a robust methodology of the costs and adverse effects of SSI 
that could be used by hospitals and other healthcare providers to evaluate and justify the cost 
benefits of strategies to reduce the risk of SSI.  
 
3.2.6 Subsequent research contributions to the field 
Since the publication of Coello et al 2005 there have been further studies reporting adverse effects 
associated with SSI.  Studies on mortality have tended to focus on the effect of HCAI as a whole 
rather than SSI specifically (Fabbro-Peray et al 2007, Roberts et al 2010).  One study by Pollard et al 
(2006) in a matched case control study identified that patients who acquired a deep SSI after 
proximal femoral fracture repair had significantly longer LOS and were 4.5 times less likely to survive 
to discharge (p=0.002) and were three times less likely to return their original place of residence 
(p=0.05).  This emphasised that our analysis underestimated the effect of SSI on both LOS and 
mortality since we were unable to measure their effect after discharge from hospital.   
 
3.2.6.1 Unlike our analysis, most studies which have evaluated the costs of SSI have employed a 
matched case control design.  Monge Jodra et al (2006) reported that the median excess length of 
post-operative stay associated with SSI following hip replacement was 32 days (double that of 
matched patients without SSI; p<0.001).  Although they did not attribute costs to this additional 
hospital stay, the excess attributable to SSI was the same magnitude as we had identified.  Weber et 
al used a nested, matched, case control design on data captured at a European University hospital to 
determine the additional costs attributable to 168 cases of SSI in general vascular and trauma 
surgery (Weber et al 2008).  Again, this study confirmed the findings in our study that SSI more than 
doubled the length of post-operative hospital stay (29 vs 12 days; p<0.001).  Weber et al conducted 
a more sophisticated cost analysis than in our study by using data derived from the hospital internal 
cost and activity accounting database.  This enabled them to include costs associated with all 
treatments, unit time of attending personnel and hospital overheads unlike the approach of applying 
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estimated costs that our study had employed.  Their estimates suggested that SSIs increased costs 
by 61% (121% for organ/space SSI) although did not account for any additional costs incurred after 
discharge.  This approach of measuring costs as a percentage increase has the advantage of 
facilitating comparisons between countries and institutions, regardless of variation in currency or 
base costs (Weber et al 2008).  Another approach described by de Lissovoy et al used discharge 
diagnosis codes to determine increased length of hospital stay attributed to SSI, adjusted this using a 
‘propensity to develop SSI score’ and estimated that SSI increased the mean length of stay by 9.7 
days (de Lissovoy et al 2009). The increase in mean cost of treatment associated with SSI of $20,842 
was higher than in Coello et al, but this may reflect the approach to billing of costs in the US 
healthcare system. 
 
3.2.6.2 As discussed previously (section 2.2.3.2), length of stay in hospital has declined during the 
last decade and this is likely to transfer some of the costs of SSI to primary care settings (Plowman et 
al 2001).  Only a few studies have explored costs incurred post-discharge (Graves et al 2008, Tanner 
et al 2009). Tanner et al reported a cost of £10 523 associated with the treatment of SSI after 
colorectal surgery, 15% of which were met by primary care (Tanner et al 2009).  Graves et al (2008) 
used a model to estimate the distribution of economic costs between in-hospital and post discharge. 
They suggested that 67% of costs occurred in the hospital phase if ‘losses to production’ after the 
patient had been discharged were excluded from the total costs but 31% if these were included.  
These ‘losses to production’ reflect the amount of time that patients would be unable to work (or 
contribute to society in other ways) because of impairment of their health due to the infection 
(Plowman et al 2001).  Others have studied the impact of advances in medical technology and have 
evaluated the effect of minimally invasive techniques.  Whilst the minimally invasive approach was 
not found to significantly reduce the risk of SSI in lumbar fusion it was associated with significant 
cost reductions ($756 vs $1140; p = 0.03) (McGirt et al 2011).  In colorectal surgery, a laprascopic 
approach was found to significantly reduce the rate of SSI (9% minimally invasive vs 16% open 
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surgery; p = 0.001) after accounting for the greater age and ASA score of patients undergoing open 
surgery, but this study did not evaluate costs (Kiran et al 2010). Dobson et al (2011) identified 
reduced costs associated with laprascopic colon surgery due to fewer dressing changes, reduction in 
use of wound VAC systems and contact with healthcare professionals.  This is an important area of 
development given the widespread emergence of this technology across many types of surgery and 
the associated reductions in the costs associated with surgery and days spent in hospital.  However, 
at the time of our analysis, minimally invasive surgery was confined to a few procedures in English 
hospitals and average length of stays for elective surgery were at least seven days (Health Protection 
Agency (HPA) 2006).  
 
3.2.6.3  Olsen et al (2010) studied the attributable costs of incisional SSI and endometritis following 
caesarean section delivery in 1605 women using multivariate generalized least squares regression 
models and using two sources of data to estimate costs, either administrative or medical record 
data.  This approach provided a more detailed approach to defining costs than was available for our 
study.  The estimated attributable hospitals costs ranged from $2852 to $3956 depending on the 
infection type (incisional infection or endometritis) and were similar for both the data sources used 
for estimation, with the majority of excess costs associated with length of stay and pharmacy costs.  
However, Graves et al (2007) have also argued that estimated costs that include fixed hospital 
overheads are not useful for influencing the debate on the cost-benefit of investing in infection 
prevention as fixed expenditure will not be affected by a reduction in rates of HCAI.  Economic 
analyses should therefore be based on length of stay and the variable costs associated with 
treatment of the infection.  Since our costs were derived from Plowman et al (1999) and applied to 
multicentre surveillance data we were not able to make this adjustment.   
 
3.2.6.4 Another aspect of costs that we were unable to address was the financial benefit to the 
hospital of preventing SSI as a result of increased ‘opportunity costs’ associated with bed-days not 
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occupied by patients with SSI.  Jenks et al (2014) accounted for this by using the hospital patient 
level costing system to estimate the attributable postoperative length of stay, cost and impact on 
hospital profitability of SSI in patients undergoing major surgical procedures.  Patients who 
developed SSI had a three to four fold increase in length of stay and were three times more likely to 
be readmitted to hospitals.  However, although SSI were responsible for the loss of 4694 bed days 
and an aggregate additional cost of almost £2.5 million over a two year period, the predicted 
financial benefit of eliminating all SSI was only £700 000, and for some categories there was a 
financial disadvantage.  This effect was explained the hospital continuing to receive income for 
hospital bed days due to SSI thereby obscuring the actual opportunity cost of the infection, plus that 
it anyway made a loss on most categories of surgery.   The findings of Jenks et al illustrate the 
challenge of justifying expenditure on infection prevention, particularly surveillance programmes 
which, although demonstrable effective, are expensive to establish and maintain and current 
charging systems in the NHS do not truly reflect the cost of treating patients with SSI.   
 
3.2.6.5 In the next section, I present a study which explored significant independent risk factors for 
SSI in one important category of surgery, hip prosthesis, in which SSI are relatively uncommon but, 
as we demonstrated in Coello et al 2005, have a major impact on both LOS and mortality.  
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3.3 Published Work 2: Surgical site infection following hip prosthesis 
Ridgeway, S., Wilson, J., Charlett, A., Kafatos, G., Pearson, A., Coello, R. (2005) Infection of the 
surgical site after arthroplasty of the hip.  Journal of Bone & Joint Surgery. 87(6): 844-50. 
(Appendix 3.2) 
 
3.3.1 Background 
When the Nosocomial Infection National Surveillance System (NINSS) was established in England in 
1997, it offered hospitals the opportunity to conduct surveillance in one or more of twelve categories 
of surgical procedure.  As discussed in Chapter 2 (section 2.2.1.1) these categories comprised groups 
of clinically similar procedure where the intrinsic risk of infection could be expected to be similar.  In 
the first three years of the NINSS surveillance system, data was collected on more than 48 000 
operations by 113 hospitals.  By far the most common procedure that hospitals included in their 
surveillance was hip prosthesis, which accounted for 34% of the surveillance data (Public Health 
Laboratory Service (PHLS) 2000).  These procedures involve the replacement of the ball and socket 
joint comprising the head of the femur and pelvis and are most commonly performed as treatment 
for severe pain and disability caused by osteoarthritis. Whilst the incidence of deep infections 
following hip replacement is expected to be low (Royal College of Surgeons (RCS) 2000) the impact of 
such infections is recognised to be considerable, resulting in prolonged treatment with antimicrobial 
agents, re-operation to replace the joint and in some cases permanent disability or death (RCS 2000). 
Whilst multicentre research on the risk of SSI related to hip prosthesis surgery had been conducted in 
the UK 1980s to establish the effect of ultraclean air systems and antibiotic prophylaxis (Lidwell et al 
1984; 1987), subsequent studies were largely confined to single centres and therefore limited 
numbers of procedures collected over prolonged periods (Taylor et al 1994; Berbari et al 1998).  
Since the risk of infection in joint surgery is relatively low, such studies were vulnerable to 
methodological problems associated with small datasets (Berbari et al 1998).  By the 2000s more 
than 40 000 primary hip replacements were being performed annually in the UK (National Audit 
Chapter 3: Investigation of the impact of SSI and the influence of risk factors on rates 
 63 
Office (NAO) 2003), with a further 40 000 or more hip prosthesis operations conducted to treat 
fractures to the neck of femur, the majority of which occur in women over 75 years of age in 
association with osteoporosis (Balasegaram et al 2001).  Since disease of the hip is age-related, the 
demand for hip replacements was growing in line with increasing life-expectancy (RCS 2000).   Two 
reports by the National Audit Office in 2000 and 2003 highlighted the need for more efficient and 
effective provision of hip replacement services to meet increasing demand and ensure optimal 
management.  They also identified a widespread lack of complete and accurate data on the risk of 
infection associated with the procedure, with only about half of orthopaedic consultants collecting 
outcome data (NAO 2000). This context was an important driver for hospitals to participate in the hip 
prosthesis category in the English SSI surveillance system and by 2001 data on over 20,000 
operations had been included in the surveillance.  Since data submitted to NINSS was captured by 
participating hospitals using a standard methodology comprising active, prospective surveillance for 
cases of SSI meeting pre-defined case definitions, we could combine the data to measure the rate of 
SSI with greater precision than could be obtained from a single centre.  My next publication reflects a 
collaboration between myself and an orthopaedic surgeon based on an analysis of data on hip 
prosthesis submitted to NINSS which defined the incidence of SSI following different types of hip 
prosthesis procedure and explored key risk factors associated with these infections.   
 
3.3.2 Conceptual and methodological development 
Most surveillance systems have historically captured data on risk factors for SSI using the NNIS Risk 
Index (Culver et al 1991).  This had been modified from the approach taken by Haley et al in the 
SENIC study who used stepwise logistic regression to develop a simple model that could be used to 
predict the probability of developing an SSI from a range of pre or intra-operative risk factors (Haley 
et al 1985b).  The intention of these risk indices was to provide a practical approach to risk 
adjustment for SSI surveillance.  Simplicity was a key consideration because of the resources required 
to collect data and the difficulty of enabling complex statistical modelling as part of a routine 
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surveillance system.  The adoption of the simple risk index by national surveillance systems such as 
SSISS enabled basic risk factor data to be captured on all operations included in the surveillance and 
analysed to adjust rates for these factors (Gaynes et al 2000; 2001b).  
 
3.3.2.1 NINSS had adopted the NNIS Risk Index although the dataset also included some other 
potential risk factors for SSI.  However, crude analysis of hip prosthesis in the NINSS dataset also 
suggested important differences in the risk of SSI associated with total hip replacements (THR) and 
partial replacements (hip hemiarthroplasty; HH).  The latter are generally undertaken to treat 
fractured neck of femur and most commonly performed in elderly patients.  The crude rate of SSI 
following the HH was twice that of THR and this difference could not be explained by the NNIS Risk 
Index and the risk of SSI was higher in procedures where a previous hip replacement procedure was 
being revised (Mahomed et al 2003).  This analysis therefore set out to explore the specific risk 
factors for SSI in patients undergoing hip prosthesis operations in the NINSS dataset with two main 
aims: 
1. To provide precise estimates of the risk of SSI in different types of hip prosthesis procedures 
(THR; HH) 
2. To determine significant risk factors for SSI and determine if these explained the difference in 
risk of SSI between THR and HH 
 
3.3.2.2 Measuring the risk of SSI: When the surveillance dataset was initially designed in 1996 it 
included four-digit Office of Population Censuses and Surveys (OPCS) Surgical Operation Codes.  
These codes distinguished total and partial hip replacement procedures, with the fourth digit within 
the main procedure classification indicating when a revision procedure had been performed.  This 
coding structure enabled difference in risk of SSI in sub-groups of hip prosthesis procedures to be 
distinguished.  The surveillance system captured data on three levels of SSI: superficial, deep and 
organ/space (section 2.2.2.1).  Most studies of SSI related to hip prosthesis had focused on deep 
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wound infections which were indicative of significant morbidity and failure of the joint (Katz et al 
2001; Coello et al 2005; Lidwell et al 1984; 1987).  We considered it important to include the 
superficial SSI because they represented a significant burden of disease and SSI rates were 
conventionally based on all three levels of SSI (Emori et al 1991; Horan et al 1992).  Another 
argument for combining superficial and deep SSI in the analysis is that superficial infections are also a 
marker of the efficacy of infection prevention practice.  Although, the case definitions used to 
capture data for the surveillance system did not enable the risk of developing deep SSI subsequent to 
a superficial SSI to be determined because only the most severe level of SSI would be reported, there 
was evidence for this association from a case control study (Berbari et al 1998). It is possible that risk 
factors for superficial SSI might differ from those for deep SSI, however although we considered 
conducting a separate analysis on risk factors for deep SSI only, there were insufficient of these 
infections to enable a robust analysis of this subset of data.   
 
3.3.2.3 Risk factors for SSI: The surveillance dataset included a basic set of demographic and 
operation data captured on all patients undergoing the operation (see Table 3.2).  Whilst not a 
comprehensive set of risk factors, it did include important epidemiological variables such as age and 
sex, markers of underlying illness previously demonstrated to be associated with increased risk of SSI 
(ASA score) and intrinsic factors likely to influence the risk of SSI (trauma, duration of operation, 
wound class).  Most previous studies of rates of SSI associated with hip prosthesis had combined all 
types of hip replacement procedure and adjusted rates only by the NNIS Risk Index score (Delgardo-
Rodriguez  et al 1997; CDC 2004).  In this dataset we were able to define the risk of SSI associated 
with different types of hip replacement procedures using the OPCS codes.  A key aim of this analysis 
was therefore to determine if this difference in risk could be explained by intrinsic risk factors in the 
patients undergoing HH, in particular their age and exposure to traumatic injury.   
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Table 3.2: SSISS surveillance dataset for orthopaedic procedures (1997 to 2004) 
Data Item Risk factor 
Sex  Gender 
Date of birth Age 
Date of hospital admission Pre-operative length of stay 
Data of operation Pre/post operative lengths of stay 
Type of surgery Elective/emergency operation 
Operation due to trauma Traumatic injury 
Implant (permanent, non-human foreign body) Implant 
Use of cement (derived from OPCS code) Cemented prosthesis 
Multiple procedures through the same incision Increased tissue exposure 
Height & weight BMI 
ASA score Severity of underlying illness 
Wound class (clean, contaminated, dirty) Wound classification 
Duration of operation Complexity of procedure 
Peri-operative prophylaxis (at time of operation) Antimicrobial prophylaxis  
Date surveillance discontinued (discharged/died) Post-operative length of stay 
 
Linear regression methods were employed to determine significant independent predictors of the 
risk of SSI, which as described in 2.1.1 enabled the dependant variable (SSI) to be correlated with 
more than one predictor (risk factor) variable at the same time (Bland 2000 p. 321).  This approach 
enabled the strength of relationship between SSI and the available potential risk factors for SSI, 
expressed as odds ratios, to be measured whilst accounting for the confounding effect of other of 
inter-related factors, such as age and ASA score.  Logistic regression was used as it enabled values 
between zero and one to be obtained for the estimated proportions and a mixed set of predictor 
variables to be included in the model, either continuous (e.g. age), discrete (e.g. pre-operative stay) 
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or dichotomous (e.g. gender).  In practice, the model was simplified by converting potential 
continuous variables such as age and duration of surgery to discrete groups and other scores such as 
ASA and wound class to dichotomous variables (Bewick 2005).  By including the type of hip prosthesis 
procedure (THR and HH) as a predictor variable in the model it was possible to identify factors that 
significantly affected the risk of SSI independently of the type of procedure, thereby answering the 
question as to whether the higher rate of SSI in HH procedures was due to the procedure or 
explained by specific underlying risk factors.   
 
3.3.3 Summary of main methods and findings 
The data included in this analysis was a set of 24 808 hip replacement procedures and 761 SSI from 
102 hospitals that had participated in the national SSI surveillance between 1997 and 2001.  We 
included only those SSI identified during the inpatient stay, as defined methods of post-discharge 
surveillance were not in place at this time and inpatient SSI could be more consistently and reliably 
identified.  Using the 4-digit OPCS codes, hip replacement procedures were assigned to one of four 
categories: total hip replacement (THR), revision of THR, hip hemiarthroplasty (HH) and revision of 
HH. 
 
3.3.3.1 Rates of SSI and patient characteristics: Rates and associated normal approximation 
confidence intervals were calculated for each category.  This analysis confirmed that the crude rate 
of SSI was significantly greater in HH than primary THR, but since the median length of hospital stay 
for patients undergoing HH was five days longer than THR (14 vs 9 days) these rates were affected 
by case-ascertainment bias.  This was an important factor to take into account when explaining 
differences in risk of SSI between the procedures in the multivariate regression models (see section 
3.3.3.4).  The mean time to detection of SSI varied by type of SSI from eight days for superficial 
incisional SSI to 11 days for deep incisional and joint/bone SSI and, as established in Coello et al 
2005, the mean length of stay doubled for patients with a SSI; this effect was apparent across all 
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types of hip prosthesis procedure.  There was also a striking difference in median age at the time of 
HH (83 years; inter-quartile range 11) and THR (70 years; inter-quartile range 15).  HH were more 
likely to be performed in women (80% compared to 60% in THR) and 85% of HH were performed as 
a result of trauma compared to only 4% of THR.  As might be expected because of the significantly 
greater age and traumatic injury associated with HH procedures, these patients also had a higher 
median ASA score than patients undergoing THR.  These variations in key characteristics between 
different types of hip prosthesis procedure highlighted the importance of multivariate regression 
analysis to determine the factors that were independently associated with SSI and whether the 
variation in risk could be explained by the type of procedure or underlying intrinsic risk factors.  For 
example, it was possible that the significant effect of age on risk of SSI could be entirely explained by 
higher ASA score in older age groups.   
 
3.3.3.2 Risk factors for SSI: The initial univariate analysis of potential risk factors within each 
category of hip replacement used Chi2 test and odds ratios to estimate the strength of association 
and a p value of 0.05 or less to identify significant results.  Table 3.3 summarises the significant risk 
factors for SSI identified for each category of replacement procedure as a result of this analysis.   
 
3.3.3.3 The logistic regression model: Whilst associations in a univariate analysis are of interest in 
exploring characteristics that increase the risk of SSI, they do not take account of confounding 
between predictors (Bewick 2005). In order to take account of such confounding the following 
predictor variables were included in the logistic regression model 
 Operation due to trauma 
 ASA score 
 Wound class 
 Prophylactic antibiotic therapy 
 Gender 
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 Age group 
 Use of cement 
 Pre-operative stay 
 Duration of surgery 
 Type of hip prosthesis procedure  
 
Table 3.3:  Summary of significant risk factors in univariate analysis of risk of SSI following hip prosthesis 
Primary THR Revision THR Primary HH Revision HH 
n = 16291 n = 2550 n = 5769 n = 198 
Risk Index 2 or 3 Risk Index 2 or 3 Age >80  
Female Male ASA score>=3 ASA score>=3 
Trauma Trauma Operation <60min  
Age >75 Pre-op stay>3   
BMI>30 ASA score>=3   
Pre-op stay>3 Wound class not clean   
ASA score>=3    
Operation >120min    
 
 
A backward stepwise method was used to construct the model in which all predictor variables are 
included at the outset and then eliminated in sequence based on the selection of the term with the 
highest p value.  We assessed the goodness of fit of these models using likelihood ratio tests, which 
provide measures of model deviance by comparing it with a model with theoretically perfect fit and 
one with no predictors (Bewick 2005).  Tests for interactions between significant independent 
predictors (a variable that has a diﬀerent eﬀect on the outcome depending on the values of another 
independent variable) were examined but none identified.  Although body mass index (BMI) had 
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been included in the univariate analysis, it was excluded from the logistic regression model, as it 
would have restricted the application of the model to the 33% of patients for whom BMI data was 
available.  This multivariable analysis identified four independent risk factors associated with the risk 
of SSI: 
 ASA score greater than or equal to 3 
 Age group of patient 
 Duration of procedure greater than T time (120mins) 
 Procedure performed after trauma 
 
This analysis demonstrated that these four factors were associated with the risk of SSI regardless of 
the type of hip procedure performed.  The combination of higher median age, procedures following 
trauma and high ASA scores in patients undergoing HH were the key factors in explaining the 
increased risk of SSI (since the majority of HH were of short duration).  This was an important finding 
given that despite the increased risk of SSI in patients requiring HH due to these underlying risk 
factors, such patients were often not afforded the same standards of care as those undergoing 
primary THR, with HH procedures often performed by junior doctors in emergency operating 
theatres (NAO 2000; 03).  The model also tested the effect of including the hospital where the 
procedure was performed and found that the hospital was a significant independent predictor of risk 
of SSI, suggesting that there is considerable variation in rates of SSI between hospitals that cannot 
be explained by the other predictors such as case-mix.  Whilst it could be argued that some of this 
variation was explained by risk factors not included in the dataset, these would need to have a 
strong effect on the risk of SSI and vary widely in distribution between hospitals in order to explain 
the observed inter-hospital variation.   
 
3.3.3.4 Poisson regression model: Finally, since the length of postoperative stay affected the chance 
of an SSI being detected and the crude data indicated significant variation in length of post-operative 
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stay between procedures, we repeated the multivariate analysis as a Poisson regression and used 
length of postoperative stay as an explanatory variable in order to allow for variation in the time of 
follow-up.  A Poisson distribution assumes that events (SSI) occur independently and with a constant 
probability within a fixed time and measures the association between SSI and a set of predictor 
(explanatory) variables.  This method would only provide a partial adjustment as the time to 
detection of SSI does not occur in a linear fashion but appears to peak at six to 10 days post 
operation (HELICS 2001; 2005).  The Poisson analysis found that age was no longer a predictor of SSI, 
suggesting that at least some of the increased risk of SSI associated with older age groups may be 
related to their increased length of post operative and stay and therefore chance of SSI being 
detected.    
 
3.3.4 Conclusions 
The use of logistic regression to build an epidemiological model of the relationship between risk 
factors and SSI has important advantages over testing significant relationships using stratification, in 
particular it can be used to explore many risk factors at the same time and remove the effect of 
confounding (Grave et al 2010).  Our approach was to include all the potential predictors in the 
model and then using the backwards stepwise method to exclude the least important predictor, one 
at a time.  Whilst the Log Likelihood Ratios for both the logistic regression and Poisson models 
indicated they significantly improved prediction of SSI, regression models still need to be interpreted 
with caution as they can generate false positive associations and be distorted by outlier values 
(Dobson and Barnet 2002).  Since the same set of data were used to both estimate and then ‘fit’ the 
model, one method that we could have used to improve our analysis was to split the data using one 
half to develop and the other to validate the model.   This was an approach used by Haley et al in first 
designing the NNIS Risk Index (Haley et al 1985b).   
 
3.3.4.1 In common with the analyses in Coello et al (Appendix 3.1) described in section 3.2, this 
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analysis relied on the risk factors included in the surveillance dataset and these may not have 
reflected a comprehensive set of risk factors for SSI following hip prosthesis.  In addition, records 
where a high proportion of data was missing (e.g. 25% of records did not have data on ASA score and 
only a third included BMI data) could not be included in the model.  This reduced the records 
available for analysis and resulted in some important risk factors, such as body mass index (a 
significant risk factor in the univariate analysis) being excluded from the model.  One advantage of 
conducting this study on data captured in the late 1990s to early 2000s was that the length of post-
operative stay in England was relatively long at this time thus minimizing the bias associated with 
length of follow-up.  Interestingly, the median length of stay in the dataset used for this analysis was 
14 days for HH and nine days for THR; by 2011 this had reduced to five days for the latter (Health 
Protection Agency (HPA) 2011).  We attempted to adjust for the effect of LOS on risk of SSI using a 
Poisson regression analysis, and indeed this approach clearly modified the variables included in the 
risk factor model for hip prosthesis.  An enhancement of this method would be to apply a more 
sophisticated approach to adjusting for time to SSI by segmenting the period of follow-up in order to 
account for the time to SSI being non-linear and basing the analysis on more complete post-
discharge surveillance (PDS) data. 
 
3.3.4.2 Another important disadvantage of using surveillance data for epidemiological analyses is 
that it may be prone to local variation in application of data collection methods.  The SSI surveillance 
system was based on a standard methodology and surveillance personnel were trained in data 
collection methods in order to minimise these problems and assure the reliability of the data.  Since 
the data used in this study was captured early in the life of the scheme and prior to mandation of 
orthopaedic SSI surveillance, the majority of hospitals were participating voluntarily and therefore 
more likely to be motivated to capture data accurately.  Once the surveillance became subject to 
performance management in 2004 the incentive for hospitals to establish robust data capture 
systems changed (Tanner et al 2013a).  Nonetheless, differences in case finding and reporting may 
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have explained some of the significant hospital-effect that we observed in the risk of SSI following 
hip prosthesis.  
 
 3.3.4.3 My contribution to this research 
In this paper I applied the knowledge I had gained from conducting an analysis of risk factors for 
vascular surgery.  I designed the backwards, stepwise regression model using an approach to 
handling the combination of categorical and continuous variables that I had previously developed as 
predictors in the vascular dataset (Wilson 2002).  In addition to designing the methods and approach 
to data analysis, I interpreted the results in conjunction with the statistician and developed the 
conclusions in collaboration with the orthopedic surgeon.  This collaborative relationship with a 
clinician was important in order to set the findings in the appropriate clinical context and prepare a 
manuscript that would be appropriate for an audience of orthopaedic surgeons.  
 
3.3.5 Contribution of this study to contemporary knowledge 
This work was innovative because the large dataset enabled the application of statistical methods 
that could account for the individual effect of related variables and therefore identify significant 
independent risk factors for SSI.  These analyses influenced the development the national SSI 
surveillance system methods which subsequently used incidence density to adjust rates for length of 
post-operative stay and account for the effect of variation of length of stay on the estimated rate of 
SSI (HPA 2005).  In addition, we created a separate category for HH in order to more accurately 
reflect the different risk factors in these patients without using a complex regression analysis to 
report rates on a hip prosthesis category (HPA 2004b).  At the time of this publication most 
surveillance systems used the NNIS risk Index as the basis for data capture on risk factors for SSI and 
there had been little research on the specific risk factors for SSI following hip prosthesis.  There were 
a few examples of the use of this type of methodology in the identification of risk factors for SSI. 
These had been conducted on considerably smaller populations in case control studies (Minnema et 
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al 2004; Barberi et al 1998), a retrospective cohort study (Mahomed et al 2003) and small 
prospective muticenter study (Moro et al 1996) and the corresponding power to detect significant 
risk factors was limited by the small numbers of procedures included.  This analysis was therefore 
important as it was based on a large number of procedures and able to use logistic regression 
methods to determine independent risk factors for SSI.  The significance of the analysis in defining 
key risks factors for SSI following hip prosthesis is demonstrated by the more than 170 citations of 
the work since it was published. 
 
3.3.5.1  Whilst since 2011 NHSN has elected to retain the single category for hip prosthesis and the 
logistic regression model to adjust for the risk associated with the type of procedure and other 
factors, our approach was different. Our analysis six years previously had demonstrated that the 
significant difference in risk of SSI between HH and THR could not be adequately adjusted for by the 
standard Risk Index because both trauma and age were key predictors.  However, rather than 
applying a complex regression model to adjust SSI rates, we chose to retain a separate HH category.  
There were a number of disadvantages that mitigated against applying the regression model.  In 
particular, the Poisson analysis indicated that length of post-operative stay confounded the effect of 
age and that this effect would be markedly increased as the length of stay following elective THRs 
declined over subsequent years (HPA 2009).  In addition, since approximately 25% of records had 
missing data on ASA score and duration of operation, adjustment using standardised infection ratio 
(SIR) would only be based on 75% of records, with the precision of the estimated rate reduced 
accordingly.  Reporting two separate categories avoided the rates of SSI at each hospital being biased 
by ratio of total to partial procedures and retained the more direct inter-hospital comparison of rates 
of the specific procedures.  We therefore chose to continue using the standard Risk Index 
stratification rather than standardisation as the method of demonstrating the effect of risk factors on 
rates.  The impact of procedure type and other risk factors for SSI following hip prosthesis identified 
in this analysis also informed the analyses of data contributed to the European SSI surveillance 
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networks, which is presented in Chapter 4, section 4.2 (Wilson et al 2007; Appendix 4.1).    
 
3.3.5.2  Whilst the mean length of post-operative stay at the time of the study was much longer 
than is the case now, SSI after implant surgery are recognised to sometimes take up to one year to 
become apparent (Horan et al 1992; 2008).  Since at the time this it was performed the surveillance 
system did not include a standardised approach to post-discharge surveillance, we were only able to 
include SSI detected during the inpatient stay in this analysis.  Whilst this should be perceived as an 
important limitation in terms of defining the absolute risk of SSI following these procedures, we 
were able to accurately define risk factors of early SSI in a large multi-centre dataset which is 
preferable to previous approaches based on small numbers of cases in single centres.  This 
surveillance data, however, did not enable us to establish whether the risk factors we identified for 
early SSI would also predict the risk of SSI developing post-discharge as the aetiology of these 
infection may differ. 
 
3.3.6 Subsequent research contributions to the field 
Subsequent studies of data contributed to national surveillance systems have reported similar 
incidence of SSI to those we reported in Ridgeway et al (2.23% after THR and 4.97% after HH).  This 
is despite SSI detected by PDS being incorporated in the results emanating from other surveillance 
systems.  An analysis of data captured by the PREZIES system in the Netherlands, reported an 
incidence of SSI following THR of 2.2% and HH of 5.3% (Geubbels et al 2005).  These rates included 
SSI captured post-discharge via a registration card completed by the surgeon and supplemented by 
chart review by the infection control practitioner, although these methods are not compulsory 
(Mannien et al 2006).  The similarity in rates may suggest that the true rates in England would have 
been higher than in the Netherlands were post-discharge surveillance (PDS) incorporated.   
Certainly, once a standard methodology for PDS was incorporated into the SSISS in England in 2008, 
the detection of deep and organ/space SSI increased by 50% (HPA 2009).  However, in Scotland 
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where surveillance of SSI after hip prosthesis included active PDS, rates of SSI were 2.67% with PDS 
and 1.75% without PDS and therefore not much higher than that found in England (Reilly et al 2006).  
In Finland, patients are followed up to identify SSI on readmission and at follow-up visits 2 months 
and 1 year after surgery, and the rates of SSI detected in in-patients and including PDS 2.1 and 3.9% 
respectively (Huotari et al 2006).  However, whilst overall 56% were detected by PDS the proportion 
detected varied markedly between hospitals suggesting considerable variation in sensitivity of case 
finding that would affect the precision of the estimated rates (Huotari et al 2006).   
 
3.3.6.1 A more comprehensive method of measuring the risk of SSI following hip prosthesis is 
reflected in the Norwegian SSI surveillance system which requires all hospitals to capture three 
months of data on hip arthroplasty for the SSI surveillance system (NOIS) and follow-up patients 
with a questionnaire at 30 and 365 days post-operation (Dale et al 2011).  Post-discharge data is 
captured on 90% of patients.  This more long-term method of follow-up identified higher rates of SSI 
of 3% after THR and 7.3% after HH, although these were based on analysis of a much smaller 
number of procedures (approximately 7000) which would have increased the possibility of chance 
error. Most SSI (72%) in this analysis were identified by PDS but only nine of 270 SSI (3%) were 
detected between day 30 and 395.  The median time to SSI for these procedures was 16 and 15 days 
respectively indicating that most additional SSI would have been detected in the first five or six days 
after discharge.  This suggests that since the median length of hospital stay in our analysis was nine 
days for THR and 14 days for HH that most SSI would have been detected even without PDS.  It also 
raises the question as to whether continuing surveillance after day 30 adds sufficient further cases of 
SSI to make it cost-beneficial (Hall et al 2013).   
 
3.3.6.2 Analysis of risk factors for SSI following hip arthroplasty was also explored by Dale et al using 
both the NOIS data set and a large dataset of 07% (182) of THR and 1.5% (128) of HH revised due to 
infection in data submitted to the Norwegian Arthroplasty Registry (Dale et al 2011).  The risk factors 
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for infection that they identified were comparable to the ones identified by our study suggesting 
that risk factors between early and late onset SSIs are similar.  This study confirmed our findings that 
after adjustment there was no significant difference in the risk of SSI between THR and HH, although 
the risk of revision was higher for SSI after HH than THR, and that age and ASA score were significant 
predictors of both SSI and revision due to infection for THR.  The predictors for revision due to 
infection were slightly different compared to our analysis, with male gender and emergency surgery 
appearing as significant predictors in addition to age and ASA score (Dale et al 2011).   Other 
analyses of national joint registry data, for example in Denmark, have also identified co-morbidities 
that have increased the relative risk of revision due to infection.  These included patients with long 
duration of surgery, in addition to other more specific factors such as operation due to non-
traumatic avascular femoral head necrosis  (Pedersen et al 2010).  In contrast, the National Joint 
Registry established in England in the early 2000s has focused analyses on the factors related to the 
operative procedure that contributed to the risk of revision in general rather than exploring the risk 
factors for revision due to infection in particular (Jameson et al 2013).  This means that our analysis 
remains the most comprehensive assessment of the overall risk of SSI following hip prosthesis in 
England.  Other studies have focused only on deep SSI.  A systematic review of risk factors for deep 
SSI following primary THR identified an incidence of 1.1% up to 5 years post-surgery (Urkuart et al 
2010).  Severity of underlying illness and duration of operation were identified as independent 
predictors of deep SSI.  The authors also identified the need for high quality, prospective studies to 
identify modifiable risk factors for deep SSI after THR.   
 
3.3.6.2 Studies using logistic regression models to improve risk adjustment based on analysis of 
specific risk factors for SSI following hip arthroplasty have also been conducted (Brandt et al 2004; 
Geubbels et al 2006b; Mu et al 2011).  Geubbels et al (2006b) included age, duration of preoperative 
hospital stay, PDS and two or more discharge diagnoses as this improved the area under the ROC (C 
index) compared to the NNIS risk index value of 0.56 to 0.64 (p p<0.001).  Subsequently, the NNIS 
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system in the USA (now renamed as the National Healthcare Safety Network) has defined category 
specific risk adjustment models for SSI surveillance.  Their model for hip prosthesis was based on 
131,826 procedures, and included the factors identified in our analysis: age, duration of surgery, 
trauma and ASA score, but in addition found the type of procedure, anaesthesia type, hospital size 
and medical school affiliation to be additional independent predictors (Mu et al 2011).  The latter 
two factors may be specific to the US healthcare environment which has a large number of small 
private hospitals treating patient with a different case-mix to the large public hospitals with affiliated 
medical schools.  It is interesting that, unlike our analysis, the predictors included in the model did 
not completely explain the variation in risk between THR and HH.  This may have been explained by 
the larger dataset and inclusion of some post-discharge surveillance data.  The model increased the 
c-index from 0.61 to 0.66 compared to the NNIS Risk Index model (p<0.0008).  Although the 
differences achieved by these more sophisticated models were statistically significant, in terms of 
practical relevance considerable extra effort would be required to capture more detailed 
surveillance data on each procedure in order to achieve a small improvement in risk predicted by the 
model.  The authors suggest that such effort is necessary where rates are to be used for 
benchmarking or public disclosure and should be focused on deep and organ-space SSI since the 
predictive power of the models is improved for these infections (Mu et al 2011).  However, there are 
disadvantages to this approach in particular the complexity of the analysis makes the calculation of 
the rates less transparent and more confusing (Brandt et al 2004).  In addition, procedures could 
only be included in the rate if complete risk factor data is available and by focusing only on severe 
infections the number of SSI and therefore the precision of the estimated rate would be markedly 
reduced.  This suggests that there is not a simple answer to handling risk adjustment in HCAI 
surveillance systems, particularly where benchmarking is a key aim. 
 
3.3.6.3 In my next publication, I explore the effect of a particular risk factor, the duration of 
operation, on SSI and compare its validity as a predictor of risk with the US NNIS data.  
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3.4 Published Work 3: Duration of operation as a predictor of surgical site infection 
Leong,G.; Wilson, J.; Charlett, A. (2006) Duration of operation as a risk factor for surgical site 
infection: comparison of English and US data. Journal Hospital Infection. 63: 255-62. 
(Appendix 3.3) 
 
3.4.1 Background 
In section 2.2.5.1 I cited the work of Haley et al (1985b) as being instrumental in identifying the 
duration of operation as a significant risk factor for SSI.  In this initial analysis of SENIC data, four 
factors from a set of 10 most commonly used indicators of SSI risk could be used to predict the 
majority of the risk.  Of these four factors (abdominal surgery, operation lasting more than 2 hours, 
contaminated or dirty wound classification and three or more underlying diagnoses) the duration of 
operation was the second best predictor of SSI after ‘abdominal surgery’.  These four factors can be 
considered to reflect a spectrum between purely intrinsic patient susceptibility at one end and risk 
of bacterial contamination of the wound at the other (Haley et al 1985b).  In the case of duration of 
operation the position on this spectrum is complex.  Longer operations increase the risk of microbial 
contamination of the wound since the wound is exposed to the environment for longer.  However, 
longer procedures are also likely to reflect intrinsic risks associated with complexity of the 
underlying condition and impairment in healing associated with the requirement to handle more 
tissue.  Others argue that duration of operation reflects extrinsic factors such as the skill of the 
surgeon or quality of care in the operating department and argue that complexity of the procedure 
is an extrinsic rather than intrinsic risk factor (Campos et al 2001; Greubbels et al 2006).  In terms of 
risk adjustment to support benchmarking of rates of SSI, the aim is to account for intrinsic risk 
factors on the basis that these are associated with the patient and cannot be changed.  On the other 
hand, adjustment for extrinsic risk factors should be avoided, as these are more likely to reflect 
variation in infection prevention practice which surveillance is aimed at discriminating (Brandt et al 
2004).  
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3.4.1.1 Extended duration of operation is therefore a complex measure of intrinsic risk that 
probably measures a combination of complexity of the individual case, some aspect of surgical 
technique and prolonged exposure of tissues to micro-organisms.  Whilst an imperfect indicator of 
intrinsic risk alone, it has been consistently shown to increase the risk of SSI and has therefore been 
incorporated into the standard adjustment of SSI rates for intrinsic risk factors (Haley et al 1985b, 
Cruse and Foord 1973, Moro et al 1996).  The simple risk adjustment model developed by Haley et al 
was subsequently modified and the standard two-hour cut point between short and long operations 
replaced with a more sophisticated, specific cut point or T time for each category of procedure 
(Culver et al 1991).  These specific cut points were calculated by identifying the time at the 75th 
percentile from the distribution of operation times, and then rounding this to the nearest whole 
number of hours (Culver et al 1991; Gaynes et al 2001b).  Some further minor modifications were 
made to the US T times over the subsequent 10 years when the data indicated a change in 
distribution of operation times associated with changes in surgical technique or case-mix (CDC 1999; 
CDC 2004). 
 
3.4.2 Conceptual and methodological development 
When the NINNS SSI surveillance was established, the duration of operation was included in the 
denominator dataset and was an essential component of the risk stratification of SSI rates.  We had 
adopted the category-specific cut points for T times developed by Culver et al on the basis that these 
had been validated as associated with risk of SSI (Culver et al 1991).  Other national surveillance 
systems adopted cut-points derived from the distribution of operation times in their own data, 
arguing that these may be a better predictor of SSI in a local setting (Gulacsi et al 2000; Campos et al 
2001; Brandt et al 2004).   Either method could provide a relatively crude distinction between 
procedures defined as at increased risk of SSI, and in the case of NNIS T times they were based on 
duration of operations conducted in the USA in the late 1980s.  Thus there were two key questions 
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that needed to be answered to support the use of duration of operation in the English SSI 
surveillance system: 
 Would a similar T time based on the current distribution of operation times in England be 
comparable to the US NNIS T times, given differences in surgical technique and 
improvements in the intervening decade?  
 How reliable was the T time in distinguishing operations of increased risk of SSI across a 
range of categories included in the English SSI surveillance system? 
 
3.4.2.1 In order to answer these questions the NNIS system T times were compared with T times 
derived from data on duration of operation captured in the English SSI surveillance, and the 
association between these T times and risk of SSI then evaluated. The English T times were 
calculated using the same method as Culver et al (1991) by taking the time in minutes at the 75th 
percentile from the distribution of operation times within the category and rounding this time to the 
nearest whole hour, rounding up where the 75th percentile time was at the half hour.  A Chi2 test 
was used to compare rates of SSI above and below the T time for both US and English times but then 
a novel method applied to determine the relationship between T time and risk of SSI that involved 
plotting the p value for the difference between rate of SSI for procedures above and below a range 
of cut points in duration of operation set at 15 minute intervals.  This enabled the values along the 
distribution of cut points where the risk of SSI was significantly different to be identified and 
therefore the T times that were associated with a risk of SSI, including the most appropriate T time 
to use in the SSI risk Index.   
 
3.4.3 Summary of main methods and findings  
Five years of data captured between 1997 to 2002 from 13 categories of surgical procedures was 
included in the analysis. The English category of coronary artery bypass graft (CABG) was separated 
into two sub-categories, chest and donor incision and chest only incision, as this allowed it to be 
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mapped to the data to NNIS in which CABG were reported in these discrete categories with different 
T times.  Data from HH was combined with THR to map to the NNIS hip prosthesis category.  
However, we were interested in the effect of T time on the risk of SSI for groups of procedures 
within both the hip prosthesis category and vascular procedures. The latter category comprised 
procedures on the aorta, carotid and femoral arteries which were likely to be associated with 
different complexity and therefore duration.  After excluding 3% of records with missing operation 
times or where a missing OPCS code prevented allocation to a specific category, data on 102 847 
operations were included in the analysis. 
 
3.4.3.1 Comparison between English and US T times: The duration of operation at 75th percentile in 
English dataset differed from the US 75th percentile time in all categories, and the confidence 
intervals indicated that these differences were significant in all categories apart from large bowel 
surgery.  However, once these times were converted to T times by rounding to the nearest hour, in 
most categories (apart from vascular and CABG) the T times were the same.  This demonstrated that 
whilst at first sight the significant differences in the 75th percentile times might seem important, the 
advantage of the T time is that by rounding a specific time in minutes to the whole hour, a more 
stable cut point is generated against which to define procedures of unusually long duration.  In the 
two categories where the English and US T times differed significantly the differences were likely to 
be explained by the combination of procedures included in the category.  This illustrated a wider 
problem of ensuring categories include ‘clinically similar’ procedures and was particularly marked in 
the vascular category where both the risk of SSI and duration of operation varied widely between 
different types of procedure.   Our analysis showed that the duration at the 75th percentile for 
vascular procedures varied from 150 mins for carotid procedures to 230 minutes for procedures on 
the aorta, whilst the risk of SSI was highest in femoral procedures (11.3%) and lowest in carotid 
procedures (0.2%).  Differences in the mix of vascular operations included in the surveillance 
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between the two countries may therefore have had an important effect on both the rate of SSI and 
the T time.  
 
3.4.3.2 The less specific cut point time provided by the T time also acknowledges the imprecision in 
documentation of this data.  Whilst the strict definition of duration is time of incision to time of 
completion of wound closure, in reality it is more likely to reflect the length of time the patient is in 
the operating room.  In addition, the distribution of documented durations included in this study 
also showed a marked digit preference, with operations times more likely to be rounded up or down 
to the nearest five or 10 minute, or 1 hour interval, demonstrating significant imprecision in the 
recording of operation duration.  Whilst digit preference is a recognised phenomenon is has not 
been previously described in relation to duration of operation (Preece 1981).  Again this supports 
the use of the T time rather than a more specific 75th percentile time since marked digit preference 
could introduce significant bias into allocation of procedures above or below the cut point if based 
on a specific time.  Since the T times were based on durations above the time at the whole hour, any 
bias introduced by digit preference would tend to underestimate the association between extended 
durations and risk of SSI.  Overall, this analysis therefore enabled us to conclude that the US T times 
developed in 1991 were still applicable to current duration of operations for categories included in 
the English SSI surveillance system and that T times remained a more appropriate indicator of risk 
associated with duration of operation than specific 75th percentile times.    
 
3.4.3.3 The proportion of procedures which the cut-point ascribed as of long duration was also an 
important factor to be taken into account and mitigated against applying the standard rule of 
rounding to the nearest whole hour in all categories.  This was clearly illustrated in the sub-category 
of HH.  In the US data these procedures were included in the hip prosthesis category, however the 
analysis of English data indicated a considerably shorter mean duration of operation with a 75th 
percentile time of 80 mins versus 130 mins for the hip prosthesis category as a whole.  If the 2hr T 
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time were applied to the HH category then only 4% of the operations would have durations longer 
than the T time.  If the time were to be rounded to the nearest hour, the T time of 1 hour would 
result in nearly half the procedures being denoted as of extended duration.  This would clearly make 
it an imprecise and impractical indictor of procedures at increased risk of SSI in this category.  An 
important outcome of this analysis was therefore the creation of a specific T time for HH of 1.5hr, 
which we found distinguished a more appropriate proportion of 15% of procedures as being of 
extended duration.  
 
3.4.3.4 Relationship between T time and risk of SSI: The analysis found evidence that the incidence 
of SSI was higher in operations with duration of operations longer that the T time.  This effect was 
observed in all categories except for hip prosthesis, and for the latter category the incidence was 
higher for the relevant T time when the procedures were segregated into THR and HH.  These 
differences were statistically significant except for bile duct and cholecystectomy (where less than 
200 operations were available and this reduced the power to detect significant differences), and limb 
amputation, and open reduction of long bone, which may have reflected more heterogenous 
procedures of widely varying durations.  Plotting the p value (set at 0.05) of the association between 
SSI and duration of operation at 15 minute intervals demonstrated that the relationship between T 
time and risk of SSI varied according to category and that the cut point used to define the T time 
could cover a wide range of operation durations whilst still indicating significant differences in risk of 
SSI above and below the time (see Figure 3.1). For example, in abdominal hysterectomy a T time of 
between 45 and 240 mins was associated with a significant increase risk of SSI, as illustrated by the 
line plotted below the 0.05 p value.  This analysis also supported our decision to separate HH.  When 
these procedures were included, the T time of 2 hours was not significantly associated with risk of SSI 
since the shorter duration of HH meant that the increased risk was evidence at durations of between 
30 and 100 minutes.  By removing these procedures the T time became significant at the 2hr cut 
point, although no specific cut point was associated with SSI in the HH category (Figure 3.1).  
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 Figure 3.1: Association betw
een p value and cut point for duration of operation for a) abdom
inal hysterectom
y procedures, b) hip prosthesis (total and hip 
hem
iarthroplasty), c) total hip prosthesis d) hip hem
iarthroplasty.  P value = 0.05 indicated by horizontal line; English and U
S T tim
es indicated by vertical lines. 
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3.4.4 Conclusions 
Our analysis of the association between SSI and duration of operation provided robust 
evidence for the association between SSI and prolonged duration of operation and support 
for the continued use of the T times we had defined at the inception of the surveillance.  As 
in both Coello et al (Appendix 3.1) and Ridgeway et al (Appendix 3.2), our analyses were 
limited by the availability of data within the surveillance dataset.  In the case of operation 
duration, whilst the time was missing in less than 3% of records, the marked digit preference 
illustrated the imprecision with which apparently simple data items may be recorded.  Whilst 
we have demonstrated that this would have resulted in the association between SSI and T 
time being underestimated rather than overestimated, it does indicate the wider potential 
for misclassification of data in surveillance datasets.  In addition, although our analysis 
demonstrated a reasonably consistent significant relationship between SSI and operations of 
prolonged duration, we are not able to distinguish whether this is an extrinsic factor, such as 
operator technique, or an intrinsic factor associated with the complexity of the procedure.  
Such an analysis would require more detailed data capture than is possible with a routine 
surveillance system. 
 
3.4.4.1 My contribution to this research 
I developed the concept for the analysis, and subsequently the interpretation of the results 
and implications of the analysis for the national surveillance system.  I worked with the 
statistician who advised on the methods of identifying valid T times.  I also informed the 
analysis and conclusions though applying my expert knowledge of benchmarking SSI rates, 
International surveillance systems and approaches to risk adjustment.  In this analysis I was 
supervising a junior scientist who conducted the statistical analysis for the study.   
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3.4.5 Contribution of this study to contemporary knowledge 
This analysis was important since duration of operation was one of three factors used for 
primary risk adjustment of the SSI surveillance data.  The underpinning methodology 
determining its application as a risk factor was based on US data and this may not have been 
applicable to surgery performed in the UK.  At the time of this research, there had been no 
specific study on the association between duration of operation of risk of SSI since the Risk 
Index was defined by Culver et al in 1991.   In addition, Culver et al had validated the impact 
of the risk index as a whole on the risk of SSI and so our study was unique in evaluating the 
specific relationship between T time and increased risk of SSI across a range of surgical 
categories.  Other studies have investigated risk factors for SSI but have identified duration 
of operation as one of a number of significant independent predictors of SSI rather than 
specifically exploring its relationship with SSI (Moro et al 1996; Gulacsi et al 2000; Campos et 
al 2001; Anderson et al 2008).  Whilst duration of operation is consistently associated with 
increased risk of SSI, controversy still exists as to whether the duration of operation 
represents a patient related risk factor or better reflects surgical technique (Mu et al 2011).  
Our study has subsequently been cited by over 60 other studies as evidence for the 
relationship between T time and risk of SSI.  
 
3.4.5.1 The second key contribution that this study made to the evidence base was further 
confirmation of the significant difference between THR and HH first described in my 
preceding study of risk factors for SSI following hip prosthesis (Ridgway et al 2005 Appendix 
3.2).  The T time analysis demonstrated that the duration of operation for HH was shorter 
than for THR and that if the two types of procedure are combined into a single category the 
standard T time of 2hrs is not a reliable method of distinguishing procedure at increased risk 
of SSI.  This provided further evidence that HH should be separated into a specific category 
in order more accurately risk adjust and report rates of SSI.   
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3.4.6 Subsequent research contributions to the field 
Our study found that whilst the time at the 75th percentile for duration of operation might 
vary from those defined by NNIS, it does not significantly affect the ability of the T time to 
predict SSI.  This same finding was also reported by Prospero et al (2007) who compared the 
predictive ability of T times using ROC analysis.   Other studies have included duration of 
operation as a key component of increasingly sophisticated risk adjustment models (Mu et al 
2011; Cohen et al 2013; Walraven and Musselman 2013).  However, others have 
recommended that it is excluded from risk adjustment models as they have considered 
duration of operation as an indicator of hospital quality rather than intrinsic risk related to 
the patient (Geubbels et al 2006; Campbell et al 2008; Gastemeier et al 2011). 
 
3.4.6.1 Our analysis was able to demonstrate a clear link between risk of SSI and durations 
of operation but it could not explain the reason for this association.  A recent study by 
Campbell et al (2008) has provided some insights into some of the possible clinical 
explanations for the observed variation in operation duration and impact on the rate of SSI.  
The premise of Campbell et al was that duration of operation was a measure of the quality 
of the surgical process, acting as a proxy of care such as the characteristics of the operative 
case, surgeon skill or other factors such as intraoperative teaching.  This study used data 
from 117 hospitals participating in the American College of Surgeons National Surgical 
Quality Improvement Program (ACS-NSQIP).  This system captures data on risk factors and 
outcomes up to 30 days post surgery for a defined set of operations.  The predicted 
probability of SSI is calculated for each patient based on their pre-surgical risk factors and 
these probabilities summed for each centre to give an expected number of SSIs. Campbell et 
al (2008) benchmarked rates based on the ratio of observed (O) to expected (E) SSIs (derived 
from the above risk adjustment) and those that were ‘high outliers’ were defined as 
hospitals with O/E > 1 and those that were low outliers, an O/E <1 (in both cases based on a 
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reasonable sample size i.e. with 95% confidence limits around the rates excluding one).  A 
range of ‘process measures’ of operating theatre practice that were considered to be 
associated with the risk of SSI were identified though survey of all participating centres.  Site 
visits to centres identified as low and high outliers were also made to assess aspects of 
practice.  Operation durations for all procedures were significantly longer (25%) at high 
outlier hospitals.  This was unlikely to be explained by procedure complexity since a 
comparison of a subset of low complexity procedures (e.g. laparoscopic cholecystectomy, 
thyroidectomy) found that these were also 30-44% longer at identified high outlier hospitals.  
High outlier hospitals did have a greater involvement in the training of young doctors and 
this may have explained the relationship with operation duration since operations assisted 
by a junior doctor are known to take longer (Papandria et al 2012) and the longer the site is 
exposed the greater the risk of SSI (Hedrick et al 2007; Barrie et al 1994).  This may not have 
been the only influence, since the study also identified that the time in the operating room 
before and after the incision was made and closed was also extended in high outliers, which 
the authors attributed to less efficient ‘teamwork’.  Low outliers were therefore more likely 
to have few or no trainees and a very small turnover of staff.  These factors are likely to have 
a positive impact on the coordination of care and efficiency with which the procedure was 
completed.  This study therefore provides important evidence to suggest that the duration 
of operation is an important extrinsic risk factor for SSI and brings into question whether it 
should continue to be incorporated into the risk index, which is intended to adjust for 
intrinsic rather than extrinsic factors.  
 
3.4.6.2 Procter et al demonstrated an independent association between increased duration 
of operation and infection events (SSI, sepsis and post-operative pneumonia) in an analysis 
of ASC-NSQIP data on a range of general surgical procedures.  The logistic regression model 
found that the adjusted rate of infection complications in general surgery increased 
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significantly for each 30 mins of operation duration (OR 1.92; p<0.001) and that increased 
duration of operation also significantly increased length of post-operative stay by 6% for 
every half hour of duration (Procter et al 2010).  This study identified a number of factors 
associated with prolonger operation duration that could explain the increased risk of SSI 
such as hypoxemia, glove perforation, increased deposition or airborne particles and 
suboptimal exposure to antimicrobial prophylaxis agents.  Some of these could be 
considered intrinsic factors but others, such as sub-optimal exposure to antimicrobial 
prophylaxis, are extrinsic risk factors.  
 
3.4.6.3 Gastmeier et al (2011) attempted to explore the impact of both hospital and patient 
factors in determining the duration of operation in data contributed to the national 
surveillance system between 2004 and 2008 and using type and size of hospital and volume 
of surgery as ‘hospital’ factors in the logistic regression modelling.  Although the predictive 
power of the models was low, they found that the duration of operation was partially 
determined by hospitals with high volume of operations associated with shorter durations 
and university size greater than the median and status associated with longer operation 
times.  All these studies confirm out findings that duration of operation is an important risk 
factor for SSI but that it reflects both an intrinsic and extrinsic risk factor.  Future work 
should consider excluding it as a risk factor for adjustment of rates.  
 
 
3.5 Summary of chapter 
The three studies included in this chapter illustrate both the advantage and disadvantage of 
using surveillance data for epidemiological analyses.  The important advantage is that they 
are able to draw on large datasets, in Coello et al over 70 000 records, Ridgeway et al over 
24 000 and in Leong et al over 100 000 records.  This enables far greater precision of 
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estimates of effect and sufficient data across most categories to conduct more complex 
analyses such as logistic regression.  The use of data from many hospitals has the 
disadvantage of introducing centre-based variation that is not captured in a routine 
surveillance dataset, for example case-mix may differ and other factors such as surgeon skill 
and involvement of trainees may also vary between hospitals.  However, these 
disadvantages are outweighed by the difficulty of capturing sufficient data at a single 
hospital to enable these types of analysis.  Coello et al 2005 was the first example of my 
contribution to providing new knowledge about risks of SSI and it finding are widely cited as 
evidence for the impact of SSI on morbidity and mortality.  My analysis of risk factors for SSI 
in a major category of surgical procedures applying similar logistic regression methods 
reflects an important and novel analysis of risk factors for SSI captured as part of a national 
surveillance system.  Both this analysis and my investigation of the impact of one particular 
risk factor, the duration of operation, influenced the subsequent development of the SSI 
surveillance system in England and Europe.  In Chapter 4, I present how I applied this 
evidence to that analysis of inter-hospital variation in England and inter-country variation in 
the European SSI surveillance system.  
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CHAPTER 4 
 
Methodological challenges in comparing rates of surgical site infection  
 
4.1 Introduction 
The work presented in this chapter explores some of the important methodological issues that arise 
when comparing rates of SSI.  Chapter 2 (section 2.2.1) described how the findings of Study of the 
Efficacy of Nosocomial Infection Control (SENIC) provided strong evidence for the premise that 
providing clinicians with information about the risk of infection in their patients affects the way that 
they deliver care and as a result reduces subsequent infection rates.  This aligns with the models of 
power described by French and Raven in which information power is one of the six bases of power, 
but has an important influence on expert power because it supports their legitimacy (French and 
Raven 1959).  Comparing rates with external benchmarks has been proposed as a means of 
enhancing the power of information to influence practice (Sherertz et al 1992; Gaynes et al 2001a) 
and has been associated with significant reductions in rates of SSI (Guebbels et al 2004; Gastmeier et 
al 2005; Guebbels et al 2006; Barzwolf et al 2006; Rioux et al 2007).  In order to make valid 
comparisons a number of questions to be considered, in particular the effect of the methodology on 
the length of follow-up and completeness of case finding, the precision of estimated rates, and the 
effect of variation in intrinsic risk factors for infection.  Methods of analysis are therefore a key 
factor in assuring validity of benchmarking systems (Haley 1995; Cooke et al 2000; Gaynes et al 
2001; Wilson et al 2002).  The first study presented in this chapter explores the implications of 
these factors on inter-country comparisons in data submitted to a collaborative European network 
of national surveillance systems (Wilson et al 2007; Appendix 4.1).  The second study demonstrates 
the development of a method of benchmarking rates of SSI rates that could be used to take into 
account the precision of estimated rates and provided a visual, and readily understandable method 
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of indicating high and low performers (Wilson et al 2008; Appendix 4.2). The third study, explores 
the impact of post-discharge surveillance on rates of SSI following caesarean section and the 
implications of variation in intensity case finding on the reliability of inter-hospital comparisons 
(Wilson et al 2013; Appendix 4.3). 
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4.2 Published work 4: Inter-country comparison of rates of surgical site infection 
Wilson, J., Suetens, C., Ramboer, I., Fabry, J. (2007) Hospitals in Europe Link for Infection Control 
through Surveillance (HELICS). Inter-country comparison of rates of surgical site infection – 
opportunities and limitations. Journal of Hospital Infection.  65(S2): 165-70. (Appendix 4.1) 
 
4.2.1 Background 
The demand for information about rates of HCAI has been driven in Europe by a recognition of the 
significance of healthcare associated infection to public health, in particular the concern about the 
associated morbidity, with an estimated 10% of hospital patients acquiring an infection and major 
costs associated with prolonged hospital stay and treatment (Plowman et al 2001; Fabro-Perray et al 
2007; Smythe et al 2006).  In addition, there were concerns about the control of communicable 
disease across country borders, including the risk from the emergence of highly resistant pathogens 
that commonly emanate from healthcare (Hospitals In Europe Link For Infection Control Through 
Surveillance (HELICS) 2005).  At the time that the national SSI surveillance system was being 
established in England, initiatives to develop systems for HCAI surveillance based on the CDC 
programme were being developed in several European countries.  Collaborations between the 
European Union (EU) countries targeted at evaluating practice for the prevention of HCAI had begun 
to develop in the 1990s, and were reinforced by the Treaty of the European Union (‘Maastricht 
Treaty’) in 1992, which gave new authority for the EU Commission to develop actions and regulation 
directed at guaranteeing the peoples’ health rather than just contributing to that goal.  The 
subsequent Amsterdam Treaty in 1997 required member states to work together to protect human 
health through ‘the definition and implementation of all Community policies and activities’ directing 
Community action ‘towards improving public health, preventing human illness and diseases’ and 
promote ‘research into their causes, their transmission and their prevention, as well as health 
information and education.’  These regulations underpinned a series of initiatives focused on 
harmonisation of public policies, methods of surveillance and prevention of HCAI.  These included 
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hospital based infection studies and projects such as ESCIM antimicrobial surveillance study group, 
EURO-Nosocomial Infection Study and European point prevalence study on infection (EPIC), as well 
as the first Hospitals in Europe Link for Infection Control through Surveillance (HELICS) project (Moro 
et al 1996, Vincent et al 2000, Cornaglia et al 2004; Fabry et al 2007).   
 
4.2.1.1 The HELICS project:  The purpose of this project was to create a framework for developing 
standard surveillance systems for HCAI, consensus on minimum requirements and recommendations 
for integrating surveillance activity into the routine of healthcare (Moro et al 1996; Mertens et al 
1996; HELICS 2005; Fabry et al 2007).  The work was undertaken by a group of experts in HCAI and 
surveillance including representatives from national surveillance centres, related societies and study 
groups.  In 1998 one of the European Parliament decisions (2119/98/EC) concerned the formation of 
a network for the epidemiological surveillance and control of communicable diseases in the 
European Community.  This included developing a framework for close co-operation and effective 
co-ordination between Member States to support appropriate actions for the protection of 
Community's populations, and integration of existing surveillance structures supported by Member 
States and creation of new structures for diseases not yet covered by existing surveillance networks.  
The European Commission subsequently commissioned the HELICS project to continue their 
previous work on developing standards for HCAI surveillance by establishing ‘national/regional 
surveillance networks using common surveillance standards and data quality evaluation systems for 
all participating networks.’ (HELICS 2002).  This resulted in consensus protocols for the surveillance 
of SSI and ICU-infections, based on systems developed previously by CDC (2.2.2), with an agreed set 
of mandatory data items and some optional data items (see table 4.1).  Rather than establishing a 
new layer of surveillance, the HELICS protocol aimed to harmonise surveillance currently conducted 
by European networks, which whilst broadly based on CDC surveillance methodology had some 
country-specific variations in dataset.  In line with the aim of the EU Commission to integrate the 
existing surveillance structures in Member States, the project aimed to assist the national networks 
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in adopting the harmonised HELICS master protocols and to assist those countries without a 
surveillance network to develop their own surveillance organisation within the HELICS partnership 
(HELICS 2005).  
 
4.2.1.2 In addition to developing a standard approach to surveillance, HELICS also needed to 
develop indicators for HCAI at a European level and solve the technical problems of producing 
epidemiological data for HCAI from heterogeneous data captured across different countries in the 
EU.  Whilst participation in HELICS required countries to agree a common protocol comprising a 
dataset and case-definitions for SSI, the methods of surveillance were not defined.  In practice, 
variation in approach to surveillance, both in terms of interpretation of case definitions and methods 
of surveillance were likely to impact on both the sensitivity and intensity of case finding (Moro et al 
2005).  Reliance on the standard NNIS Risk Index for case-mix adjustment may not sufficiently adjust 
for variation on intrinsic risk factors when comparing rates of SSI in a European context and many 
countries had concerns about being ‘labelled’ as a poor performer.    
 
4.2.1.3 The draft protocol for SSI surveillance was piloted between 2000 and 2003 and the final 
standard protocol was published in 2003 (HELICS 2004).  I had worked closely with the HELICS data 
analysis group in Brussels in designing the analysis of the pilot dataset on over 170 000 operations in 
10 countries.  The indicators for SSI that we developed as part of this analysis, we then applied to 
the first set of data collected prospectively in 2004 (HELICS 2005), which formed the basis for the 
paper presented here. This publication explores the approach to the analysis, the potential impact of 
variation in surveillance methods on interpretation of the results and the limitations of inter-country 
comparison.  
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4.2.2 Conceptual and methodological development 
As discussed in Chapter 2 (section 2.3.5) the primary method of minimising inherent variation in risk 
of SSI associated with different types of operative procedure is grouping of operations into defined 
categories.  This enables rates to be calculated for procedures that are both likely to have similar 
risks of SSI and are relevant to specific groups of specialist surgeons (Health Protection Agency (HPA) 
2004; Wilson 2013a; Wilson 2013b).  The second strategy for accounting for difference in risk of SSI 
focused on variation in intrinsic risks between patients undergoing a procedure within a specific 
operative category.  The intrinsic susceptibility to infection of patients undergoing surgery may vary 
depending on the extent of exposure of the tissues to micro-organisms of varying virulence and the 
competence of their immune system to combat them (Mangram et al 1999, NCCWCH 2008). The 
system of categorisation of surgical procedures by a Risk Index, developed by the National 
Nosocomial Infection Surveillance (NNIS) system in the USA in the mid-1980s had been adopted by 
most national surveillance systems in Europe (Haley et al 1985a; Culver et al 1991; Geubbels et al 
2000; Gastmeier et al 2003).  The factors included in the NNIS Risk Index had therefore been 
designated as core (mandatory) variables for the HELICS surveillance dataset (see Table 4.1).  To 
explore the potential impact of inter-country differences in case-mix we looked at in the distribution 
of the NNIS risk index and the types of hip procedure defined by International Classification of 
Diseases (ICD) CM codes for total and partial hip replacements.  This analysis built on the previous 
work I had undertaken in exploring intrinsic risk factors for SSI following hip prosthesis which had 
shown that the Risk Index did not sufficiently adjust for major differences in risk of SSI associated 
with different hip prosthesis procedures (see section 3.2: Ridgeway et al 2005; Appendix 3.2). 
 
4.2.2.1 Case finding methods: As discussed in Chapter 2, the HCAI surveillance systems in England 
were predicated on methods that were designed to minimise the risk of selection and measurement 
bias, in order to support the primary aim of the surveillance of permitting inter and intra-hospital 
comparisons.  In the case of the SSI surveillance data, these principles were guided by a defined 
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method of identifying patients eligible for surveillance (the denominator) and the application of 
standard, and as far as possible objective, criteria to determine cases of infection (the numerator) 
with prescribed methods of case finding based on previous research evidence (Glenister et al 1990).  
The HELICS protocol, in common with other national surveillance systems, focused on the definition 
of terms rather than the methods used to capture the data (Centers for Disease Control (CDC) 1991, 
Horan et al 1992; Emori et al 1991).  Methods for recruiting eligible patients and identifying those 
that meet the case definitions for SSI are therefore less standardised in hospitals participating in 
HELICS.  For example, a survey of HELICS partner countries in the early 2000s identified that in six 
countries the decision on whether an SSI met the case definition was made jointly by the physician 
and infection control practitioner, whilst in three other countries this decision was made only by the 
physician (HELICS 2002).  Evidence suggests that the clinical criteria used to define SSI can be difficult 
to judge and there is poor agreement between different healthcare professionals asked to identify 
SSI especially when they assess the wound at different time points after the operation (Mitchell et al 
1999, Whitby et al 2002).  In a study comparing the English case definitions with CDC definitions we 
had found differences in the detection of SSI and difficulties in applying CDC definitions consistently 
(Wilson et al 2005; Appendix 4.4).  Thus variation in the methodology used to identify SSI may affect 
both the number and type of SSI detected.  Measuring the impact of this variation in methodology is 
difficult when analysing data captured by routine surveillance systems.  In this analysis we used 
distribution in type of SSI (superficial, deep and organ/space) as a proxy indicator of consistency in 
application of the case definitions and reporting of SSI.   
 
4.2.2.2 Adjusting for length of post-operative stay: An important difference in surveillance 
methodology in HELICS participants was the approach to post-discharge surveillance (PDS), which 
was not a defined requirement of the HELICS protocol.  Whilst active and prospective surveillance 
methods were used in all countries, some continued surveillance after discharge for more than 50% 
of patients whilst others only followed patients until discharge from hospital (HELICS 2002; 
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Gastmeier et al 2003;  Moro et al 2005; Mannien et al 2006).  The duration of post-operative stay in 
hospital has a significant effect on rates of SSI because the infection may not become apparent until 
up to 30 days after surgery (up to one year in the case of surgery involving an implant) when most 
patients will have left hospital.  Whilst there is little robust data on the time to SSI, a previous PHLS 
study which followed over 6000 patients for 28 days following surgery indicated that although 90% 
of SSI had developed by day 20, only 15% had become apparent by day five (Noel et al 1997).  Other 
studies found that up to 70% of SSI were detected post-discharge, depending on the type of surgery 
and median length of postoperative stay (Stockley et al 2001; Reilly et al 2006).  Even if post-
discharge case finding systems exist, the infections are more difficult to detect once the patient has 
left hospital and the efficacy of detection methods varies (Petherick et al 2006).  Thus rates for a 
particular category and country will depend on the average length of post-operative stay in hospital 
and the intensity and effectiveness of post-discharge surveillance.  The cumulative incidence (CI) 
would therefore only provide an effective comparator if all patients are followed up for the entire 
period in which SSI could be detected, or at least a similar period in all countries, otherwise it will be 
biased by length of postoperative stay.  Differences in healthcare systems drive considerable 
variation in length of post-operative stay and even where PDS was conducted there were differences 
in approach between countries and categories that may have affected intensity of case finding.  
Another key factor to be considered is the precision of estimated rates of SSI surveillance since 
networks differed in the number of participating hospitals, categories chosen and duration of 
surveillance (HELICS 2002, 2005; Mannien et al 2008; Reilly et al 2006).  Methods selected to 
compare rates of SSI between countries therefore needed to take account of these factors.  
 
4.2.3 Summary of main methods and findings 
By 2003, 16 countries in Europe had established national networks for the surveillance of SSI and the 
majority were either participating or preparing to participate in HELICS.  Following the analysis of the 
pilot data, 2004 was the first year of ‘routine’ data contributed to HELICS and comprised data on  
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111,361 operations captured by 14 networks in 11 countries.  This dataset was therefore used for 
analysis of inter-country comparisons in this publication.  Data completeness was high with data 
available for 93% of mandatory variables shown in table 4.1, but lower for the ‘required’ (86%) and 
‘optional’ (46%) variables.  The mandatory fields most likely to have data missing were ASA score 
(93.9%) and date of SSI (91.6%).  However, some ‘required’ fields also suffered from incomplete 
data.  In particular, date of discharge was not captured by the surveillance systems in some countries 
(Germany, Poland) and in Finland was missing in 27% of records.  These records were therefore 
excluded from the calculation of ID.   
 
Table 4.1: HELICS SSI Surveillance: Standard dataset 
Source: HELICS 2004 
Variable Data Field rule* 
Operative procedure ID Unique no. M 
Age Years R 
Gender M, F, Unknown R 
Data of admission  O 
Date of operation  M 
Date of last follow-up In hospital R 
Discharge status  Alive or dead R 
Date of last follow-up Post-discharge O 
Primary operation code NNIS procedure code M 
Primary operation code ICD-9 CM code O 
Endoscopic procedure Yes/No, 9=unknown R 
Wound class 1-4, 9=unknown M 
Duration of operation Minutes, 999=unknown M 
Urgent/elective Urgent = not planned 24hrs in advance, 9=unknown R 
ASA score 1-5, 9=unknown M 
Perioperative antibiotics Within 2 hrs of primary incision, 9=unknown O 
*M = mandatory (record rejected if missing); R = Required (used for routine analysis but 
record not rejected if missing); O = optional 
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Missing or inaccurate data in other elements of the risk index meant that the risk group could only 
be calculated for 93% of records, but in order to include all data in the analysis we created a group of 
‘unknown risk index’.  Since hip prosthesis was the only category included by all 14 countries and 
accounted for 44% of the records we selected this category to explore variation in case mix between 
countries.  The next largest category was caesarean section included by eight countries and 
accounting for 18% of records.  
 
4.2.3.1 Variation in risk factors for infection: Some basic aspects of case-mix such as gender and 
age were found to be similar across all countries, however there were marked differences in 
distribution for the standard Risk Index within specific categories of procedure.  In hip prosthesis, 
80% of patients who underwent the procedure had none of the three risk factors (Austria, Lithuania 
and Netherlands) compared to only 30% of patients in Finland (Figure 4.1).  Such variation in 
distribution across risk index groups may be due to a number of factors: differences in healthcare 
system that result in patients with different levels of severity of illness accessing treatment, 
differences in interpretation of definitions of risk index criteria or imprecise distribution based on 
small numbers of procedures contributed by some countries.   
 
4.2.3.2 Another key factor likely to affect both Risk Index distribution and rate of SSI was 
heterogeneity of procedures included within a category, reflecting differences between healthcare 
systems and organisation of national surveillance systems.  ICD9-CM codes captured by 10 counties 
for the hip prosthesis category were used to explore the potential effect of these factors.  Using 
methods previously applied to English SSI surveillance data (section 3.2; Ridgeway et al 2005; 
Appendix 3.2), we identified a higher rate of SSI in patients undergoing partial hip replacement 
rather than total hip replacement (1.6% versus 4% respectively).  Clearly, if similar differences were 
evident in the European data then the mix of these procedures would influence the rate of SSI and 
affect the validity of inter-country comparisons.  The analysis of HELICS data demonstrated 
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heterogeneity in the distribution of these two types of procedure with surveillance data from some 
countries (Germany, Scotland, Hungary) only including total hip replacement procedures, whilst in 
others more than 20% of procedures were partial hip replacements.  
 
Figure 4.1: Distribution of risk index in hip prosthesis operations contributed to HELICS (2004) 
 
Key: AT Austria, BE Belgium, DE Germany, ES Spain, FI Finland, FR France, HU Hungary, LT Lithuania, NL 
Netherlands, UE England, UN Northern Ireland, US Scotland, UW Wales. 
 
4.2.3.3 Type of SSI: The inter-country comparisons also highlighted significant differences in 
distribution of type of SSI.  In hip prosthesis, there were nine countries with data on less than 50 SSI 
in this category and observed differences may therefore reflect chance variation.  Among the other 
five countries, Finland and Germany reported less than 30% of SSI as superficial whilst England and 
Scotland reported over 70% and Netherlands 50%, with no distinction between deep and 
organ/space.  Whilst it is possible that these differences reflected true variation in the occurrence of 
superficial and deep SSI, a more likely explanation is that the differences reflect variation in 
application or interpretation of the definitions of SSI.  Firstly, whilst countries participating in HELICS 
captured data according to the standard protocol, there were local differences in application of 
definitions (e.g. in England and the Netherlands a clinicians diagnosis did not meet the definitions if 
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clinical signs were absent) and in England and Finland extended criteria were applied to wound 
culture (Wilson et al 2004 (Appendix 4.4); HPA 2004; Huotari et al 2007).  In particular, the HELICS 
criteria for superficial SSI are relatively subjective and prone to variation in interpretation (Wilson et 
al 2004).  The second potential source of variation is post-discharge surveillance methods, which 
varied in terms of extend and intensity between countries and may have influenced the proportion 
of more severe SSI detected.  In Finland and the Netherlands in particular, PDS was an integral 
component of the surveillance protocol whereas in England PDS data was not included and in 
Germany was encouraged but not formalised in the surveillance protocol (Coello et al 2001; Huotari 
et al 2007).   
 
4.2.3.4 Post-discharge surveillance: The analysis found that the follow-up of patients to detect SSI 
that develop after discharge from hospital was a major source of bias.  There were two factors that 
inter-played in this relationship, firstly the length of post-operative stay in hospital which varied 
between categories of procedure but also between countries.  For example the median length of 
hospital stay after hip prosthesis for all data combined was nine days but ranged from one to 22 
days (excluding outliers).  However, the median also varied between countries from six to 12 days 
and this reflected a decline in length of hospital stay compared to the 2000-03 report where the 
median was 10 days and range six to 13 days.  In some countries, such as Finland, the short length of 
stay was influenced by a system of accelerated discharge to rehabilitation units (HELICS 2005).  If all 
patients were likely to be followed up equally throughout the surveillance period (1 year for 
procedures with an implant, 30 days for those without) the length of post-operative hospital stay 
would not be a source of bias.  However, there were significant differences in approach to PDS.  
Some countries, such as the Netherlands recommended specific methods of surveillance after 
discharge for hospital participating in the national PREZIES surveillance system.  In a study by 
Mannien et al, active PDS was performed for 49% of patients with passive surveillance for the 
remainder and as expected a greater proportion of SSI detected by the active methods (Mannien et 
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al 2006).  In Scotland, a study by Reilly et al indicated that PDS was conducted for 59% of procedures 
included in the surveillance, mostly by active methods and that the rate of SSI was significantly 
increased where active PDS was performed (Reilly et al 2006).  This variation in PDS methods meant 
that for hip prosthesis, whilst overall only 20% of SSI were detected by PDS, in some countries such 
as England and Spain, there were no SSI reported by PDS whilst in other countries 50% or more of 
SSI were detected by PDS.  Inter-country comparison of cumulative incidence rates would clearly not 
be valid if based on both inpatient and post-discharge SSI, yet if based only on inpatient SSI would be 
biased by the duration of follow-up i.e the length of post-operative stay.   
 
4.2.3.5 Incidence density rates: The solution to this problem was to use a metric that we had 
applied for comparing rates of SSI in the English surveillance system, the incidence density (ID).  This 
approach had been developed as a mechanism for accounting for variation in length of post-
operative stay and to adjust for the impact of reductions in length of stay following orthopaedic 
surgery on trends in rates of SSI (HPA 2005).  The ID uses the number of days of post-operative 
follow-up as the denominator rather than the number of procedures (HPA 2005) and accounts for 
some of the observation bias associated with different periods of follow-up adjustment. Since the 
numerator and denominator must be from the same population the ID must be based only on those 
SSI detected during the hospital stay.  Whilst this has the disadvantage of underestimating the risk of 
SSI (as infections detected post-discharge will be excluded) and is not as readily understood as a CI, it 
better meets the requirement of a valid comparator especially in the context of wide variation in 
length of stay.  Therefore, in this analysis of the HELICS data the ID and CI metrics for SSI were 
compared to explore the impact of each on inter-country comparisons.   
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The ID is calculated as follows:  
Incidence density (ID) of SSI (per 1000 days of inpatient follow-up): 
No. SSI 
   x 1000 
No. days inpatient follow-up 
 
However, this metric only partially adjusts for follow-up period as the risk of SSI cannot be assumed 
to occur at a constant rate for each day after the procedure.  Indeed, there was evidence that the 
detection of SSI was greatest at between day six and 10 after the operation (HELICS 2005).  Another 
limitation of this approach is that the rate does not include SSI detected after discharge from 
hospital and as a result would underestimate the true rate.  The incidence density could also only be 
calculated for countries where the date of discharge from hospital was captured, the datasets from 
Germany, Poland and Lithuania were therefore excluded from this analysis.  The value of this metric 
could be demonstrated by comparing the rank position of countries based on cumulative incidence 
and incidence density.   The relative position defined by these two metrics was different for nine out 
of 11 counties for whom the incidence density could be calculated for hip prosthesis (Figure 4.2).  
The confidence limits on this figure also illustrated an additional problem associated with inter-
country comparisons, that of precision of estimates.  The rate for Belgium, whilst ranked one for 
both metrics was based on 191 operations and had correspondingly wide confidence limits around 
the rate.  Most differences in rates between countries were shown not to be statistically significant 
by the overlapping confidence intervals.  
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Figure 4.2: Comparison between SSI cumulative incidence (top) and incidence density (bottom) for hip 
prosthesis by country 
 
Key: AT Austria, BE Belgium, DE Germany, ES Spain, FI Finland, FR France, HU Hungary, NL Netherlands, UE 
England, UN Northern Ireland, US Scotland, UW Wales. 
Bars = 95% confidence intervals 
 
4.2.4 Conclusions 
This analysis of this first year of SSI surveillance data submitted to HELICS highlighted key 
methodological issues that are not necessarily addressed in a standardised protocol that tends to 
focus more on the data items and less on the specific methods of case-finding.  The latter are 
difficult to regulate as they are often dictated by the systems of organising healthcare or the political 
imperatives of national policy such as the discharge to rehabilitation centres in Finland and 
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introduction of mandatory orthopaedic surveillance in England (Department of Health 2003; 
Gastmeier et al 2007).  Whilst these analyses were able to point to variation that was indicative of 
differences in underlying surveillance methodology, we could only speculate about the likely 
contributory factors because the precise causes of the observed variation and the specific effect of 
differences in methodology could not be determined from these datasets.  Another limitation was 
the paucity of data available for case-mix adjustment.  The analysis conducted on different types of 
hip prosthesis for which data was available from 14 countries, pointed to the potential effect of 
differences in case mix on rates of SSI, and it is likely that similar factors come in to play in other 
categories of procedure but these have yet to be determined.  Such case-mix differences are likely to 
be greater when making inter rather than intra-country comparisons because of variation in 
healthcare systems and patterns of ill-health.  Finally, although the completeness of the datasets 
was good for mandatory and required variables, other missing data, in particular the date of 
discharge from hospital, limited the ability to adjust for variation in duration of follow-up when 
calculating rates as incidence densities.  Nonetheless, whilst not all of the differences highlighted in 
this analysis could be explained, understanding their impact was important to ensure that the 
heterogeneity of apparently similar data is recognised and inappropriate conclusions are not drawn 
when making inter-country comparisons.   
 
4.2.4.1 My contribution to this research 
This paper represented the first major analysis of SSI data contributed to this European 
collaborative.  I was a pivotal member of the analysis team who developed the approach to analysis 
of the pilot data, I informed the approach of using incidence density and developed the methods for 
comparing rates of SSI in hip prosthesis.  My expert knowledge of SSI and surveillance systems was 
also instrumental to the interpretation of the results.  The principles that we developed for the 
analysis of the pilot data we then applied to this first prospectively captured dataset.  I subsequently 
wrote this publication as a summary of the detailed analysis and in order to explore and define the 
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implications for the comparison of rates between the HELICS countries. 
 
4.2.5 Contribution of this study to contemporary knowledge 
My work on making inter-country comparisons of rates of SSI represented an important 
collaboration between the leaders of 14 country networks for SSI surveillance, as well as the data 
managers for HELICS at the Epidemiology Unit at the Scientific Institute of Public Health in Brussels. 
At the time of this study there were few examples of such inter-country comparisons in the 
literature (Mertens et al 1994; Coello et al 2001; Moro et al 2005; Mannien et al 2007) and this work 
has subsequently been cited by at least 60 other publications.  Data contributed to the HELICS SSI 
database by 14 countries provided a unique opportunity to explore inter-country variation in rates of 
SSI as it is unusual to have access to raw, analogous data from several countries.  It was important to 
describe the key limitations of inter-country comparison to avoid inappropriate conclusions being 
drawn about relative differences in rates of SSI.  This work was also an important landmark for the 
HELICS network as it represented the first peer-reviewed publication of SSI data.  The approach that 
we developed for this analysis has formed the basis of subsequent annual statistical reports for 
HELICS (ECDC 2012a, 2012b, 2013).  Whilst the HELICS protocol was designed to report the 
cumulative incidence of SSI, our analysis demonstrated variation in surveillance methods between 
national systems that required a more sophisticated approach to the calculation of SSI rates.  Whilst 
it represented a unique, large and largely comparable set of data on the risk of SSI across a broad 
range of operative procedures, the analysis did highlight key aspects of the data that suggested 
inter-country comparisons should be made with caution.  Whilst it is often assumed that standard 
case definitions will identify the same infections in different centres or countries, they are often not 
easy to apply consistently and some criteria, in particular clinicians diagnosis and the culture of 
microorganisms from wound fluid or tissue, are prone to local variation in interpretation (Wilson et 
al; Appendix 4.4).  Ironically, acknowledging the limitations of the inter-country comparisons did 
help to sustain and increase participation in the surveillance since it enabled countries to explain 
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possible reasons for apparent differences in their rates of infection compared to other countries that 
could be used to avoid drawing unreasonable inferences about variation in performance.   
 
4.2.6 Subsequent research contributions to the field 
One of the key potential sources of variability that we identified in our attempts to compare rates 
between countries was the evidence of differences in the application of the case definitions to 
detect SSI.  A study published by Lepelletier et al in 2012 demonstrated the complexity of 
consistently identifying SSI.  They asked 140 healthcare professionals from seven specialties to 
identify SSI from 40 case-vignettes, found consensus in only 52.5% and that reading the SSI 
definition only improved agreement in specialties where the consensus had been poor initially.  
Indeed, the relatively low proportion of superficial SSI reported in the French national surveillance 
system (Figure 2: Wilson et al 2007) may have been influenced by the role of surgeons in diagnosing 
the SSI in this country, albeit according to CDC definitions (Rioux et al 2006).  Similar variation was 
found when applied to infectious disease physicians and surgeon across 10 European countries 
(Birgand et al 2013).  Talbot et al (2013) suggest that HCAI definitions are not intended for clinical 
diagnosis because the latter depend on subjective judgment to guide treatment whilst the former 
should, depend on objective criteria in order to achieve high inter-rater reliability.  Inter-rater 
reliability is strongly dependent on the systems established to capture data and audit quality and 
these are likely to vary widely between countries with different national surveillance systems 
(Lawson et al 2012).  Indeed, Gastmeier has called for a standard validation protocol that could be 
used to conduct validation studies for European surveillance systems to support more robust inter-
country comparisons and this remains a goal for the ECDC SSI surveillance network (Gastmeier et al 
2007; ECDC 2013).   
 
4.2.6.1 Post-discharge surveillance (PDS) was another key influence on rates of SSI that we 
identified.  In a comparison between SSI surveillance systems in Germany and the Netherlands major 
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differences in intensity of post-discharge surveillance were identified so that in the Dutch system 
34% of SSIs were identified after discharge compared to only 21% in the German system (Mannien et 
al 2007).  An additional problem with PDS methodology is the bias associated with some methods in 
the detection of more severe deep and organ/space SSI.  Patients with these infections are more 
likely to be readmitted to hospital for further treatment than superficial SSI and therefore more 
readily detected by active surveillance for readmissions.  This effect was clearly illustrated after the 
SSISS in England introduced requirements to report patients readmitted with SSI in 2008.  In 
orthopaedic surgery this resulted in the proportion of SSI reported that were deep and organ/space 
SSI increasing from 30 to over 50% of all SSI (HPA 2010).   Some authors do not take account of the 
effect of length of stay on case-finding.  For example, Herrazo et al (2013) identified a 7% yearly 
reduction in rates of superficial SSI in their Madrid hospital, but no variation in rate of deep SSI. 
Since they did not collect data on length of postoperative stay this study was unable to adjust for the 
potential effect of declining lengths of stay and the impact that might have on detection of 
superficial infections over this time period.  In the analysis of HELICS data we did not attempt to 
adjust rates by risk factors because missing data would have markedly reduced the precision of the 
estimated rates.  Adjustment for variation in length of post-operative stay is clearly preferable when 
comparing rates in the absence of robust PDS, and other have attempted other methods than the 
incidence density that we used in our analysis.  Astagnaeu et al (2009) included postoperative 
follow-up as a confounding variable in the logistic regression analysis that demonstrated reducing 
incidence of SSI reported by the French ISO-RAISEN surveillance network.   Mannien et al adjusted 
rates by the method used to detect SSI post-discharge in order to produce more robust estimates for 
reductions in rates of SSI following hip prosthesis observed by the Dutch PREZIES surveillance system 
between 1996 and 2006 (Mannien et al 2008).  Other surveillance systems have chosen to manage 
the problem of intensity of case finding post discharge and the bias in type of SSI detected by 
excluding superficial SSI detected PDS and only including SSI detected in inpatients or on 
readmission in the calculation of comparative rates (National Quality Forum 2008, HPA 2008).  
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However, this method also has also been demonstrated to have drawbacks since patients 
readmitted with SSI to other hospitals will underestimate the rate of SSI and, where used for public 
reporting, will undermine the accuracy of relative rankings (Yokoe et al 2013).  
 
4.2.6.2 The demand for public reporting of rates of HCAI has grown inexorably over the last decade, 
although is greater in some countries than others (Haustein et al 2011).  There are undoubtedly 
important differences between hospitals that are driven by variation in the quality of care and 
infection prevention practice, and public reporting of rates may have an important part to play in 
driving improvements (Kiernan 2013).  However, differences in case-mix and surveillance 
methodology have a marked effect on detection of cases of SSI and more work is required to 
understand how these contribute to both inter-centre and inter-country differences in rates and to 
develop mechanisms that can be used to account for them when making comparisons.  The next 
publication (Wilson et al 2008; Appendix 4.2) continues with this theme of making valid comparisons 
of rates and is focused on the development of a method for identifying hospitals with unusually high 
or low rates of SSI.  This reflects the key aim of the English surveillance system to enable comparison 
of rates with robust external benchmarks, thereby enhancing the power of the data to influence 
clinical practice and improve healthcare outcomes (Gaynes et al 2001a; Cooke et al 2002). 
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4.3 Publication 5: Rates of SSI after hip replacement as a performance indicator  
Wilson, J., Charlett, A., Leong, G. et al (2008) Rates of surgical site infection after hip 
replacement as a hospital performance indicator: analysis of data from the English 
mandatory surveillance system. Infection Control Hospital Epidemiology 19(3): 219-26. 
(Appendix 4.2) 
 
4.3.1 Background 
The demand for measures of performance in relation to healthcare began to emerge in the United 
Kingdom in the early 1990s with the introduction of the ‘internal market’ and separation of the roles 
of purchase and supplier of healthcare (Propper et al 2003).  This was underpinned by the 
publication of the Patient’s Charter in 1991, which introduced the concept of ‘performance tables’ 
designed to provide patients with information about hospitals and support their ability to choose 
services (National Health Service Executive 1991).   These measures were largely financial and 
focused on ‘processes’ rather than ‘outcomes’ until 1997 when the re-organisation of the NHS 
resulted in a new emphasis on achieving quality as well as efficiency within health services.  This 
introduced a requirement to assure ‘clinical’ as well as financial governance and the establishment 
of regional and national systems to monitor outcomes of care (Department of Health (DH ) 1998).  In 
1995, the value of measuring HCAI and enabling hospitals to compare their rates was recognised by 
the Hospital Infection Working Group of the Department of Health and PHLS which recommended 
that ‘a voluntary national reporting system should be established, which will enable hospitals to 
compare their data against aggregated anonymized data from other hospitals. Investigation by the 
hospital of areas where it appeared to differ significantly from the norm would then be possible’ (DH 
1995, Cooke et al 2000).  Initially there was reluctance to publish performance measures since it was 
perceived that the complexity of case-mix and other factors would make ‘league tables’ misleading 
(DH 1999).  However, through the 2000s as other league tables, notably those applied to schools 
were developed these views changed and a range of performance measures or ‘clinical indicators’ 
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began to be published (DH 1999).  The Department of Health began to suggest that improvements in 
data quality would enable meaningful comparison of HCAI data, and that action would be driven by 
their results (DH 2000).  This approach was supported by the National Audit Office in its report on 
the management and control of HCAI that recommended the use of HCAI surveillance data for inter-
hospital comparison and identifying poor performers (National Audit Office (NAO) 2000).  In 
February 2002, the first league table of HCAI in acute NHS Trusts in England was published in the 
form of rates of meticillin resistant Staphylococcus aureus bacteraemia rates (Chief Medical Officer 
(CMO) 2006)  Tables of performance in relation to SSI were first published by SSISS in late 2005 
following the introduction of mandatory orthopaedic SSI surveillance in April 2004 (CMO 2003).  
 
4.3.1.1 Concerns remained about the validity of healthcare performance measures, in particular 
whether the observed variation in performance can reasonably be attributed to variation in clinical 
practice (Nutley and Smith 1998) and key methodological issues that influence interpretation of 
comparisons (Goldstein and Spiegelhalter 1996; Davies and Lampel 1998; Goddard et al 2002; Adab 
et al 2002; Freeman 2002; Bird et al 2005).   
 
These concerns included:  
1. Variation in inherent risk of infection between different groups of patients exposed to 
different procedures and appropriate denominators that address this variation. 
2. Comparability of methods used to capture denominator and numerator data. 
3. Robust analytical methods that take account of the precision of point estimates and the 
effects of sampling and case-finding variation. 
4. Mechanisms of representing data to non-expert audiences (ranging across the public, 
clinicians, manager and politicians) that make the results accessible whilst minimising 
the possibility of misinterpretation. 
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4.3.1.2 Mandation of SSI surveillance in orthopaedic surgery: The national SSI surveillance system 
in England had been established on a voluntary, confidential basis in 1997.  However, in response to 
the political imperative to measure performance the Department of Health made participation in 
surveillance of SSI in orthopaedic surgery mandatory for all NHS Trusts in England from April 2004 
(CMO 2003).  The data would be published annually, be made available to the public and used to 
inform patients about risk of SSI at individual hospitals via the NHS Choice website.  The study 
described in this publication reports the analyses we used explore the issues surrounding these rate 
comparisons, factors that influence variability in the risk of developing SSI following hip prosthesis, 
and the development of robust methodologies to identify hospitals with outlying rates of SSI that 
would justify investigation.  
 
4.3.2 Conceptual and methodological development 
The mandatory orthopaedic SSI surveillance system had the advantage of being based on clearly 
defined methods and robust data quality management systems and whilst the intensity of case 
finding might vary between centres, unlike the inter-country comparisons, there were not major 
differences in approach to surveillance and healthcare delivery systems (see section 2.2.3).  At the 
time these analyses were conducted, the methodology did not include post-discharge surveillance 
(PDS) and although the length of hospital stay for elective orthopaedic surgery had decreased 
significantly in preceding decade, it was fairly consistent across participating NHS hospitals (HPA 
2005).   
 
4.3.2.1 One of the difficulties in making comparisons in rates of SSI is disparity between centres in 
the number of procedures undertaken which results in variation in the precision of estimated rates 
and highly imprecise rates being generated where surgical throughput is low.  As illustrated in figure 
2.2 (section 2.3.1.2) our initial approach to identifying hospitals with outlying rates of SSI was the 
box and whisker plot where rates above the 90th percentile were deemed as outliers.  However, 
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imprecise rates based on low number of procedures could not be reliably distinguished by this 
method and hospitals that had contributed data on less than 50 procedures were therefore excluded 
from the plot.  Since the mandatory surveillance required performance data to be available for all 
hospitals, the first set of data were published in large table and based on CI rates of SSI (the 
proportion of 100 operations that developed SSI) as it was perceived that ID would not be readily 
understood or translated back into the more intuitive measure of risk.  Confidence intervals around 
these rates were used to indicate the precision of the estimated rate and whilst they were 
accompanied by a simple description of how to interpret the rates of SSI presented in these tables; 
the concept was undoubtedly difficult for non-experts to comprehend. A different, more robust 
graphical method of discriminating hospitals with outlying rates of SSI was therefore required and 
my publication describes an approach based on the funnel plot that we subsequently developed.   
 
4.3.2.2 The concept behind the funnel plot: Distinguishing exceptional results from those expected 
by normal chance variation had been recognised as a problem in manufacturing industry by 
Shewhart in the 1920s (Shewhart 1939).  Shewhart developed the theory of statistical process 
control (SPC), which used the principles of statistical distribution to distinguish random or common 
cause variation from special cause (non random) variation (Berwick 1991).   A core component of 
this methodology is the use of prediction values, or control limits.  These are based on the principle 
that within a normal distribution, 95% of the measurements will fall with two standard deviations 
(SD) of the mean and 99% within three standard deviations (Berwick 1991, Lee and Sellick 1994).  
Measurements that fall outside these ranges therefore reflect non-random variation.  One of the key 
advantages of this methodology is that charts can be created with minimal statistical analysis but 
can detect significant signals from the data in a powerful, graphical form (Benneyan 1998a and 
1998b; Mohammed et al 2001; Benneyan et al 2003).  Although SPC charts had largely been 
confined to industrial processes, in the late 1990s Benneyan began to apply the methodology to 
measuring and communicating healthcare improvements (Benneyan et al 1998, 2003; Curran et al 
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2006).  Whilst the standard SPC chart was essentially a run chart with a series of measurements 
plotted in time order, a variation of this chart proposed that plotted observed events against the 
sample size as an indicator its precision in order to detect centres or units with outlying performance 
(Spiegelhalter 2002).  In the case of healthcare events such as the deaths associated with the GP 
Harold Shipman the number of deaths were plotted against the denominator of GP case-load 
(Mohammed et al 2001).  These funnel plots illustrate graphically the distribution of rates across 
several centres and superimpose thresholds at which the observed indicator is significantly different 
from the distribution mean that equate to the 95% (2SD) and 99.8% (3SD) control limits and equate 
to significance levels of p<0.05 and p<0.001.  These control limits can then be used as a ‘warning’ or 
‘alarm’ of poor performance and can be used to trigger investigation (Speigelhalter 2005a).  Marshall 
et al illustrated the value of funnel plots in encouraging health-service decision-makers to reduce 
over-investigation of unusual performance when compared to standard league tables (Marshall et al 
2004).  This approach therefore seemed to offer a potential solution to the problem of presenting 
data on rates of SSI in such a way that would avoid inappropriate action but encourage investigation 
of poor performance.  In addition to exploring the use of funnel plots as a method of identifying 
hospitals with outlying rates of SSI, this study also set out to describe the risk of SSI associated with 
THR and HH in England, using ID to illustrate that whilst the CI rate for HH was significantly higher 
than THR, this difference was markedly reduced if adjusted by the length of postoperative stay.   
 
4.3.3 Summary of main methods and findings 
A total of 22 160 hip prosthesis operations undertaken during a 12 months period and 430 SSI 
detected during the post-operative stay in 125 hospitals were included in the analysis.  The CI 
indicated that the rate of SSI in HH (4.06%) was three times greater than the rate for THR (1.26%).  
However, using ID (see section 4.2.3.5) to account for differences in case finding period 
demonstrated that the rate in HH was only 1.7 times higher than THR when the longer length of 
hospital stay (median 14 days vs. 7 days) was accounted for.  The rate of SSI was also significantly 
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higher following revision surgery and even higher at 11% (95%CI 6.5% - 16.9%; p<0.001) where the 
revision was due to infection.  A chi2 test for trend was used to confirm that in the 82% of records 
where complete risk factor data was available, there was a significant association between rate of 
SSI and the number of risk factors present, confirming the applicability of the risk index to this 
English dataset.  Unlike other national surveillance systems we captured data on microorganisms 
found to be causing SSI and this data was available for 84% of the SSI.  This provided evidence for the 
significant role of methicillin resistant Staphylococcus aureus as a cause of SSI, accounting for 36% of 
the infections, with 67% of the S. aureus causing SSI resistant to methicillin.  
 
4.3.3.1 Identifying outlying rates of SSI using box and whisker plots: The mandatory surveillance 
requirements were that hospitals were required to conduct a minimum of three months surveillance 
and participation by hospitals varied from all four quarters (28%) of hospitals to only one quarter 
(41% of hospitals).  In order to explore the effect of ranking hospitals by cumulative incidence of SSI 
we plotted the rates for each hospital in a box and whisker plot where the lines in the box represent 
the rate of SSI at the 25th, 50th and 75th percentile of the distribution, and the end of the lines 
(whiskers) the 10th and 90th percentiles (see figure 2.2; section 2.3.1.2).  Hospitals with rates above 
the 90th percentile were identified as outliers on the basis that a rate that was higher than 90% of 
other hospitals was more likely to reflect a problem that required investigation with sufficient 
margin for error to reduce the chance the rate was influenced by case-mix.  We identified 19 
hospitals with rates above the 90th percentile but 10 of these were based on less than 50 operations 
in both categories. This reflected two factors, firstly that there is marked variation in orthopaedic 
surgical capacity between centres and secondly that hospitals undertook surveillance for between 
three and 12 months in any year and therefore accumulate different volumes of data.  We used 
exact confidence intervals to measure the precision of these estimates, since normal approximation 
methods are unreliable for a dataset where the number of SSIs is less than 10 and can generate 
lower confidence intervals of less than zero (clearly an unrealistic value for an estimate of 
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proportion).  However, exact confidence intervals tend to be conservative and therefore generate 
intervals that are wider than necessary for a 95% confidence that they contain the true rate. 
 
4.3.3.2 Identifying outlying rates of SSI using funnel plots:  We constructed funnel plots with the 
same data, plotting the incidence rate for each hospital against the number of operations (or 
number of postoperative patient days) on which the rate was based.  We created ‘warning’ and 
‘action’ limits based on exact 95% and 99% confidence intervals (CI) around the pooled incidence 
rate and used two-sided CIs so that hospitals with either unusually high or low rates could be 
identified.  One phenomenon that is often observed with data in funnel plots is over-dispersion.  This 
occurs when there is excess variability between centres, which is not explained by chance and which 
results in a disproportionate number of centres being labelled as above or below the control limits 
(Spiegelhalter 2005b).  Such variability suggests a non-homogenous population and that other 
factors are contributing to the observed variation.  Where over-dispersion is evident, mechanisms 
such as grouping or risk stratifying centres or including a random effect to account for variation 
between hospitals in calculating control limits are required to reliably identify outliers (Spiegelhalter 
2005b; 2005c).  In the case of healthcare events, variation in the size and nature of hospitals and the 
case-mix of patients that they treat commonly result in over-dispersion.  In this SSI dataset there was 
no evidence of over-dispersion, probably because the data is based on groups of clinically similar 
procedures which minimises heterogeneity between centres.  The control intervals therefore did not 
require adjustment for over-dispersion.  Figure 4.3 illustrates the funnel plot for the cumulative 
incidence rates for THR with exact confidence intervals (control limits) set at 90%, 95% and 99%.  
This shows that only two hospitals identified as outliers by the Box and Whisker plot are identified as 
outliers with a rate above the 95% control limit on the funnel plot (see also Wilson et al 2008; 
Appendix 4.2).  The imprecision of the rates for the other Box and Whisker plot outliers means that 
their position on the funnel plot is to the far left and below the control limits.  A rate above the 
control limit should be perceived as a ‘trigger for investigation’ rather than indicating a poorly 
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performing hospital since the rate could still be explained by chance or by unusual case-mix.  
However, the value of this approach is that it focuses effort on those centres most likely to have 
unusually high (or low) rates and minimises resources being spent on the investigation of high rates 
of SSI that reflect chance variation.  In addition, by varying the point at which the control limits are 
set it is possible to balance the certainty with which outliers will be defined and the trigger for 
investigation.  
 
Figure 4.3: Funnel plot comparing rates of SSI in total hip replacement between hospitals. 
Key: Dot = rate at a hospital; Dotted line 90%CL; Dashed line 95%CL; Solid line 99%CL 
 
 
 
 
 
 
 
 
 
 
 
4.3.3.3 We also considered adjusting the rates for case-mix as this could account for high rates 
associated with case-mix variation.  However, about 20% of records in the English surveillance 
dataset could not be allocated to a NNIS Risk Group because one or more of the contributory 
variables was missing, and these would have to be excluded from the analysis.  This would make 
reduce the precision of the estimated rate still further.  In a previous analysis exploring variation in 
rates of SSI in vascular surgery I had found that whilst there was some variation in the distribution of 
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risk index between centres, in the majority of hospitals adjusting rates by indirect standardisation 
did not significantly affect their relative position compared to the crude rates (Figure 4.4).  This 
suggested that, in a UK setting where NHS hospitals are likely to have a broadly similar case-mix for 
this type of general surgery, there is limited benefit to risk-adjusting rates in the funnel plot and 
significant adverse impact associated with the reduction in eligible records to include in the rate.  
Provided that rates above the control limits are considered a trigger for investigation rather than 
punitive indicators of poor performance, then the role of risk factors in explaining a high rate can be 
explored in the subsequent investigation.  Prior risk adjustment of rates would therefore add little 
benefit.  In addition, others have pointed out the problems of using an indirect method of 
standardisation because it applies stratum specific rates of the reference population to different 
populations with the potential for confounding if the distributions are different (Delgado-Rodriguez 
and Llorca 2005). 
 
Figure 4.4: Relationship between crude rate of SSI and rate adjusted for NNIS risk index and age of patients. 
Source: Wilson 2002  
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Another important finding was the high number of hospitals with rates below the 10% control limits.  
Whilst this might reflect good performance, other likely explanations are inadequate surveillance 
methods and low sensitivity of case finding.  This is a particular problem if rates are to be used for 
inter-hospital comparison and benchmarking (Tanner et al 2013a; 2013b).   
 
4.3.4 Conclusions 
This impact of this publication was that it presented a novel method of identifying outlying rates of 
SSI developing the funnel plots for a unique use in the national benchmarking system.  In addition, 
we built on the analysis of risk factors for SSI following hip prosthesis described in Chapter 3 
(Ridgeway et al 2005; Appendix 3.2) where we had identified the issue of variation in follow-up 
period between HH and THR procedures.  We presented comprehensive data on risk factors for SSI 
with robust estimates derived from a uniquely large dataset.  In applying the methodology for 
calculating rates of SSI that we had developed for surveillance reports and used in the analysis of 
HELICS data (HPA 2005; Wilson et al 2007; Appendix 4.1), we demonstrated the more robust 
comparison of risk of SSI based on ID rather than CI.   
 
4.3.4.1 As acknowledged in the discussion, the presentation of variation in rates of SSI in a funnel 
plot might have been improved if rates could be adjusted the by risk factors for SSI, in particular the 
Risk Index factors, age and trauma which we had previously shown to significantly affect the risk of 
SSI (Ridgeway et al 2005; Appendix 3.2).  However, the disadvantage of this approach was the lack of 
complete data on these risk factors.  This meant that indirect standardisation could only be applied 
to the proportion of records with complete data and the precision of any standardised rates would 
therefore be markedly reduced.  In addition, although the standardised infection ratio (SIR) was a 
standard feature of other national surveillance systems, our evidence was that there was insufficient 
between-hospitals variation in risk factors to explain most high rates of SSI (Wilson 2002).  Evidence 
from other European surveillance systems suggested that risk adjustment does not substantially 
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alter the rank positions of individual centres because the risk factors are relatively uncommon and 
their distribution is similar across most acute care hospitals (Brümmer et al 2006).  Although some 
authors consider risk adjustment essential if rates are used for public reporting, there needs to be a 
balance between the purpose and value of risk adjustment and the effort required to collect risk 
factor data (Geubbels et al 2006; Mu et al 2011).  Evidence from the evaluation of inter-country 
comparisons suggested that variation in surveillance methodology might be a more important 
source of variation (Wilson et al 2007; Appendix 4.1).  Indeed, the high proportion of low outliers 
identified by the funnel plots in this study suggested that variation in intensity of case finding might 
also be an important factor in the English data.  This problem was explored in a survey we conducted 
of hospitals participating in SSI surveillance in 2006 where we found that 17% were using passive 
surveillance methods rather than the active case finding methods required by the surveillance 
protocol (McDougall et al 2007; Appendix 2.4).  Funnel plots therefore provided an effective 
mechanism of identifying hospitals, which may not have adequately applied the surveillance 
protocol and could be selected for further investigation of their surveillance procedures.  
 
4.3.4.2 A limitation of the SSISS surveillance at the time of this analysis was the lack of data on SSI 
that occurred after discharge.  Whilst we made some adjustment for duration of follow-up using 
incidence density, this could not account for the changing risk of SSI in the days following the 
operation.  With rapidly declining length of post-operative stays associated with elective surgery the 
need to establish robust methods of PDS that could provide reliable data on which to make inter-
hospital comparisons became an important priority for the surveillance system. The next publication 
described in this chapter presents and evaluation of the efficacy of PDS systems and the implications 
for benchmarking (Wilson et al 2013; Appendix 4.3).   
 
4.3.4.3 My contribution to this research 
 As leader of the national SSI surveillance service I had an instrumental role in developing effective 
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methods of identifying hospitals with outlying rates of SSI.  This was particularly relevant to 
orthopaedic data since the mandatory surveillance data was available to the public and rates based 
on small numbers of procedure were open to misinterpretation.  I developed the concepts 
underpinning the research and wrote the publication in order to present a detailed analysis of rates 
of SSI in hip prosthesis and demonstrate or work the advantage of funnel plots as a mechanism of 
identifying outliers. I worked with the statistician to define the funnel plot methodology and 
supervised a junior scientist who then built them. 
 
4.3.5 Contribution of this study to contemporary knowledge 
This paper represented a unique, detailed analysis of data on rates of SSI following hip prosthesis 
from a large, multicentre surveillance system together with an innovative approach to performance 
monitoring.  It has subsequently been cited by 30 other authors in relation to both rates of SSI in hip 
prosthesis and benchmarking of HCAI rates.  In terms of the application of funnel plots, whilst 
standard SPC charts had been applied to HCAI data the use of funnel plots was uncommon.  
Mohammed et al (2001) and Spiegelhalter (2005a) proposed their use as a mechanism for 
discouraging inappropriate ranking in performance monitoring of health systems and had applied 
them to evaluating mortality and MRSA bacteraemia data as a mechanism of exploring whether the 
observed variation in rates reflected true differences or normal variation (Spiegelhalter 2005c).  My 
publication was the first to demonstrate the value of funnel plots as a mechanism for displaying 
benchmarking data for SSI.  The analysis reflected the unique position of the English surveillance 
system at that time of having a mandatory component of national SSI surveillance that both enabled 
and demanded methods to support the comparison of rates across all orthopaedic centres in 
England (Haustein et al 2011).  Subsequently, funnel plots have become the standard approach to 
presentation of inter-hospital comparisons of SSI rates for the surgical site surveillance service and 
were subsequently adopted by other surveillance systems and for benchmarking other types of HCAI 
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such as ventilator-associated pneumonia in the German national surveillance system (Meyer et al 
2009; Vrijens and Hulstaert 2010; Health Protection Scotland 2013).  
 
4.3.6 Subsequent research contributions to the field 
Funnel plots are now widely recommended for assessing quality of healthcare related to surgery and 
their advantage in drawing attention to those units that lie outside statistical control limits have 
begun to be recognised, albeit that encouraging both healthcare processionals and the public to 
understand and use them is challenging (Meyer et al 2009; Marshall et al 2004).  We did not attempt 
to include risk adjustment in our funnel plots and there are no examples in the literature where this 
has been attempted with SSI data, possibly because there are few examples of SSI benchmarking 
systems where public reporting is required (Haustien et al 2011).  In a development to the crude 
rates used in our funnel plots, Morton et al (2011) developed risk adjusted funnel plots for 
comparing rates of in-hospital bacteraemia.  These rates are based on count data with a population 
level denominator such as occupied bed-days, rather than the binary data used in SSI rate 
comparisons, and may be prone to problems of ‘over-dispersion’ unless a method of adjusting for 
excess variability between institutions (e.g. size, services, activity) is applied (Morton et al 2011). 
They plotted observed counts against the expected counts (based on indirect standardization of 
rates from all institutions) and control limits calculated based on the weighted average of the risk 
adjusted rates.  Whilst acknowledging their value as an improvement tool for discouraging 
inappropriate action, the authors cite a key disadvantage of this approach is bias associated with 
indirect standardisation where there is heterogeneity of denominators (Delgardo-Rodriguez and 
Llorca 2005; Morton et al 2011).  Van Dishoeck et al suggest that differences in rates of SSI are 
explained by case-mix, however, their analysis was based on only 13,629 records in 34 Dutch 
hospitals and pooled data from a range of categories of surgery with major differences in intrinsic 
risk of SSI (Van Dishoeck et al 2013).   
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4.3.6.1 One example of a benchmarking surveillance system is the American College of Surgeons 
National Surgical Quality Improvement Program (ACS-NSQIP) which captures data on morbidity and 
mortality up to 30 days post-surgery across a range of surgical specialties (Ingraham et al 2010).  The 
standard mechanism of detecting ‘outliers’ in this system was based on the odds ratio (OR) of the 
hospital-adjusted rate and the all hospitals-adjusted rate (where an OR >1 is high outlier; OR <1 low 
outlier) combined with hospitals above and below the 10th and 90th percentile. Lawson et al 2011 
compared this standard method with control charts in reliably identifying outliers and hospitals that 
had improved or worsened between 2008 and 2009.  Among the 95 hospitals on which the analysis 
was based, the control chart method was better at discriminating hospitals with stable performance 
(specificity of 86.6%) than identifying those with worsening performance (sensitivity of 61.5%).  Thus 
57.9% of hospitals where the control chart indicated worsening performance were true and 6.6% of 
those hospitals with a worsening performance were not detected by the control chart.   This study 
assumed that the standard method of detecting outliers is completely accurate, when in reality it is 
still prone to error.  Our approach of using control limits in a funnel plot did not attempt to detect a 
trend in performance.  The evidence from Lawson et al (2011) suggested that whilst their control 
chart methodology could provide a trigger mechanism for investigating potential problems, they 
should be used with caution to avoid outliers being labelled as poor performers without further 
investigation of other important factors that might explain the rate.    
 
4.3.6.2 There have been few examples of the application of SPC chart methodology to multi-centre 
benchmarking systems for HCAI, however, there have been a number developments in this 
methodology applied to monitoring the performance of a health facility over time. These have 
included the CUSUM chart, where the difference between the benchmark and each binary outcome 
or event is cumulatively summed and deviation from the benchmark identified when the CUSUM 
value reaches a pre-determined ‘decision value’ (Noyez 2009).  Methods of risk-adjusting the 
CUSUM chart have also been proposed so that the risk of ‘failure’ is taken account of in the 
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cumulative sum.  Morton et al describe the use of cumulative ‘observed-minus-expected’ charts 
which are based on the CUSUM methodology.  In these charts the rate of SSI is adjusted by the 
factors in the Risk Index to enable the observed (O) and expected (E) rate after adjustment of risk 
factors to be calculated.  The O-E is then cumulatively summed and two standard deviation control 
limits added to indicate when the cumulated events differ from what would be expected (Morton et 
al 2010).  This approach is based on the variable life-adjusted display (VLAD) method, which has 
been used for plotting trends in mortality in order to adjust for the risk of death following cardiac 
surgery, but is based on observation of trends rather than setting defined control limits to trigger 
action (Pagel et al 2013).  As pointed out by Morton et al (2008) effective risk adjustment in relation 
to rates of SSI is limited by poor discrimination of variation in risk of SSI when the NNIS risk index is 
applied to clean and clean contaminated surgery.  In our analysis we also identified that such 
adjustment depends on the availability of complete risk factor data and this, together with the 
limitations of adjustment in discriminating risk, mean that our approach of using control limits as 
triggers for investigation rather than definitive indicators of poor performance is probably the most 
effective approach. 
 
4.3.6.3 Finally, I extended my own work in relation to monitoring performance in relation to rates of 
SSI in an analysis of overall trends in rates of SSI since the inception of mandatory surveillance for 
hip prosthesis in 2004 based on small area estimation methods (Wilson et al 2009; Appendix 4.5).  
We used this approach to adjust for small sample sizes for some hospitals (areas) by allowing their 
random effects to be correlated and adjusted for the major risk factors of ASA score and wound 
class.  In order to determine whether the observed downward trend in rates of SSI was explained by 
the declining post-operative stay (and therefore case-finding) we also included length of hospital 
stay in the models.  This analysis suggested that the introduction of mandatory surveillance was 
associated with a reduction in rate of SSI when the effects risk factors, hospital variation and 
reductions in length of post-operative stay are taken into account (Wilson et al 2009; Appendix 4.5).  
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This provided evidence that participation in this national benchmarking system was associated with 
a reduction in rate of SSI, although it was not possible to determine how such reductions might have 
been achieved or whether factors, such as changes in intensity of case-finding, may have played a 
part.  These factors are explored in the next publication presented in this chapter which was 
developed in order to explore the feasibility of benchmarking rates of SSI following caesarean 
section delivery (Wilson et al 2013; Appendix 4.3).  This category of procedures presented particular 
challenges because patients undergoing these procedures generally stay in hospital for less than four 
days.  In these circumstances, the previous approach we had used of calculating the ID of inpatient 
SSI would clearly be very imprecise as most infections would occur after discharge.  The alternative 
approach, to include SSI detected post-discharge required an evaluation of the reliability and 
reproducibility of the methods and their impact on detecting hospitals with high rates of SSI. 
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4.4 Published work 6: Inter-hospital comparison of rates of SSI following caesarean section 
delivery 
Wilson, J., Wloch, C., Saei, A., et al (2013) Inter-hospital comparison of rates of surgical site 
infection following caesarean section delivery: evaluation of a multicentre surveillance 
study. Journal of Hospital Infection. 84:44-51 (Appendix 4.3)  
 
4.4.1 Background 
Since a small number of microorganisms left behind in an operative wound take time to multiply and 
invade the surrounding tissue it can take several days after surgery for surgical site infections (SSI) to 
become apparent.  In the analysis of the European HELICS data we modelled the relationship 
between time of operation and rate of SSI (Figure 4.5).  Whilst this analysis could not account for the 
decline in intensity of case finding after discharge it did demonstrate a peak in incidence of SSI 
between six and 10 days after surgery.  This illustrates that where the length of post-operative stay is 
short a high proportion of SSI will not be detected by inpatient surveillance alone.  As discussed in 
section 4.2, this analysis of the European HELICS data also demonstrated the strong influence of 
post-discharge surveillance (PDS) on the cumulative incidence of SSI and the implications for 
comparing rates of SSI (HELICS 2005). 
 
4.4.1.1 A number of different approaches to PDS have been reported in the literature and are 
summarised in Table 4.2.  Common approaches include review of patients at out-patient visits, 
surgeon questionnaire and patient questionnaire, report cards or telephone interviews (see Table 
4.2).  However, they demonstrate some of the key challenges of PDS, in particular the difficulty in 
obtaining follow-up data on all cases and imprecision in detection of SSI from questionnaire surveys 
of both healthcare workers and patients (Whitby et al 2002).  Active review by healthcare 
professionals has also been described, but has tended to be either part of a research project rather 
than routine surveillance, or focused on specific types of surgery such as breast or caesarean section 
Chapter 4: Methodological challenges in comparing rates of surgical site infection 
 130 
where follow-up by designated healthcare professionals was part of routine care (Reilly et al 2006, 
Johnson et al 2006; Ward et al 2008).   
 
Figure 4.5: Incidence rate of surgical site infection by number of days since operation and 95% confidence 
curves (dotted lines) in 5-day analysis periods (smoothed).  Source: HELICS 2005 
 
 
Whilst it might be expected that healthcare workers could reliably identify SSI, evidence has 
suggested that sensitivity and specificity of case finding by healthcare professionals is low (Manian et 
al 1997; Whitby et al 2002; Taylor et al 2003; Sands et al 2003; Mannien et al 2006; McNeish et al 
2007).  This may reflect inconsistent interpretation of surveillance case definitions, which are 
generally complex and do not necessarily match to clinician expectation of SSI (Talbot et al 2013).  
The efficacy of some systems would also be strongly dependant on the healthcare system (Manian et 
al 1997).  For example, in the largely private healthcare systems in the USA, surgeon questionnaires 
and review of administrative data may be more effective than in the NHS where responsibility for 
surgery is likely to be devolved across a surgical team rather than a single surgeon and availability of 
detailed computerised records is limited.   
 
4.4.1.2 Another approach to PDS proposed by Reilly et al (2006) was to systematically capture SSI in 
patients readmitted with SSI.  A study by Huotari et al (2006) indicated that readmission surveillance 
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 Table 4.2: Evaluation of different m
ethods of identifying surgical site infection after discharge from
 literature published betw
een 1990 and 2010. 
 M
ethod 
Advantages 
Disadvantages 
Evidence 
Direct exam
ination of w
ound by 
trained surveillance healthcare 
professional  
Active case finding; High sensitivity 
and specificity 
Resource intensive 
U
sed as Gold Standard (W
hitby et al 2002, 
2007) or research (Bailey et al 1992) 
Direct exam
ination of w
ound as 
part of routine care 
Active case finding; data captured 
using established system
s of clinical 
care 
Case finding m
ay not be com
plete 
and m
ay be variable (W
ard et al 
2008) 
Has been used for surveillance of caesarean 
section (Johnson et al 2006, W
ard et al 
2008, Reilly et al 2006) and breast surgery 
(Reilly et al 2006).  No data on sensitivity 
and specificity. 
Patient questionnaire (paper or 
telephone) 
 
Com
bined w
ith HCW
 
questionnaire 
 
Com
bined w
ith visit by 
surveillance nurse or to GP 
Active case finding; high response 
rates can be achieved (if include 
rem
inders); Requires lim
ited 
resources. 
 Increase reliability of diagnosis of SSI 
by com
bining w
ith HCW
 review
  
HCW
 confirm
 50-75%
 of patients 
reported sym
ptom
s as SSI (Reilly et 
al 2005, M
cN
eish et al 2007, Taylor 
et al 2003). 
 PPV variable (30-83%
) but N
PV high 
(98%
)  (W
hitby et al 2002, 2007) 
Response rates of over 90%
 w
here 
com
bined m
ethods used (Stockley et al 
2001, M
itt et al 2005). 
 Response rate m
ay vary according to 
patient characteristics (Noel et al 1997) 
Surgeon questionnaire 
Can be active or passive; inexpensive; 
response rate 50-70%
 (Fanning et al 
1995, M
anian &
 M
eyer 1997) 
Response rate m
ay be highly 
variable (M
anian &
 M
eyer 1997); 
poor sensitivity/specificity (W
hitby 
et al 2002, Sands et al 1996) 
Efficacy probably dependant on healthcare 
system
; m
onthly com
puter generated lists 
of patients w
ork best (M
anian &
 M
eyer 
1997) 
Review
 w
ound at outpatient clinic 
(O
PC) visits 
High sensitivity and specificity if use 
trained observers 
Delay betw
een operation and 
attendance at O
PC; now
 
uncom
m
on for m
any procedures 
and 
68-94%
 review
ed at centralised O
PC (Ferraz 
et al 1995) 11%
 of orthopaedic SSI detected 
by this m
ethod (Huotari et al 2006) 
Review
 of adm
inistrative data 
(infection diagnoses or antibiotics) 
Inexpensive once established 
Lim
ited evidence for 
sensitivity/specificity (M
iner et al 
2004, Sands et al 2003) 
Efficacy dependant availability of data 
w
ithin healthcare system
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following orthopaedic surgery detected 43% of post-discharge SSI, however this approach was biased 
towards the detection of more severe infections and would therefore underestimate the occurrence 
of superficial SSI where the patient is likely to be treated in the community.  Several studies have 
based the PDS on reporting of SSI by the patient and have suggested that high response rates of 
approximately 80% are possible and associated with high negative predictive values, with over 90% 
of patients able to reliably indicate that they did not have an SSI (Whitby et al 2002, 2007; Reilly et al 
2006).  However, the positive predictive value of patient reporting of SSI appears to be much lower  
 (between 30-50%).  Other studies suggested that the reliability could be improved by using other 
methods to confirm patient-reported SSI, for example by contact with the GP or other healthcare 
personnel (Stockley et al 2001; Taylor et al 2003; McNeish et al 2007).   
 
4.4.1.3 The literature provided limited evidence for the efficacy of different methods of PDS as most 
studies did not compare validity or reliability or had other methodological limitations that made it 
difficult to determine efficacy, in particular they did not determine the sensitivity and specificity of 
the method (Petherick et al 2006; Taylor et al 2003; McNeish et al 2007).  Most examples of 
validation studies on SSI surveillance had involved single centres and therefore did not evaluate the 
efficacy of methods across multiple centres (Broderick et al 1990; Cardo et al 1993).  
 
4.4.1.4 As discussed in 2.3.3.2, when SSISS was established in the late 1990s the surveillance was 
directed at SSI detected during the inpatient stay.  However, the decline in length of hospital stay 
that occurred in England during the 2000s resulted in the length of post-operative stay after some 
types of elective surgery reducing to five days or less, and thus a high proportion of SSI were likely to 
be missed by inpatient based surveillance.  To address this problem, in July 2008 we introduced a 
defined methodology for PDS that included both voluntary and compulsory elements (see Table 2.1).  
These included methods for detection of SSI on readmission to hospital, post-discharge patient 
questionnaires, and review by healthcare professionals post-discharge. However, a particular 
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concern for SSISS was the potential impact of PDS methods on inter-hospital comparisons as 
variation in both the length of postoperative stay and proportion of patients followed up post 
discharge could have a significant impact on the estimated rate of SSI.  In order to explore the 
potential impact of PDS on benchmarking and the reliability of the surveillance methods we had 
implemented, I designed a study to determine the utility and validity of the methods in a set of 
hospitals conducting surveillance of SSI following caesarean section delivery (CSD), a category not 
previously included in SSISS.  The results of this study were subsequently published in Wilson et al 
2013 (Appendix 4.3). 
 
4.4.2 Conceptual and methodological development 
Surveillance for SSI following CSD would be heavily dependent on the efficacy of PDS since the 
median length of post-operative stay was only three days (Ward et al 2008).  However, unlike most 
other types of surgery the routine follow up of all women for up to 10 days post delivery by a 
community midwife (CMW) enabled active surveillance by a healthcare professional for this period 
(Ward et al 2008).  In addition to CMW follow-up, a patient questionnaire (PQ) was used to identify 
SSI that occurred between 10 and 30 days post operation or missed by the other surveillance 
methods.  Since evidence from other studies indicated that patients were likely to over-report 
problems with their wound as SSI (Whitby et al 2002), our method did not require patients to identify 
if they had an SSI but to answer questions about the wound.  Patients whose responses suggested a 
possible SSI were then phoned by the surveillance coordinator to check the symptoms and only those 
that met the definition of SSI were included.  Since the wounds of these patients were not directly 
visualised by the surveillance personnel, the criteria for SSI had to be slightly adapted to account for 
the ‘clinician diagnosis’ of SSI being made by the GP.  The study was therefore designed to evaluate 
the reliability of the combination of these surveillance methods for detecting SSI in inpatients and 
readmissions, and post discharge by CMW and patient questionnaire.   
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4.4.2.1 Recruitment of hospitals and data collection: This was a pragmatic study to assess the 
reliability of these methods applied by hospitals participating in SSISS.  We therefore recruited 
hospitals to participate in the study from those already participating in SSISS, used the local hospital 
staff to collect the surveillance data and trained them to collect additional data required to evaluate 
the surveillance.  Each hospital undertook either one or two three-month surveillance periods and 
established systems for implementing and coordinating the surveillance locally, based on the 
standard surveillance protocol and methods of case-finding described in Table 2.1.  This approach 
enabled us to evaluate the reliability of the surveillance methods in detecting SSI and the feasibility 
of using methods based on PDS for benchmarking rates of SSI.  Since SSIs reported by the patient 
might be considered as less reliable than those reported by a healthcare worker, we categorised 
rates into those reported only by healthcare professionals and those reported by both patient and 
healthcare professional; where the SSI was reported by a healthcare profession and the patient the 
latter took precedence in the classification of detection source. 
 
4.4.2.2 Methods used to determine sensitivity and specificity of case finding: The optimal design for 
a study to validate the accuracy of diagnostic tests (such as the detection of SSI) has been suggested 
to contain three key features (Petherick et al 2006): 
 Series of patients from an appropriate clinical spectrum 
 Patients undergo both the test and a reference or Gold standard test regardless of the results 
of either test 
 The reference or Gold Standard test should be measured independently of the study test 
 
In designing our study we selected a random sample of four hospitals from the 14 participating in 
the study in which to validate the surveillance methods and used review of clinical records by two 
expert assessors as the Gold Standard test.  Conventionally, the calculation of the parameters used 
to describe the reliability of a test (namely, the prevalence, sensitivity, specificity, positive predictive 
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value (PPV) and negative predictive value (NPV)) require the test to be measured against the Gold 
Standard for all negative and positive results.  However, it was impractical to review all the 
surveillance reports from each of these hospitals against this Gold Standard since this would require 
assessment of over 1000 records. A random sample of 10% of reports from patients where no SSI 
was documented was therefore selected, together with all patients who were documented in the 
surveillance to have an SSI.  However, since measurement of the parameters from this sample would 
be extremely biased we needed to take account of this when making our estimates.  We chose to 
achieve this by treating test negative cases and test positive cases as two samples from two 
independent binomial distributions and applying a logistic linear mixed effect model to predict non-
sampled cases.  This method also enabled us to estimate 95% confidence intervals for each of the 
measures.  
 
4.4.2.3 Evaluation of the impact of the surveillance methods on benchmarking: Other studies had 
reported the involvement of community midwives (CMW) in surveillance but had not explored 
variation in response rates of either CMW or patients, and had not considered the implications of 
variation in case-finding for a benchmarking system (Huotari et al 2006; Reilly et al 2006; Johnson et 
al 2006; Ward et al 2008).  The second aim of this study was therefore to determine the utility of 
these surveillance methods in establishing benchmark rates of SSI and the implications for valid 
inter-hospital comparison of rates.  Accurate data on both denominator and numerator are required 
to calculate reliable rates of SSI, we therefore aimed to determine the reliability of the denominator 
by comparing the number of CSD captured by the surveillance with the number captured by the 
routine administrative databases in each hospital.  We evaluated the reliability of the numerator 
based on all SSI detected up to 30 days after CSD (in line with the definition of SSI) by exploring the 
proportion of women followed-up after discharge by the CMW and the proportion from whom data 
was captured in the PQ at each participating hospital.  However, we also attempted to define this 
relationship statistically using a multinomial linear mixed model, which included category of PDS 
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detection method for SSI or no SSI and surveillance period as predictors, and added hospital as a 
random effect to take account of variation not explained by the detection method.  This enabled us 
to develop more robust estimates of the impact of variation in case-finding on rates of SSI by 
adjusting for the effect of PDS method, hospital and surveillance period.  
 
4.4.2.4 Resources required for surveillance and experience of establishing surveillance locally: We 
gave a structured questionnaire to the surveillance coordinator at each participating hospital to 
capture data on staff time and other resources required to conduct the surveillance; the number of 
patients readmitted to hospital and how many of these had SSI; CSD identified in hospitals databases 
and not detected by surveillance; the method used to captured data on PQs, number followed up 
and how many were determined to have SSI; and their views on the efficacy of the surveillance.  This 
combination of qualitative and quantitative data was used to draw conclusions about the value of 
the surveillance for benchmarking and contextual factors that might influence the efficacy of the 
surveillance and reliability of the rates of SSI.  
 
4.4.3 Summary of main methods and findings 
We recruited 15 hospitals to participate in the study, although one discontinued surveillance after 
six weeks and was subsequently excluded from the analysis.  The remaining 14 hospitals captured 
data in a total of 21 surveillance periods on 4107 operations and 404 SSI.  Overall, the surveillance 
identified an SSI rate of 9.8% following CSD; with 89% of the SSI detected post-discharge, 55% by the 
CMW and 34% by the PQ.   If the SSI was based only on those SSI detected by healthcare workers 
then the rate of SSI was 6.5%.  Not only were these rates of SSI relatively high compared to other 
types of clean contaminated surgery (Wloch et al 2012), but there was considerable variation in 
infection rate between hospitals, with the overall rates ranging from 2.5 to 26.7% and those based 
on healthcare-worker defined SSI ranging from 0.8 to 18.3%.  A key criteria for a benchmarking 
system is that as far as possible sources of variation attributable to surveillance methodology and 
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case mix are eliminated so that observed differences are more likely to be attributable to variation in 
clinical practice.  However, despite the standardised surveillance protocol and training programme 
for hospitals participating in the study, there was marked variation in completeness of follow-up by 
both CMW and PQ between hospitals.  Whilst the median return rate for CMW surveillance record 
and PQs was 71% and 44% respectively, there was marked variation in return rate between 
hospitals.  In terms of CMWs return rates ranged from 8.8% to 97.8% with a return rate of less than 
70% in 48% of the surveillance periods.  For PQs the range was 5.6% to 73.4% with only three 
hospitals achieving a return rate of over 70%.   
 
4.4.3.1 The efficacy of PDS was clearly paramount for robust benchmarking since the majority of 
SSIs were detected after discharge from hospital.  The linear relationship between the observed rate 
of SSI and the proportion of patients with a CMW surveillance report could be seen in a simple graph 
(Figure 4.6).   However, the multinomial linear mixed model enabled us to more accurately 
determine the relationship between the PDS method and odds of detecting SSI.  In the case of CMW 
follow-up, the odds ratio of detecting SSI increased significantly with each unit (percentage) increase 
in the proportion of patients reviewed above the mean of 62.4% (OR 1.02; 95%CI 1.005 – 1.026; 
p=0.003).  With PDS based on PQ, the odds ratio of detecting SSI also increased significantly in 
response rates above the mean of 43.5% (OR 1.034; 95% CI 1.016-1.052; p=0.025).  This finding had 
important implications for using a surveillance system based largely on method of PDS for 
benchmarking, since variation in rates of SSI detected by the surveillance were at least in part 
explained by inter-hospital variation in intensity of case-finding.  
 
4.4.3.2 The data captured in the survey of surveillance coordinators pointed to some factors related 
to local organisation of the surveillance that affected the efficacy of case-finding and contributed to 
this variation.  Hospitals that achieved greater than 70% return rates for PQs used a method based 
on phoning patients and surveillance periods.   
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Figure 4.6: Relationship betw
een proportion of operations w
ith post-discharge follow
-up and rate of SSI (a) Percentage of com
m
unity m
idw
ife (CM
W
) form
s returned 
versus the rate of SSI (detected by healthcare professional) (b) Percentage of patient post- discharge patient questionnaire (PDQ
) com
pleted versus the rate of SSI 
(detected by all m
ethods).  
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In addition, where the surveillance was coordinated by maternity rather than infection control, 
CMW return rates were significantly higher (79% vs 56%; p<0.001) but PQ return rates significantly 
lower (35% vs 47%; p<0.001).  Other factors reported by the hospitals to support implementation of 
the surveillance were high quality information systems, a designated surveillance coordinator, 
specific training of CMW and involvement of a senior member of the maternity department.  
Interestingly, whilst the average resource requirement for surveillance of 200 CSD per quarter was 
estimated from the hospital survey to be 23 person-hours per week the median time ranged from 28 
to 219 hours per week and more time spent of surveillance was not necessarily associated with 
better follow-up rates.  
 
4.4.3.3 Results of the validation of the methods: A total of 226 cases from the four hospitals chosen 
for the case-note were included in the validation study, 136 of which were SSI. In the linear predictor 
model developed to estimate the sensitivity and specificity of the surveillance methods we included 
a hospital random effect to account for the extra variation that was not explained by fixed effects.  
The estimated values from this model were used to predict non-sampled cases and these were 
added to sample cases to determine the best linear unbiased estimates for prevalence, sensitivity, 
specificity, PPV and NPVs and their associated 95% confidence intervals. This analysis found that the 
combined surveillance methods were very reliable in identifying patients without SSI with a high 
specificity and NPV of 99%, and did not mis-classify patients with SSI.  Although the sensitivity of 
case finding and PPV was lower, at 91% was still good, and mis-classification of patients with SSI was 
largely attributable to misinterpretation of the patient questionnaire at one hospital.   This finding 
was interesting because it illustrated that by using PQs as a trigger for detecting SSI we could reliably 
identify SSIs, but it also pointed to the potential for inter-hospital variation where the responses 
were not accurately validated by the surveillance coordinator.  In addition, in a separate analysis of 
the PQ responses we found that in PQs where the patient had reported potential signs of SSI the 
follow-up by the surveillance coordinator resulted in 39% being found not to meet the criteria for 
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SSI.  These findings resonated with those of Whitby et al (2002) who reported that whilst patients 
could not reliably identify symptoms that met the definition of SSI, their recall of antibiotics 
prescribed by the GP was the most valid proxy measure of SSI (Pearson correlation coefficient 0.76) 
and that the negative predictive value associated with patients reporting was very high (98%).  This 
compares with our approach of using patients to report problems with wound healing potentially 
indicative of SSI but combining this with clinician assessment to improve the sensitivity of case 
finding. 
 
4.4.3.5 Whilst the study was not designed to formally test reductions in rates of SSI associated with 
the surveillance, data from the hospital survey identified 10 that reported improvements in 
operative care made as a result of the focus provided by the surveillance.  In five of the seven 
hospitals that participated in two surveillance periods, there was a decrease in rate of SSI with a 
mean decrease of 50% between the two periods. 
 
4.4.4 Conclusions 
This study confirmed the feasibility of the surveillance methods applied to CSD, where the length of 
postoperative stay was very short and therefore detection of SSI was largely reliant on PDS.  It also 
demonstrated the high rates of SSI associated with CSD and the potential for surveillance to drive 
improvements in practice and reductions in rates of SSI.  However, whilst the study demonstrated 
the reliability of the PDS methods to detect SSI, it also identified the major problem of achieving 
consistent follow-up after discharge across multiple centres and the limitations of benchmarking 
where surveillance is heavily reliant on PDS with these inherent difficulties.  The variation in follow-
up of cases was very marked, ranging from less than 10% to over 97% for CMW and less than 6% to 
over 73% for PQ, with only half of hospitals achieving CMW or PQ follow-up rates of more than 50%.  
This means that not only is PDS likely to miss a high proportion of SSI where follow-up rates are poor 
but that the rates reported will be strongly dependant on the efficacy of the surveillance.  Local 
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organisation of the surveillance appeared to have an important effect in determining the efficacy of 
case-finding and thus the reliability of the estimated rate and this was not explained by resources 
allocated to the surveillance.  Although clinical involvement in the surveillance was associated with 
better response rates, the study also demonstrated the practical challenges of accomplishing this 
across all centres in a devolved surveillance system.  Whilst other authors have focused on the need 
to develop valid and reliable methods of case-ascertainment post discharge (Petherick et al 2006), 
this study was unique in highlighting the additional challenge of creating a method that produces 
consistent and reproducible results across a range of different centres.  
 
4.4.4.1 My contribution to this research 
The introduction of methods of PDS to the SSI surveillance system prompted me to undertaken this 
study as a means of evaluating their efficacy.   In addition, there was considerable demand for 
adding CSD as a surveillance category but in the light of my experience of inter-country differences 
in application of PDS, I was interested in investigating the potential effect of variation in intensity of 
PDS on rates of SSI and the implications for benchmarking.  I therefore designed the study, 
developed the approach to analysis and sought advice from the statistician about how to handling 
the sampling strategy for assessing reliability of the methods and in estimating the effect of variation 
in case-finding on reported rates of SSI.  I then used my knowledge and experience of SSI 
surveillance benchmarking to develop the discussion and consider the findings in the context of 
using SSI rates for performance measurement. I interpreted the data and took the lead on writing 
the paper. 
 
4.4.5 Contribution of this study to contemporary knowledge 
At the time of this study there were three examples in the literature of validation studies conducted 
on SSI surveillance systems, all of which had significant limitations.  McCoubrey et al (2006) studied 
surveillance data collected by 27 hospitals participating in the national SSI surveillance programme.  
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They randomly selected 60 cases without SSI and the 15 most recent cases with SSI from each 
hospital.  The presence or absence of SSI was validated by review of the case notes by a trained, 
independent member of staff.  The main limitation was that the assessment was made on only a 
sample of cases rather than all cases independently of the test result, however it was not clear 
whether the calculations for sensitivity and specificity were adjusted in the analysis to account for 
the bias inherent in this approach. Secondly since the case definitions included a criteria for ‘clinician 
diagnosis’ which was frequently not documented, calculations of sensitivity and specificity were 
made on the assumption that SSI reported to the surveillance system were valid even if not 
documented in case records.  This would tend to over-estimate the reliability of the method.  A 
second study used a similar approach of sampling patient charts (10 with SSI and 40 without) and 
applied the results to the aggregated data without accounting for bias in the sampling method 
(Huotari et al 2007). A validation study conducted on the national SSI surveillance system in the 
Netherlands, involved validating the 20 most recently completed records of patients included in the 
surveillance regardless of SSI status and five most recently completed records of patients reported 
with SSI, with the judgement of the validation team considered to be the Gold Standard test 
(Mannien et al 2007). This study acknowledged the overestimation of sensitivity and specific 
associated with this method and reported only the NPV and PPV.  However, because only a small 
number of records were evaluated at each hospital, the confidence intervals around these estimates 
would be very wide.  Thus our research is important because it describes a practical approach to 
measuring reliability of PDS and a pragmatic analysis of the impact of variation in intensity of PDS on 
the reliability of rate comparisons. 
 
4.4.6 Subsequent research contributions to the field 
PDS has become a source of considerable controversy with some authors asserting it should be a 
required component of national benchmarking systems in order to capture data on the full burden of 
SSI (Tanner et al 2013; Leaper et al 2013).  However, our study has clearly illustrated that this 
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approach is fraught with difficulty, that even within the environment of a research project complete 
follow-up of all surgical cases once they have been discharged from hospital is unrealistic (Lamagni et 
al 2013).   As contested by Hall et al (2013) PDS is generally not cost-effective and rates of SSI based 
on PDS are not a good indicator for performance measurement and should therefore be used with 
caution in benchmarking.  Similarly, linking incentives to SSI rates when variation in case-finding is 
either not considered or accounted for have been recognised as a significant danger associated with 
quality improvement programmes such as the Hospital Inpatient Quality Reporting system in the USA 
(Bratzler 2013).  The solutions appear to lie either in developing focused, resource intensive but high 
quality data capture systems such as the American College of Surgeons NSQIP where data on a 
proportion of surgical procedures is captured by designated staff and subject to comprehensive 
validation and audit, or working with underestimated rates based on SSI detected in hospital or 
through incomplete post-discharge data, and using more complex methods of adjusting for cases the 
surveillance methods may have missed (Anderson et al 2008; Biscione et al 2009; Cohen et al 2013; 
Bratzler 2013). 
 
4.5 Summary of chapter 
The three studies included in this chapter illustrate some of the challenges associated with 
comparing rates of SSI.  In both the European and English datasets one of the key difficulties is the 
lack of consistent follow-up after discharge from hospital and the profound effect that this has on 
the detection of SSI for procedures where the length of hospital stay is short (Wilson et al 2007; 
Appendix 4.1, Wilson et al 2013; Appendix 4.3).  Whilst my research has not necessarily provided a 
simple solution to this problem it has illustrated the need for caution in making comparisons 
between rates of SSI and provided evidence to counter the argument that PDS is should be an 
essential component of benchmarking systems.  I have also illustrated that there are other 
approaches to adjusting for variation in length of follow-up such as a metric based on incidence-
density that maybe more appropriate for making comparisons where there is wide variation in 
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length of post-operative stay (Wilson et al 2007; Appendix 4.1).  Whilst developing SSI surveillance 
systems that assure complete follow-up of all eligible patient both in hospital and after discharge is 
an unrealistic proposition, it is important to recognise that this is not essential when the value of 
benchmarking systems lies in their ability to identify potentially poor performance that can then be 
investigated further.  The use of data to improve the quality of care was identified as a key benefit of 
the CSD surveillance, even though the variation in case-finding made it difficult to draw precise 
conclusions about variations in rates between hospitals (Wilson et al 2013; Appendix 4.3).  In using 
funnel plots to support the detection of outliers we have developed a simple and visually effective 
method of supporting this aim that is now being increasingly recognized as useful for benchmarking. 
In Chapter 5, I will explore some of the different methodological issues that emerge when exploring 
trends in rates of infection using a different type of surveillance data captured on cases of 
bloodstream infection. 
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CHAPTER 5 
 
Exploring the epidemiology of healthcare associated infection through 
the analysis of trends in national surveillance data 
 
5.1 Introduction 
The research presented in this chapter focuses on the analysis of trends emerging from 
national surveillance data.  It includes two published works in which examine bloodstream 
infection (BSI) surveillance data from both a general surveillance system (LabBase) and a 
specific system for methicillin resistant Staphylococcus aureus (MESS).  Key to these analyses 
were mechanisms to address methodological issues associated with using surveillance data 
for analysis of trends.  Bloodstream infections cause significant morbidity and mortality.  
They affect two in every 1000 hospital admissions and are associated with an almost three 
time increased risk of mortality (OR 2.8; 95%CI 1.4 – 5.6) (Fabbro-Peray et al 2007).  They are 
estimated to account for mortality in 6.22 per 1000 discharges (Pittet and Wenzel 1996).  In 
the UK, BSI surveillance had been established as part of the Public Health Laboratory Service 
(PHLS) laboratory surveillance system since the 1940s although not in a comprehensive way 
until the 1990s when the centralised database (LabBase), electronic data capture and 
reporting systems were established (Grant and Eke 1993) (see section 2.2.4).  This 
surveillance was ‘microorganism’ rather than infection focused and therefore cases were 
referred to as ‘bacteraemia’, since clinical data to support the diagnosis of infection was not 
captured.  The PHLS (later the Health Protection Agency (HPA)) reported the number of 
cases of bacteraemia detected by this surveillance in the Communicable Disease Reports.  
These reports focused on a single genus or species of pathogen and tended to report actual 
number of cases and regional differences rather than trends over time, or the comparative 
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importance of difference pathogens.  There were a number of problems with this 
bacteraemia surveillance that complicated the analysis of trends.  Firstly, it was a passive 
surveillance system that relied on laboratories voluntarily reporting cases to the central 
system and was therefore vulnerable to variation in case ascertainment associated with 
changes in the number of reporting laboratories and the methods of reporting over time.  
The development in the early 1990s of software (CoSurv) to support the automatic transfer 
of data from local Laboratory Information Management Systems (LIMS) was particularly 
influential.  This electronic reporting increased the quality, completeness and timeliness of 
reporting by enabling file outputs from the laboratory to be converted to a standard format 
(LabLink), exported into CoSurv and from there into LabBase (HPA 2008b).  Secondly, whilst 
BSI are more easily identified than most other HCAI because the diagnosis is primarily based 
on a laboratory result (Horan et al 2008), the laboratory data includes little information 
about the clinical condition of the patient.  This makes it difficult to determine the primary 
source of the BSI and reliably attribute it to a hospital or a community source.  In addition, 
whilst laboratories would be expected to report ‘clinically significant’ isolates from blood, 
this was not based on defined criteria (HPA 2008b).  Although the presence of any organisms 
in the blood is generally a significant finding, it is possible to contaminate a blood culture 
with skin microorganisms at the time the sample is taken (Thylefors et al 1998; Dhillon et al 
2009).  This produces a ‘false positive’ result that can be difficult to distinguish from a true 
infection without information on specific criteria such as presence of fever or hypotension 
(Horan et al 2008).   
 
5.1.2 Despite these limitations, the surveillance of BSIs at a national level has the unique 
advantage of enabling changes in the epidemiology of pathogens causing serious infections 
to be detected, that would not be apparent from the relatively small number of cases 
available from single laboratories.  The trends apparent in this bacteraemia surveillance 
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undoubtedly influenced the national policy.  The year on year increase in the proportion of 
Staphylococcus aureus isolates resistant to methicillin that occurred during the 1990s (rising 
from 2% in 1990 to a peak of 43% in 2002) detected by this surveillance was one of the main 
factors that compelled the Government to establish a programme of activity aimed at 
reducing MRSA bacteraemia by 50%.  This included the patient level, web-based reporting 
system called the MRSA bacteraemia Electronic Surveillance System (MESS) which was 
established in October 2005 and was the basis of data analysis presented in section 5.3  
(Pearson et al 2009).  The following research work describes the analysis of trends in 
pathogens causing bacteraemia in the 2000s, the factors influencing the changing 
epidemiology of these organisms and implications for public health. 
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5.2 Published work 7: Trends in pathogen causing bacteremia in England 
Wilson, J., Elgohari, S., Livermore, D. et al (2011). Trends among pathogens reported 
as causing bacteraemia in England: 2004 – 2008.  Clinical Microbiology & Infection. 
17(3): 451-8 (Appendix 5.1). 
 
5.2.1 Background 
The central LabBase database in England and Wales was unique in capturing data on all 
bloodstream infections from microbiology laboratories at a large number of hospitals (see 
section 2.2.3).  Most other surveillance systems were principally hospital or regionally based, 
focused on only primary bacteraemia or hospital-acquired bacteraemia, or targeted specific 
pathogens in sentinel hospitals (Wisplinghoff et al 2004; Perencevich et al 2008; Rojo et al 
1999; Vrijens et al 2010; Gagliotti et al 2011).  Nonetheless, the only comprehensive analysis 
of the pathogens causing bacteraemias reported to LabBase, and associated trends, had 
been published 10 years previously (Reacher et al 2000).  Although the data was described in 
routine Communicable Disease Reports published by the PHLS/HPA, the focus of these was 
single pathogens or groups of related pathogens.  Therefore, recent comparative trends in 
causative organisms particularly in the context of the marked decline of Staphylococcus 
aureus in the late 2000s, had not been investigated.  Similarly, although by 2007 the annual 
report on HCAI surveillance mentioned that Escherichia coli had replaced S. aureus as the 
most common cause of bacteraemia it only included a crude analysis of case reports (HPA 
2007; 2008a).  My observation of the crude comparative trends of these pathogens that 
were apparent in this report prompted me to develop a methodology that could be used to 
analyse these trends, that would account for variation in case ascertainment over time and 
more fully investigate the epidemiology of the infections.  
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5.2.2 Conceptual and methodological development 
Laboratories participating in the laboratory surveillance system in England reported all 
‘clinically significant isolates’ from clinical cultures including blood to the national database 
(LabBase) via the local CoSurv modules.  Records included a patient identifier, mostly the 
surname encoded as a Soundex code.  These are used to assure the confidentiality of the 
report since the Soundex code is not unique to a surname but when combined with other 
patient data can be used to enable record matching and de-duplication.  Laboratories were 
asked to make the reports as soon as possible after the organism was identified, preferably 
at the same time as the report was issued to the requester, however they had up to six 
months after identification for reports to be submitted (HPA 2008b).  A record within CoSurv 
and LabBase is based on a principle called OPIE (Organism-Patient-Illness-Episode).  This 
means that each OPIE record constitutes a distinct organism in a patient in a defined period 
of time.  If a patient had been infected by two different organisms at the same time 
(including two different sub-types of a single species), there would be two distinct OPIEs. 
Similarly, an episode period is set at two weeks, therefore when the same organism is 
isolated from the same patient within two weeks it would be allocated to the same OPIE but 
after two weeks would be recorded as a new OPIE.  Laboratories are expected to report all 
clinically significant isolates/infections, although in practice, without further investigation, 
the laboratory may not be able to distinguish whether some isolates from blood were 
‘clinically significant’.  For each OPIE there was a limited set of data associated with the 
infection as shown in table 5.1.  Whilst some OPIEs may have reflected blood cultures that 
were contaminated during collection, contamination is most likely to be due to skin 
microorganisms, such as Staphylococcus epidermidis, and most other pathogens isolated 
from blood are highly likely to reflect infection (Horan 1992; 2008; Nosocomial Infection 
National Surveillance Service 2001). 
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Table 5.1: Core dataset reported to the national laboratory surveillance system in England 
Data item Description 
Source Lab  Required data item 
Reporting Lab*  
Patient identification* Soundex and initial; or surname and initial; or NHS 
number; or hospital number 
Date of birth* Or age if not available  
Sex*  
Organism* Full organism name and any typing results 
Date of onset Date of onset of the illness caused by the  organism being 
reported 
Specimen type(s)* E.g. CSF, blood, sputum, serum (serology results) 
Specimen date(s)* Date the specimen was collected from the patient. If this is 
not known, use the date the specimen was received at the 
source laboratory 
Identification method(s) Method used to identify the organism 
Postcode  Full postcode of the patient residence. 
District of residence:  Patient’s Health Authority and Local Authority of residence 
(or of GP if not available). 
Ethnicity  Required under the Race Relations Amendment Act 2001. 
 
5.2.2.1 Establishing an appropriate denominator: The approach to calculating and 
comparing rates of bloodstream infection is dependent of the population included in 
surveillance and the criteria used to define cases of infection.  Although a positive blood 
culture result indicates a BSI, defining those associated with healthcare and capturing 
denominator data that corresponds to hospital patients at risk of BSI is much more 
problematic because not all healthcare is delivered in a hospital setting and the source of 
the primary infection may not be easily identified.  Although ‘hospital-acquired’ was 
included as a field in the supplementary ‘epidemiological features’ dataset in LabBase, 
reporting this data was voluntary, there was no specific definition and their identification 
would require review of the patient by a clinician, it was rarely completed.  The location of 
the patient when the blood culture was taken was available for 69% of episodes, although 
this was also not a reliable indicator of a hospital or community source since it would be 
likely that most patients would have the blood taken in hospital regardless of the origin of 
their infection.  Whilst we could have attempted to calculate rates of BSI by the number of 
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patients admitted or the total number of ‘patient-days’ in the hospitals associated with the 
reporting laboratory, we chose instead to use a denominator derived from the Office for 
National Statistics mid-year population estimates.  This was for two main reasons, firstly we 
could not be certain that all the cases were hospital acquired and secondly because some 
reporting laboratories processed specimens from more than one hospital and the source of 
the records could not be reliably distinguished (Anon 2001).  
 
5.2.2.2 Methods used in trend analysis: Our primary interest was to establish if there was 
an increase in overall incidence of BSI and whether there was evidence of changes in the 
proportion of episodes attributable to different pathogens that might suggest an underlying 
changing epidemiology of these infections, whilst adjusting for changes in the number of 
cases over time.  We used data from 2008 to describe the current distribution of pathogens 
causing bacteramia in England, since for some laboratories there could be a delay of up to 
six months before data was uploaded this was the most recent complete dataset available.  
The period we selected for review of trends was the five years prior to 2009.  However, we 
noticed that although LabBase generally received approximately 100 000 bacteraemia 
reports annually from laboratories in England, there was a 20% increase in reports in the 
period between 2004 and 2008.  Since this coincided with a major project by the HPA to 
extend participation by commissioning LabLink outputs from two major providers of LIMS 
which resulted in new laboratories contributing data and some existing laboratories 
increasing reporting, our analysis of trends needed to take account of these structural 
changes in order minimise potential bias associated with variation in case ascertainment.  
We sought to do this by excluding data from laboratories that had converted from annual to 
electronic reporting during this period, or where there was evidence of incomplete or 
inconsistent reporting.   
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5.2.2.3 In determining whether there was evidence of trends in the relative importance of 
different pathogens causing bacteraemia in England we chose to use a generalized linear 
model to compare the proportions of microorganisms responsible for bacteraemia between 
two rolling years.  This model allows for the ‘events’ to have an arbitrary distribution rather 
than a normal distribution, and rather than assuming that the response to the predictor 
variables is linear, the model uses an arbitrary function of the dependent variable (a link 
function) that varies linearly with the predictor variables.  Such models account for 
associations that may be geometric rather than constant and where the dependent variable 
is not normally distributed, for example it has fixed limits or varies by small amounts 
(Dobsen and Barnet 2002).  Since we were modeling count data i.e. number of infections in a 
defined period of time, we used a Poisson log-link function since the occurrence of events 
over time would reflect a Poisson probability distribution.  A similar Poisson regression 
model had been used in the previous analysis of trends in LabBase data (Reacher et al 2000), 
in the evaluation of secular trends in incidence in data on BSIs submitted to the 
communicable disease surveillance registry in Finland (Lyytikäinen et al 2005, Skogberg et al 
2008), and in a time-series analysis exploring the association between season and number of 
infections in a hospital population (Perencevich et al 2008).  Other studies had used less 
sophisticated approaches such as the Cochran-Armitage test for trends in categorical data to 
evaluate changes in annual proportion of Gram-negative organisms and differences across 
units (Albrecht et al 2006), or Chi2 and two sample T tests as used by Wisplinghoff et al 
(2004) to evaluate secular trends in organisms causing hospital-acquired BSI.  
 
5.2.2.4 Whilst other studies have evaluated trends in a wide range of clinical specimens 
(Perencevich et al 2008), this study focused only on bacteremia.  This has the advantage of 
providing a greater precision of identification than might be the case with some specimens 
such as urines or wound cultures where the level of identification may not go beyond genus 
Chapter 5: Analysis of trends in surveillance data 
 153 
or main group, such as coliforms, or be clearly indicative of infection.  We defined the 
pathogens by a combination of species and genus depending on the predominance of the 
organism and conventional approach used in previous analyses of LabBase data (HPR 
2008b).  
 
5.2.3 Summary of main methods and findings 
We found that in 2008 the overall rate of BSI was 189 per 100 000 population reported by 
the 210 (95% of all) laboratories in England reporting to LabBase at this time.  This was 
higher than that reported by the only other study based on a national surveillance system in 
Finland which found an annualised incidence of 125 cases/100 000 population between 
1995 and 2002 (Skogberg et al 2008).  We were unable to compare the rate with the 
incidence in England in the previous analysis as this was not reported by Reacher et al (2000) 
although the validity of such comparison would be limited by changes in case ascertainment 
and completeness of reporting that occurred between the 1990s and 2008.   
 
5.2.3.1 Age/sex distribution: We found that age and gender significantly affected the 
epidemiology of bacteremia.  A higher proportion of cases occurred in males (54%) and they 
were more likely than females to have bacteraemia caused by Staphylococcus aureus (13% 
vs 10%; p <0.001) and less likely to have bacteremia caused by E. coli (19% vs 27%; P<0.001).  
The increased risk of S. aureus bacteraemia in males had been reported by the mandatory 
MRSA surveillance system, although without comparisons to other pathogens (HPA 2007; 
2008a).  Other studies on bacteraemia either did not report data on gender or did not 
explore differences in risk associated with different pathogens (Skoberg et al 2008; Reacher 
at al 2000; Wisplinghoff et al 2004).  Our analysis was also able to describe the significant 
variation in risk of bacteremia by age, and demonstrated differences in causative pathogen 
among different age groups.  More than half the bacteraemias (55%) occurred in people 
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over 65 years.  As might be expected, the extremes of age were most vulnerable to these 
infections with the rate in the over 75 year old age group over four times higher than the 
average rate (857/100 000 population) and in the under one year olds over three times 
higher.  Reacher et al (2000) also identified increased risk of bacteraemia in these age 
groups but much lower population rates (437 and 366 /100 000 respectively).  The 
difference in distribution of pathogens between gender and age groups pointed to 
differences in in risk of for source infections, with the genitourinary tract being a primary 
source of E. coli bacteraemia and evidence that the risk of urinary tract infection increases 
with age especially in women (Mathews and Lancaster 2011; Wilson et al 2011).  In the 
under one year-olds over a third of bacteraemia were caused by coagulase negative 
staphylococci (CNS), and this remained a common cause of bacteremia in all paediatric age 
groups, compared to adults where in the over 65s they accounted for less than 20% of the 
infections.  Whilst some of these cases may have reflected blood cultures contaminated with 
skin organisms during collection, CNS bacteraemia are also commonly linked to device-
associated infections in children and this analysis underlined the key importance of these as 
a source of infection in children (Favre et al 2005; Venkatesh et al 2006; Henderson et al 
2010).   
 
5.2.3.2 Trends in pathogens causing bacteraemia: We used the 2008 data to determine the 
predominant pathogens causing bacteraemia.  We focused the analysis on the 12 most 
common pathogens, which accounted for 80% of the cases.  We were able to demonstrate 
that whilst S. aureus bacteremia had been the predominant pathogen in the early 2000s, E. 
coli had now emerged as the major cause of bacteraemia accounting for 22% of cases by 
2008.  As a result S. aureus had moved into third place causing 11.6% of bacteraemias.  
Coagulase negative staphylococci, previously the third most common cause, had also 
increased in importance and in 2008 was the second most common pathogen accounting for 
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17% of cases.  This analysis suggested that there had been major change in epidemiology of 
these infections in England the past decade.  Clearly, the recent changes could have been 
explained by changes in the data capture systems, especially since the extension of 
electronic reporting had increased the number of participating laboratories and the move 
from manual to automated data imports could have could have altered the nature of 
reporting.  We therefore identified a subset of laboratories to use for the analysis of trends 
that would enable us to minimise the risk of ascertainment bias.  We did this by excluding 
those that during the period of analysis (2004 and 2008) had changed from manual to 
automated reporting, had not submitted complete datasets for one or more years, or 
demonstrated fluctuations in numbers of reports that were not explained by changes in 
reporting arrangements e.g. laboratory mergers.  These criteria identified 137 of the total of 
210 (65%) laboratories as being consistent reporters, although these laboratories actually 
accounted for almost 80% of the total episodes reported during the period of analysis.  This 
approach enabled us to demonstrate that reports of bacteraemia had increased significantly 
by 7% (p <0.001) during this period, but that this overall trend disguised a remarkable 
variation in trend over this time that was driven by changing epidemiology of different 
pathogens.  Thus, whilst the number of episodes of bacteraemia increased by 15% between 
2004 and 2006, it subsequently declined with over 90% of the decline between 2006 and 
2008 attributable to S. aureus (58%) and CNS 34%.   
 
5.2.3.3 The Poisson generalised linear regression model: This enabled us to investigate 
trends in individual pathogens whilst adjusting for changes in the overall number of episodes 
and to determine the variation in trend over time by making rolling two-year comparisons of 
incidence rate ratios, generating confidence intervals and p values to identify significant 
differences.  Using this method we identified that E. coli was the most common causative 
pathogen in each of five years included in the analysis, that the number of reports increased 
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by almost a third (p< 0.001), and the trend was especially prominent in the over 75 year-olds 
where by 2008 it accounted for 30% of bacteraemias.  The analysis also provided evidence of 
significant increases in other Gram negative pathogens (Klebsiella spp 14%; Pseudomonas 
spp 24%; Proteeae 13%).  Such trends would not be obvious in most blood stream infection 
surveillance systems which are focused on the detection of hospital-acquired primary 
(device-associated) rather than secondary infections (Anon 2000; Albrecht et al 2006), but 
are powerful early indicators of potential changes in epidemiology and associated 
implications for public health.   
 
5.2.3.4 Exploration of potential contributory factors: Whilst it is difficult to determine a 
cause and effect relationship from surveillance data, it is important to consider the possible 
contributory factors to these observed trends.  The significant decline in S. aureus from 
2006, which by 2008 accounted for 3% of bacteraemia compared to 6% in 2004, appears to 
have been entirely due to the decline in MRSA.  Similarly prior to 2000, S. aureus had not 
been the most common cause of bacteraemia and the rise in cases between 2000 and 2006 
also appeared to have been related to MRSA rather than meticillin-sensitive (MSSA) strains 
(Johnstone et al 2001).  Johnstone et al (2005) reported that the proportion of S. aureus 
bacteraemia resistant to meticillin rose from 2% in 1990 to 43% in 2002.  We demonstrated 
that by 2008 this proportion had decreased to 23%.  The decline in cases of MRSA from 2006 
coincided with major national initiatives to tackle MRSA.  Each NHS Trust was set reduction 
targets for MRSA bacteraemia, and strategies to reduce infections from invasive devices 
(such as intravenous and urine catheters), prevent cross-infection (such as enhanced hand 
hygiene, screening patient admitted to hospital for skin carriage and treating them to 
eliminate colonization) were actively promoted (Johnstone et al 2012).  We contended that 
whilst some of these measures would specifically target MRSA (e.g. screening and 
decolonization), others such as invasive device could have been expected to have an equal 
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effect on MSSA and MRSA.  Other evidence suggests that the increase in MRSA as a cause of 
bacteraemia emerged in the late 1990s with the spread of new epidemic strains (EMRSA 15 
and 16) and that one of these strains started to decline in the early 2000s (Johnstone et al 
2001; Ellington et al 2010; Wyllie et al 2011).  The emergence and disappearance of EMRSA 
stains is not a new phenomenon (Murchan et al 2004) and we postulated that the ecology of 
S. aureus may, at least in part, explain the difference in trend between MSSA and MRSA.  In 
contrast to S. aureus, CNS increased between 2004 and 2007 and then significantly declined 
between 2007 and 2008, although the trend was only apparent in adults.  CNS bacteraemia 
are often associated with invasive devices as they have a propensity to form biolfilms on 
catheter surfaces (Raad 1998; O’Grady et al 2011) and as a common skin commensal they 
also readily contaminate the blood culture specimen if this is not taken aseptically (Beekman 
et al 2006).  We suggested that the trend we observed may have been influenced by the 
guidance on taking blood cultures that was issued in 2006, in combination with 
improvements in the management of intravascular devices that was driven by the strategies 
to prevent MRSA bacteraemia (Department of Health 2007, Dawson 2014). 
 
5.3.3.5 Evidence of seasonal trends: Another remarkable finding in the trend analysis was 
the marked seasonal trend in cases of E. coli and other Gram negative pathogens (see Figure 
5.1).  Seasonal variation in infection rates are not uncommon but had previously been 
associated with the winter months and increased risk of respiratory tract infection.  Winter 
peaks of MRSA bacteraemia, Strepococcus pneumoniae and Clostridium difficile were 
evident from other surveillance data (HPA 2008a; Ampofo et al 2008; Jansen et al 2008).  
Whilst our dataset could not provide data on the source of the bacteraemia, we considered 
evidence available from other datasets about the main cause of Gram negative and E. coli 
bloodstream infections.  The British Society for Antimicrobial Chemotherapy (BSAC) 
operates a sentinel surveillance system to capture isolates of 12 pathogens (or groups of 
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pathogens) in order to study trends in antimicrobial resistance (Reynolds et al 2008).  This 
data is captured by between 25 and 30 hospital laboratories, and whilst clinical data 
associated with the specimens is limited, the presumed focus of infection is reported.  
Although based on relatively small numbers of cases and over-represented by large, 
teaching hospitals,the focus of infection was reported as the genitourinary tract infections in 
44% of cases of E. coli bacteraemias and accounting for 64% where a presumed focus was 
known (Livermore et al 2008).  Whilst these infections often originate in community-based 
patients they are frequently linked to healthcare.  Marshall et al found that over 80% of 
patients who had been hospitalised for less than 48hrs when bacteraemia due to Gram 
negative bacteria was identified had a history of recent hospital admission, outpatient 
treatment or were resident in long term care facility (Marshall et al 2009).  The seasonal 
effect that we observed was particularly marked in the over 75 years age group who 
accounted for 30% of cases of E. coli bacteraemia.  Since dehydration has been suggested to 
increase the risk of urinary tract infection (UTI) we postulated that during period of high 
temperature in the summer months, the elderly who due to deficits in thirst reflex and other 
underlying morbidity, are at increased risk of dehydration and subsequent UTI and that this 
could be a plausible driver of the observed increase in Gram negative bacteremia in the 
summer months (Phillips et al 1993; Abdulla et al 1994; Mentes 2006). 
 
5.2.4 Conclusions 
This publication was the first population-based investigation of the pathogens causing 
bacteraemia in England that attempted to define trends more accurately by attempting to 
address the affect of changes in case ascertainment.  Whilst our methods provided a more 
robust analysis than Reacher et al (2000) there were limitations.  Firstly, the selection of a 
subset of consistently reporting laboratories had the potential to introduce bias if these 
were different from the excluded laboratories.  This risk was probably small given that whilst  
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Figure 5.1: Trends in total num
ber of reported episodes of bacteraem
ia in England for all laboratories (n=210) and for the 12 m
ost com
m
only reported pathogens in 
consistently reporting laboratories (n=137) betw
een 2004 and 2008. Source: W
ilson et al 2011. 
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the selected laboratories represented 64% of the laboratories they accounted for 80% of 
cases reported, suggesting that the excluded laboratories were mostly small.  There was also 
an element of judgment in the identification of ‘consistent reporting’ since the many Trust, 
and therefore laboratory mergers that took place during the period under review made it 
difficult to establish whether a large period range in number of reports from a specific 
laboratory was due to inconsistent reporting or re-configuration of the service.  We probably 
erred on the ‘side of caution’ in excluding data from laboratories where there was a wide 
variation in reports between periods indicative of incomplete data exports, but this was to 
some extent subjective as the volume of data varied widely according to the size of the 
laboratory and normal variation in number of ‘events’.  However, if anything this approach 
would have resulted in an underestimation of trends as those laboratories with sharp peaks 
in reports would have been excluded.  By using a subset of laboratories to explore changes 
in the numbers and proportion of pathogens we were also not able to calculate the change 
in population incidence over this time, although it is unlikely that the trends observed would 
have been explained by changes in the population denominator.  
 
5.2.4.1 The other main limitation of the dataset used for this analysis is the lack of clinical 
data associated with the reports.  The surveillance system is reliant on laboratories reporting 
only bacteraemia considered to be ‘clinically significant’ and in reality these judgments may 
not be made with any consistency, especially when automated data downloads are used.  
That said, among the top twelve pathogens (which accounted for 80% of reports) all but CNS 
would be highly unlikely to be detected in the blood if the patient did not have infection.  E. 
coli and other Gram negative pathogens, in particular, are unlikely to represent 
contaminants, and although a subsequent analysis of MRSA bacteraemia data demonstrated 
evidence for some of these cases being probable contaminants, this was in less than 10% of 
cases (Wilson et al 2011b; Appendix 5.2).  However, in the trends we observed in CNS it is 
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difficult to distinguish changing epidemiology of the organism from changes in practice that 
may reduced the risk of blood culture contamination (Beekman et al 2005; Dhillon et al 
2009, Henderson et al 2010).  
 
5.2.4.2 The absence of clinical data meant that we were unable to determine the 
explanation for the trends observed, including the seasonal effect in Gram negative 
pathogens and whilst we drew on other sources of data to postulate on possible causes this 
needs to be the subject of future analytical studies.  In addition, although in 80% of cases for 
which the data was available the blood culture was taken in hospital, without a date of 
hospital admission it is not possible to determine whether the patient acquired the infection 
in hospital or the community.  However, the study also demonstrated the value of not 
focusing purely on HCAI by drawing attention to changing risks of infection in a wider, public 
health context.  
 
5.2.4.3 My contribution to this research 
Whilst most of my research had been focused on data captured by SSI surveillance, the 
origins of this research were my curiosity about trends in pathogens causing bacteraemia 
that I first observed in the data included in an HPA annual report (HPA 2007).  I subsequently 
devised the approach to minimsing case ascertainment bias by selecting consistently 
reporting laboratories and used my expert knowledge of microbiology, infection and 
surveillance data to develop the analysis, interpret the results and draw conclusions from 
the results.  I was also mainly responsible for drafting the publication.  
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5.3 Application of these methods to other bacteraemia surveillance data 
Published work 8: Analysis of trends in sources of MRSA bacteraemia 
Wilson, J., Guy, R., Elgohari, S. et al (2011) Trends in sources of meticillin resistant 
Staphylococcus aureus bacteraemia: data from the National mandatory surveillance 
of MRSA bacteraemia in England, 2006 to 2009. Journal of Hospital Infection. 79: 
211-217 (Appendix 5.2) 
 
5.3.1 Overview 
Concerns about the proportion of S. aureus bacteraemia resistant to methicillin identified in 
LabBase and in sentinel surveillance data submitted to the European Antimicrobial 
Resistance Surveillance System (EARSS) emerged in the 2000s.  This data indicated that the 
proportion of S .aureus that were resistant to meticillin (MRSA) had risen from 2% in 1991 to 
42% in 2000 and were far more prevalent in the UK than most other countries in Europe 
(Duckworth et al 2002; Johnson et al 2005; Pearson 2009). In 2001 the Government 
announced that surveillance of methicillin resistant Staphylococcus aureus (MRSA) 
bacteremia would become mandatory, data would be captured separately from the routine 
LabBase reporting system, and a new MRSA bacteremia system would be established (see 
section 2.2.7).  Initially, this system was based on aggregate quarterly reports of cases by 
each NHS Trust, but in October 2005, a patient level, web-based reporting system called the 
MRSA bacteraemia Electronic Surveillance System (MESS) was developed.  All NHS Trusts in 
England were required to report each episode of MRSA bacteraemia via this system, 
together with a small dataset on the specialty and admission-type of the patient.  Unlike the 
data in LabBase, the MESS system included an option to enter clinical data on the primary 
source of the bacteraemia.  Using the methods that we developed for the analysis of trends 
in LabBase data, we evaluated trends in the reported sources of MRSA bacteraemia in cases 
entered into the system between 2006 and 2009.  In common with the LabBase data, this 
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surveillance data had some key limitations, in particular that data on source was completed 
for only 40% of episodes and there were different levels of ‘certainty’ attached to the 
reported source and the sources were not based on precise case definitions.  We therefore 
included data on the 4400 cases of infections (26% of all MRSA bacteraemia reported during 
this period) where the reported source was considered as ‘certain’, highly likely’ or 
‘probable’.  Using the same approach as described previously (see section 5.2.2.3), we 
developed a generalized linear model with a log link for the Poisson distribution, and made 
rolling two-year comparisons of incidence rate ratios of the proportions of cases attributable 
to each source adjusted for the total counts.  This enabled us to demonstrate a significant 
decline in the proportion of episodes of MRSA bacteremia associated with central vascular 
catheters (IRR 0.42; 95%CI 0.29-0.61; p=<0.001), peripheral vascular catheters (IRR 0.69; 
95%CI 0.48-0.99; p=0.042) and surgical site infections (IRR 0.42; 95%CI 0.25-0.72; p=0.001) in 
the context of a general decline in the rate of MRSA bacteraemia since 2006.  This analysis 
therefore provided evidence that the strategy of improving practice surrounding the care of 
IV devices and the widespread adoption of screening and decolonization prior to surgery 
were instrumental to the significant decline in MRSA bloodstream infection in England since 
2006.  It also demonstrated that a significant proportion of cases of MRSA bacteremia 
attributed as community-acquired due to their detection within 48hr of admission to 
hospital were in fact associated with invasive devices or procedures linked to hospital care.  
 
5.3.2 My contribution to this research 
I used my previous experience in developing the bacteremia surveillance system for NINSS 
to develop the approach to this research.  My clinical knowledge and experience was 
essential for informing the analysis and interpretation of the results.  I also cleaned the data 
and grouped and classified the reported sources of bacteraemia, and then developed and 
wrote the publication. 
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5.4 Contribution of these publications to contemporary knowledge 
At the time of this research limited data had been published on population trends in 
pathogens causing bacteraemia in adults.  A recent analysis of trends in children had 
identified a markedly different picture to the one we identified, with S. aureus a 
predominant pathogen, an overall increase in reports of bacteraemia but declining trend in 
vaccine preventable infections such as Strep. Pneumoniae (Henderson et al 2010).  Although 
no attempt to adjust for ascertainment bias was made in this analysis, E. coli accounted for 
only 5% of pathogens and an increasing trend was only apparent in children aged 1 – 11 
months (Henderson et al 2010).   In the USA the surveillance of BSI was focused on primary 
hospital-acquired infections and there was no national system for laboratory-based 
surveillance such as in the UK (Horan et al 2008).  Analyses of trends were therefore 
concentrated on this limited group of essentially device-associated infections rather than 
considering BSI more broadly (Pittet & Wenzel 1995; Anon 2000; Warren et al 2001; 
Wisplinghoff et al 2004; Albrecht et al 2006).  The rationale for this approach was that 
secondary BSI reflected an infection at another site and therefore did not merit targeted 
surveillance in their own right (Horan et al 2008).  However, as our analysis has shown 
exploring trends in pathogens causing bacteraemia, whilst unable to establish cause and 
effect can identify important epidemiological trends that would not be apparent if limited to 
only primary BSI.  The steady growth in systems that support the delivery of healthcare 
interventions in community settings means that focusing only on bloodstream infections 
acquired in the inpatient setting is an increasingly inappropriate approach.   
 
5.4.1 Finland is one of few other countries to operate a population-based BSI surveillance 
system.  Their analysis of trends in bloodstream infection between 1995 and 2002 found 
that the annual incidence of these infection had increased by 40% and, as in our analysis of 
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English data, approximately 30% of cases occurred in those aged 75 years or older (Skogberg 
et al 2008).  E. coli was the most common pathogen followed by S. aureus although there 
were no changes in relative proportion observed during this time period (Skogberg et al 
2008).  Unlike the UK, the proportion of S. aureus that were resistant to meticllin was very 
low (less than 1%) and therefore the increase in proportion of bloodstream infections due to 
MRSA that probably explained the predominance of S. aureus bloodstream infections at this 
time in the UK did not occur in Finland (Lyytikainen et al 2005, Johnson et al 2005; Pearson 
et al 2009).  In the absence of population-based studies of the incidence of bloodstream 
infection, our study was also unique in presenting data on the differences in risk associated 
with both age and gender. Whilst the HPA published crude reports of number of 
bacteraemias submitted to LabBase, the detailed analysis of trends had been focused only 
on MRSA bacteraemia which was the subject of a separate mandatory surveillance system 
during this period, and no previous analysis in the context of trends in other pathogens had 
been published (Johnson et al 2005; Pearson et al 2009).  
 
5.4.2 The seasonal effect on the incidence of bacteraemia caused by Gram negative 
pathogens was a particularly striking finding.  We identified only two previous references to 
this seasonal effect, the first included all types of cultures not only blood and was conducted 
in a single medical centre and in a time-series analysis found a 19% increase in E. coli 
infections in the summer months (Perenevich et al 2006).  The second study was a 
population-level analysis of laboratory data captured across Minnestota in the USA and used 
Poisson regression methods to explore the association between incidence of E. coli and BSI 
and average monthly temperature adjusted for age and calendar year (Al-Hasan et al 2009).  
They identified a 35% increase incidence rates of E. coli bloodstream infection in the 
summer months and a 7% increase in risk for each 10oF increase in average temperature.  As 
in our analysis, neither of these observational studies were able to demonstrate the cause of 
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this association but speculated about food or water-borne sources, prevalence of clonal 
strains and human behavior such as sexual activity and water recreation, although the need 
for further studies to determine the precise reasons behind the seasonality of E. coli 
infections was recognised (Perenevich et al 2006; Freeman et al 2009).   
 
5.4.3 At the time of our analysis of the trends in sources of MRSA bacteraemia, there had 
been limited research by others and the few other studies had been conducted had focused 
on specific patient groups or involved small case series (Big et al 2010; Das et al 2007).  The 
unique nature of both the mandatory surveillance system for MRSA in the UK, and marked 
declining trend in MRSA bacteraemia after 2006 also provided a rare opportunity to explore 
factors that might underpin these changes based on clinical data about the cases as opposed 
to population level associations that infer a causal effect (Stone et al 2012; Wylie et al 2011).   
 
5.5 Subsequent research contributions to the field 
The significant decline in MRSA as a cause of bacteraemia in England has been mirrored in a 
number of other European countries.  In 2002, data captured by the European Antimicrobial 
Resistance Surveillance System (EARSS) indicated many countries where MRSA accounted 
for more than 25% of S. aureus isolates from blood but by 2008 more countries were 
showing decreasing rather than increasing trends in prevalence of MRSA (Johnson et al 
2011; de Kraker et al 2013).  There has been much speculation as to the reasons for the 
marked decline in the UK which have included the action taken by the Government to set 
improvement targets, the package of guidance on preventing MRSA transmission and 
infection, widespread change in antimicrobial agent prescribing and change in epidemiology 
of the underlying epidemic strains (Ellington et al 2010; Livermore 2012; Wylie et al 2011; 
Johnson et al 2012).  However, the studies that exist are largely descriptive or focused on a 
single institution and are unable to shed light on the underlying reasons for the changing 
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epidemiology of MRSA bacteraemia or extend knowledge on the sources of these infections 
(Johnson et al 2012).   
 
5.4.1 In a study of bloodstream infections in an Australian tertiary referral hospital 
between 2001 and 2009 found a similar increasing trend in Gram negative pathogens as 
causative organisms linked to community-onset infections, with 53% of cases occurring in 
the over-70s and a significant age-dependant increase in E. coli infections (Aung et al 2012).  
The seasonal effect has also been confirmed in a study in Israel where rates of E. coli 
bloodstream infection were approximately 20% greater in the summer months compared to 
winter and autumn/spring and a link with urinary tract infection was suggested by the 
finding that the urinary tract was the source of 67% of the infections (Chazan et al 2011).  
Alcorn et al also observed an increase in episodes of healthcare associated bloodstream 
infection caused by Gram negative pathogens in summer months, but only in patients 
receiving care outside hospital the source was attributed to intravascular devices in 38% of 
cases (Alcom et al 2013).  Further evidence for a relationship between high ambient 
temperature and gram negative BSI is provided by an analysis of data from 132 US hospitals 
found a significant increase in BSI due to Gram negative bacteria in summer months.  They 
identified a 3.5% (95%CI 2.1-4.9) increase in frequency of E.coli BSI with each 10oF increase 
in mean monthly temperature (Eber et al 2013).  
 
5.5.2 The role of antimicrobial agents in driving the changing epidemiology of E.coli has 
also been highlighted.  EARSS data (now EARS-Net) identified a 71% increase in E.coli 
bloodstream infection reported from 198 participating hospitals in 22 countries between 
2002 and 2009, in comparison with a 43% increase in S.aureus infection during the same 
period. (Gagliotti et al 2011).  During this time resistance to third-generation cephalosporins 
increased significantly from 1.7% to 8% and resistance to all four classes of agent 
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(aminoglycosides, aminopenicillins, fluroquinolones) from 0.6% to 3.4%.  Siedelman et al 
found that previous antibiotic use and recurrent urinary tract infection were significant risk 
factors for both community and hospital-acquired bloodstream infection caused by resistant 
E. coli strains (Siedelman et al 2012).  Extended-Spectrum beta-lactamases (ESBLs) began to 
emerge in Gram-negative pathogens in the UK in the early 2000s initially in Klebsiella species 
but spreading to E. coli (Livermore 2012).  The predominate type of E. coli ESBL (ST131) has 
been found to carry a number of virulence factors that promote colonisation and invasion of 
bladder cells and this may explain the observed increase in E. coli bloodstream infections 
(Totsika et al 2011; Livermore 2012).  This changing epidemiology is highly significant since 
UTI is a common infections, acquired by up to 50% of women and 5% of men in their lifetime 
(Ulett et al 2013).  Not only is E. coli significantly increasing as a cause of severe infection, 
resistant strains are associated excess mortality.  Patients with bloodstream infections 
caused by E. coli resistant to third-generation cephalosporin were found to be 2.5 times 
more likely to die within the first 30 days after infection than matched patients with 
sensitive strains (de Kraker et al 2011).  However, prevention of these infections is likely to 
be challenging, as unlike other HCAI many emerge in patients living in community settings 
and hence receive lesser attention.  As yet, no studies have been published on approaches 
to reduce the risk of these infections.  
 
 
5.6 Summary of chapter 
The methods that I have described in these two studies used observational data captured by 
surveillance systems to investigate the epidemiology of bacteraemia.  As with any data 
derived by surveillance rather than research there are limitations in its interpretation and 
challenges in analysis created by partial data and incomplete records.  In both studies we 
were presented with incomplete set of data.  The first analysis addressed the effect of 
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potential case ascertainment bias on observed trends by focusing on a subset of consistently 
reporting laboratories used generalized linear models to adjust for variation in number of 
cases over time.  In the second study, we identified a subset of cases where there was 
reasonable evidence of the source of bacteremia to investigate trends in causes of MRSA 
bacteremia and associated implications for practice.  Whilst both studies illustrate the 
imperfections in surveillance datasets they also demonstrate the value of careful analysis of 
population-level data in identifying emerging problems that need to be addressed to protect 
the public from the risk of infection.  They also provide important insights that can help to 
improve our understanding of potential causes of infection and inform the development of 
strategies that may help to prevent them.   
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CHAPTER(6(
(
My(professional(development(as(a(researcher(
(
My#initial#introduction#to,#and#interest#in,#conducting#research#was#engendered#through#a#
research#assistant#post#at#the#Nursing#Practice#Research#Unit#based#at#Northwick#Park#
Hospital#in#London#and#funded#by#the#Department#of#health#and#Social#Security.##My#role#
was#on#a#project#investigating#the#risks#of#urinary#tract#infection#associated#with#catheters,#
which#allowed#me#to#combine#my#experience#from#my#honours#degree#in#microbiology#with#
a#registered#general#nurse#qualification.##These#were#significant#assets#for#this#research,#
which#required#observation#of#clinical#practice#and#collection#of#epidemiology#data#on#
patients#who#were#catheterised#and#the#UTI#they#acquired.##As#part#of#a#small#research#team,#
this#role#enabled#me#to#develop#skills#in#study#design#and#analysis,#and#the#practical#
problems#of#capturing#data#on#the#use#and#management#of#urinary#catheters#in#clinical#
settings.##It#also#introduced#me#to#the#concept#of#healthcare#associated#infections#and#the#
challenges#of#assuring#adherence#to#infection#prevention#practice#and#to#some#of#the#
practical#problems#of#surveillance#and#principles#of#data#capture#and#analysis#(Crow#et(al#
1988).####
#
My#specific#interest#in#surveillance#developed#in#the#late#1980s.##At#that#time,#surveillance#of#
healthcare#associated#infections#(HCAI)#was#not#a#widely#recognised#strategy#for#infection#
control#specialists#in#the#UK,#but#the#evidence#emerging#from#the#Study#of#the#Efficacy#of#
Nosocomial#Infection#Control#(Haley#et(al#1985a)#highlighted#the#critical#importance#of#
surveillance#in#driving#improvements#in#practice#and#reducing#rates#of#HCAI.##A#keynote#
lecture#about#the#role#of#surveillance#in#preventing#HCAI#given#at#the#Infection#Control#
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nurses#Association#annual#conference#in#1988#by#Professor#Robert#Haley,#who#had#been#
Director#of#the#SENIC#project,#inspired#my#subsequent#research#interests.##Through#my#
contact#with#Professor#Haley,#who#was#then#Director#of#the#Division#of#Epidemiology#at#the#
Southwestern#Medical#Centre#in#Dallas#Texas,#I#visited#a#number#of#hospitals#in#the#USA#that#
he#recommended#had#expertise#in#using#surveillance#as#part#of#their#infection#control#
programme.##I#was#subsequently#able#to#apply#the#knowledge#I#acquired#from#these#visits#
about#methodology,#data#capture#and#analysis#to#build#surveillance#into#the#infection#control#
programme#in#my#own#institution.##My#clinical#background#and#expertise#has#subsequently#
had#an#important#influence#on#my#development#as#a#researcher,#with#my#experience#as#a#
nurse#playing#a#key#role#in#both#directing#my#interests#in#relation#to#the#practical#value#of#
surveillance,#and#in#providing#a#relevant#clinical#focus#to#how#I#have#interpreted#and#
analysed#surveillance#data.###
#
In#my#next#role#as#Programme#Lead#for#surveillance#Public#Health#Laboratory#Service#(later#to#
become#the#Health#Protection#Agency)#I#was#able#to#further#develop#my#understanding#of#
the#application#of#surveillance#methods#to#support#infection#control#and#reduce#HCAI.##I#was#
involved#in#the#design#and#development#of#a#landmark#project#at#the#PHLS#S#the#SocioS
economic#Burden#of#Healthcare#Associated#Infection#project#which#has#provided#the#
framework#for#defining#costs#of#HCAI#both#in#the#UK#and#Internationally#for#the#last#decade#
(Plowman#et(al#2001).##This#gave#me#important#insights#into#the#principles#of#determining#
the#costs#of#HCAI#and#informed#my#contribution#to#our#subsequent#analysis#of#the#costs#
associated#with#SSI#(Coello#et(al#2005).##My#involvement#in#the#design#and#delivery#of#a#
second#major#PHLS#project#–#the#Clinical#Audit#of#Hospital#Infection#Control#Activity#(Glynn#et(
al#1997)#S#developed#my#skills#in#research#and#project#design,#but#also#extended#my#
knowledge#of#HCAI#data#capture,#analysis#and#interpretation#across#several#hospitals.##I#
subsequently#was#able#to#apply#this#knowledge#to#the#development#of#the#first#national#HCAI#
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surveillance#systems#in#the#UK,#which#has#formed#the#basis#of#the#work#described#in#this#
thesis.###
#
In#my#role#leading#the#national#SSI#surveillance#system#there#were#two#key#influences#on#my#
research#strategy.##Firstly,#I#was#interested#in#exploiting#the#unique#size#of#the#surveillance#
dataset#to#improve#understanding#of#the#impact#of#SSI#and#the#factors#that#affected#its#
acquisition.##I#perceived#that#studies#that#define#these#relationships#are#essential#to#both#
direct#effective#prevention#measures#and#to#inform#the#design#of#appropriate#surveillance#
systems.##These#same#guiding#principles#influenced#my#subsequent#research#on#bloodstream#
infections.##My#second#research#focus#was#exploring#surveillance#methodology,#both#to#
establish#the#robustness#of#its#metrics#and#to#enhance#its#impact#in#driving#improvements#in#
infection#prevention#practice.###
#
My#formal#training#in#the#principles#and#methods#of#epidemiology#and#statistics#I#gained#from#
studying#an#MSc#in#Public#Health.#My#dissertation#for#this#MSc#entitled#Surgical(site(infection(
following(vascular(surgery:(risk(factors(for(infection(and(the(use(of(rates(as(performance(
indicators.##In#this#work#I#analysed#SSISS#data#on#3901#vascular#operations#from#40#hospitals#
in#order#to#identify#significant#risk#factors#and#how#these#influenced#variation#in#rates#of#SSI#
between#hospitals.# In#addtion#to#a#systematic#review#of#the#literature#for#evidence#for#
potential#risk#factors#for#SSI,#I#used#backwards#stepwise#logistic#regression#techniques#to#
identify#significant#independent#risk#factors#for#SSI#and#used#the#risk#adjusted#rates#
generated#from#this#model#to#indirectly#standardise#rates#of#SSI#for#each#hospital.##This#
grounding#in#these#statistical#methods#was#invaluable#in#developing#my#approach#to#the#
analysis#of#the#large#national#surveillance#datasets,#particularly#the#SSI#data#where#the#
structure#of#the#dataset#made#it#possible#to#use#these#techniques#to#clearly#define#risk#factors#
for#infection.##This#method#of#adjustment#enabled#us#to#make#robust#estimates#of#the#
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independent#effect#of#SSI#on#length#of#hospital#stay#and#mortality#in#Coello(et(al#2005,#and#
determine#the#factors#influencing#the#variation#in#risk#between#hip#hemiarthroplasty#and#
total#hip#replacement#procedures#by#including#the#procedure#type#as#a#predictor#(Ridgway#et(
al#2005).##This#study#was#also#the#first#time#that#I#had#sought#to#work#in#collaboration#with#an#
orthopaedic#surgeon#(S.#Ridgeway)#to#analyse#the#data#and#write#the#publication.##This#
collaboration#was#essential#in#ensuring#we#designed#the#data#analysis#appropriately#and#
appraised#the#relevance#of#potential#risk#factors#for#SSI#using#his#expert#knowledge#of#the#
procedures.##This#collaboration#as#also#invaluable#for#the#interpretation#of#the#results#as#it#
provided#insight#into#the#potential#explanations#for#the#observed#risk#factors#and#expert#
knowledge#with#which#we#could#check#the#face#validity#of#the#regression#models.###This#also#
illustrates#the#influence#that#working#in#teams#and#learning#from#others#has#had#on#my#
research.##Key#players#in#the#teams#I#have#worked#with#in#developing#my#research#have#
included#statisticians,#clinicians,#scientists#and#epidemiologists.#The#analyses#of#these#large#
surveillance#datasets#require#complex#statistics#and#I#have#learnt#that#bringing#together#my#
knowledge#of#the#surveillance#system/dataset#and#my#experience#of#healthcare#systems#and#
HCAI#with#the#statisticians’#expert#knowledge#of#statistical#analyses#was#highly#effective#in#
developing#a#robust#approach#to#analyzing#and#interpreting#the#data.##Similarly,#combining#
ideas#and#insights#from#members#of#the#team#with#different#knowledge#and#skills#generates#
innovative#ideas#and#approaches.##These#team#relationships#are#wholly#symbiotic#with#
neither#member#able#to#conduct#the#study#effectively#without#the#input#of#the#other,#and#I#
have#continued#to#apply#this#philosophy#throughout#my#subsequent#research.####
#
The#knowledge#I#gained#from#undertaking#the#analysis#for#Ridgeway#et(al#2005,#in#particular#
the#important#differences#in#risk#between#hip#hemiarthroplasty#and#total#hip#replacement#
procedures#that#could#not#be#distinguished#by#the#standard#risk#index,#influenced#research#I#
subsequently#undertook#in#exploring#the#relationship#between#duration#of#operation#and#risk#
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of#SSI#in#which#the#segregation#of#hip#hemiarthroplasty#procedures#was#fundamental#to#the#
analysis#(Leong#et(al#2006).##The#T#time#analysis#was#an#important#step#in#order#to#validate#
the#national#SSI#surveillance#methodology#since#common#criticism#was#the#use#of#US#T#times#
as#these#were#seen#to#be#outSdated#and#not#representative#of#UK#operation#times.##This#
analysis#was#important#in#developing#my#thinking#about#the#key#advantage#of#the#T#time#in#
providing#a#stable#indicator#of#increased#duration#of#operation,#although#I#now#believe#that#
recent#studies#indicate#it#is#a#strong#extrinsic#rather#than#intrinsic#risk#factor#and#its#use#for#
risk#adjustment#should#therefore#be#reconsidered.###
#
My#findings#from#both#these#studies,#as#well#as#the#inSdepth#knowledge#of#the#structure#of#
SSI#dataset#that#I#had#gained#through#these#analyses,#informed#my#subsequent#work#with#
European#colleagues#on#exploring#interScountry#variation#in#rates#of#SSI#(Wilson#et(al#2007).##I#
was#an#active#participant#in#the#Hospitals#in#Europe#Linked#through#Infection#Control#
network#of#HCAI#surveillance#networks#and#as#a#result#gained#a#broad#knowledge#of#
methodology#used#by#other#national#surveillance#systems#in#relation#to#both#SSI#and#HCAI#in#
intensive#care#surveillance.##The#value#of#this#collaboration#was#combining#the#technical#
proficiency#of#statisticians#at#the#HELICS#coordinating#centre#in#Brussels#with#my#expertise#in#
understanding#SSI#surveillance#data#to#shape#the#analysis.##This#enabled#us#to#identify#the#
key#variables#with#which#to#investigate#variation#and#interpret#the#implications#for#SSI#
surveillance#methodology#and#interScountry#comparisons.##I#prepared#the#analysis#for#a#
presentation#on#interScountry#variation#in#HELICS#data#for#the#International#Hospital#
Infection#Society#conference#and#subsequently#wrote#this#first#publication#exploring#
variation#between#countries#in#rates#of#SSI#data.##On#reflection,#I#could#have#improved#this#
publication#by#incorporating#greater#detail#about#the#methods#and#approach#that#we#took#to#
this#analysis#as#this#is#key#to#understanding#the#results#and#our#interpretation.##As#I#have#
developed#as#a#researcher#I#now#have#a#greater#appreciation#of#the#importance#of#clearly#
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describing#the#methodology,#especially#for#the#complex#approaches#to#modeling#that#are#
used#in#the#analysis#of#surveillance#data.##
#
In#leading#the#team#responsible#for#managing#the#SSI#surveillance#system#I#was#able#to#drive#
and#direct#the#programme#of#research.##One#key#aspect#of#the#surveillance#that#I#recognised#
needed#more#research#was#the#mechanisms#for#reporting#of#results#of#the#surveillance#to#
participating#hospitals.##The#scientific#literature#supported#the#fundamental#role#played#by#
feedback#of#surveillance#data#in#reducing#infection#rates#and#that#benchmarking#was#an#
important#driver#of#improvement#(Taylor#et#al#1994;#Gastemeier#et#al#2005;#Geubels#et#al#
2006).##However,#through#my#work#with#HELICS#I#realised#that#methods#of#benchmarking#in#
national#surveillance#systems#largely#relied#on#comparisons#between#the#pooled#mean#and#
individual#hospital#rates,#with#or#without#standardisation#to#account#for#caseSmix#variation#
but#without#consideration#for#the#precision#of#estimated#rates.##Whilst#we#used#this#approach#
in#the#first#reports#of#mandatory#orthopedic#surveillance,#I#sought#to#find#a#more#effective#
means#of#accurately#communicating#variation#in#rates#of#SSI#and#detecting#outlying#rates#of#
SSI,#to#clinical#staff#of#hospitals#participating#in#SSISS#and#those#responsible#for#monitoring#
performance.##My#publication#about#funnel#plots#(Wilson#et(al#2008)#again#reflected#a#
collaboration#between#statistical#and#surveillance#expertise#to#create#a#novel#application#of#a#
statistical#method#to#solve#a#surveillance#problem.##My#experience#with#exploring#
international#comparisons#had#illustrated#the#effect#that#PDS#exerted#on#rates#of#SSI#and#the#
difficulties#of#developing#an#accurate#metric#for#comparing#rates#based#on#PDS#where#rates#
of#followSup#differed.#The#analysis#of#HELICS#data#was#limited#because#it#was#based#only#on#
data#captured#by#the#routine#surveillance#systems#in#each#country#and#we#had#little#data#on#
the#reliability#of#the#methods#used#to#capture#it.##In#designing#my#study#on#surveillance#
following#caesarean#section#delivery#I#sought#to#address#these#limitations#by#capturing#data#
on#the#proportion#of#patients#followedSup#by#PDS#methods#and#estimating#the#reliability#of#
Chapter(6:(Professional(development(as(a(researcher(
( 177#
the#methods#in#detecting#SSI.##Whilst#this#study#still#had#its#own#limitations,#in#particular#the#
practical#problems#of#accurately#measuring#sensitivity#and#specificity,#I#was#able#to#define#
differences#in#application#of#surveillance#methods#and#their#impact#on#rates,#at#least#in#this#
one#category#of#surgical#procedures.#
#
Whilst#I#was#initially#less#closely#involved#in#developing#methodology#for#bacteraemia#
surveillance#after#the#NNISS#surveillance#was#discontinued,#my#detailed#knowledge#of#HCAI#
surveillance#systems#was#invaluable#in#informing#my#work#on#designing#the#methods#for#the#
analysis#of#trends#in#sources#of#MRSA#and#pathogens#causing#bacteraemia.###Whilst#I#was#
aware#of#limitations#of#using#data#captured#by#surveillance#systems#for#drawing#conclusions#
about#‘cause#and#effect’,#my#research#interests#were#driven#by#recognition#that#these#large#
national#datasets#presented#unique#opportunities#not#available#in#local#small#scale#
surveillance,#to#define#and#communicate#HCAI#problems,#understand#and#influence#factors#
that#affect#them#and#improve#the#data#capture#systems#to#support#effective#infection#
prevention#efforts.#
#
Building#this#body#of#research,#I#have#developed#and#applied#knowledge#and#skills#in#the#
analysis#and#interpretation#of#surveillance#data.##During#this#time#my#development#as#a#
researcher#has#been#strongly#influenced#by#the#opportunities#I#have#had#to#work#with#
experts#in#epidemiology,#surveillance#and#data#analysis,#at#the#HPA,#in#Europe#and#the#USA#
who#have#shaped#my#ideas,#triggered#many#of#the#questions#that#I#have#endeavored#to#
answer#and#identified#the#challenges#that#my#research#has#sought#to#address.##These#
collaborations#have#enabled#me#to#develop#as#a#researcher#with#National#and#International#
recognition#through#my#publications,#presentations#at#conferences#and#invited#lectures.####
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(
Conclusions(and(future(research(
(
7.1( Introduction(
In#this#thesis#I#have#described#the#principles#underpinning#the#development#of#HCAI#
surveillance#systems#in#England,#how#my#research#has#contributed#to#their#development#and#
how#I#have#made#use#of#the#large#datasets#captured#by#these#national#surveillance#systems#
to#explore#risk#factors,#outcomes#for#infection#and#epidemiology#of#pathogens#that#cause#
them.##In#this#final#chapter#I#will#draw#conclusions#about#my#work#and#explore#future#
directions#for#my#research.###
#
7.2( Conclusions(from(my(programme(of(research(
My#research#has#provided#new#knowledge#about#risks#of#SSI#in#terms#of#mortality#and#
increased#length#of#hospital#stay#that#have#been#widely#used#to#provide#evidence#for#the#
impact#of#SSI,#derive#costs#associated#with#these#infections#and#justify#the#benefits#of#
strategies#to#prevent#SSI.#My#work#has#also#contributed#to#the#body#of#knowledge#on#risk#
factors#for#SSI,#with#the#large#datasets#captured#by#the#SSI#surveillance#system#providing#the#
unique#opportunity#to#determine#significant#independent#risk#factors#for#SSI#following#hip#
prosthesis#and#to#provide#robust#evidence#for#the#relationship#between#duration#of#
operations#and#risk#of#SSI.##Both#these#analyses#have#influenced#the#subsequent#
development#of#the#SSI#surveillance#system#in#England#and#Europe#and#supported#more#
accurate#risk#adjustment#and#comparison#of#rates.##My#research#also#comprises#the#first#
publication#on#interEcountry#comparisons#of#rates#of#SSI#in#data#captured#by#the#14#countries#
participating#in#the#European#HELICS#network.##It#highlighted#key#methodological#issues#and#
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at#the#time#of#its#publication#there#were#few#examples#of#such#interEcountry#comparisons#in#
the#literature.##The#limitations#of#the#comparisons#recognised#by#this#analysis#have#helped#to#
sustain#and#increase#participation#in#the#surveillance#by#highlighting#heterogeneity#between#
countries#evident#in#the#data#the#risk#of#unreasonable#inferences#about#variation#in#
performance#being#drawn#can#be#reduced.###
#
7.2.1# My#unique,#detailed#analysis#of#data#on#rates#of#SSI#following#hip#prosthesis#together#
with#an#innovative#approach#to#performance#monitoring#has#demonstrated#the#value#of#
funnel#plots#as#a#mechanism#for#supporting#the#comparison#of#rates#of#SSI#and#providing#a#
robust#mechanism#for#identifying#outliers.##The#value#of#this#approach#has#been#recognised#
by#other#HCAI#surveillance#systems#who#now#also#use#funnel#plots#for#displaying#interEcentre#
comparisons.##My#work#has#also#provided#evidence#for#the#impact#of#postEdischarge#
surveillance#on#benchmarking#and#the#challenges#of#producing#consistent#and#reproducible#
results#across#a#range#of#different#centres#when#most#SSI#are#detected#after#discharge.##This#
work#is#particularly#important#in#the#context#of#declining#length#of#postoperative#stay#in#
hospital#and#has#also#provided#a#new,#practical#methodology#for#evaluating#the#reliability#of#
SSI#surveillance#methods.###
#
7.2.2# Finally,#my#research#has#highlighted#important#emerging#trends#in#pathogens#
causing#infection,#with#the#striking#findings#on#seasonal#variation#in#E.(coli#bacteraemias#
providing#important#evidence#about#possible#contributory#factors#and#informing#public#
health#strategy#to#prevent#them.##My#research#on#sources#of#MRSA#bacteremia#provided#
important#insights#into#reasons#why#the#strategies#that#were#put#in#place#to#prevent#these#
infections#may#have#been#effective#which#are#highly#relevant#to#understanding#best#practice#
in#relation#to#infection#prevention#and#control.###
#
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#
7.3( Proposals(for(future(research(
(
7.3.1( Reducing(rates(of(HCAI(through(benchmarking(
The#establishment#of#the#national#surveillance#system#in#the#late#1990s#provided#a#standard#
surveillance#methodology#that#for#the#first#time#enabled#hospitals#in#England#to#compare#
their#rates#of#SSI#(Cooke#et(al#2000).##From#its#inception,#SSISS#identified#variation#between#
the#lowest#and#highest#rate#of#SSI,#which#was#so#large#that#it#was#unlikely#to#be#explained#by#
differences#in#caseEmix#(PHLS#2000).##The#ability#to#make#these#comparisons#was#highly#
valued#by#participating#hospitals#and#was#cited#as#being#a#key#reason#for#their#participation#
in#the#surveillance#(Wilson#et(al(2002).##However,#whilst#other#national#surveillance#systems#
such#as#Germany,#France#and#until#latterly#the#USA,#resisted#publication#of#comparative#rates#
the#mandation#of#SSI#surveillance#in#England#made#public#reporting#of#such#comparisons#
inevitable#(Haustien#et#al#2011;#Bratzler#2013).#However,#presenting#this#data#in#a#way#that#
focused#attention#on#those#hospitals#most#likely#to#have#problems#with#infection#prevention#
practice#was#a#major#challenge#that#had#not#been#addressed#by#other#national#surveillance#
programmes#(Haustien#et(al#2011).##In#using#funnel#plots#to#present#institutional#
comparisons#of#rates#of#SSI,#I#was#able#to#address#the#difficulty#of#presenting#benchmarking#
data#for#the#mandatory#surveillance#of#SSI#following#orthopedic#surgery#and#avoiding#
spurious#ranking#systems#that#did#not#allow#for#the#effect#of#variation#in#volume#of#
procedures.##These#visual#methods#have#become#an#important#development#to#support#
effective#comparison#of#performance#and#act#as#triggers#to#take#corrective#action.##In#the#
four#years#following#the#introduction#of#mandatory#surveillance#in#orthopaedic#surgery#and#
use#of#this#funnel#plot#methodology#to#identify#outliers,#the#rates#of#SSI#across#all#four#
categories#of#orthopaedic#procedures#declined#significantly#(HPA#2009;#European#Center#for#
Disease#Prevention#&#Control#2009;#Wilson#et(al#2009;#Appendix(4.5).##Whilst#it#is#not#
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possible#to#directly#attribute#this#decline#to#the#measurement#of#performance#through#
surveillance,#it#seems#likely#that#it#made#a#contribution#since#other#studies#have#
demonstrated#a#link#between#participation#in#national#SSI#surveillance#systems#and#declines#
in#rates#of#SSI#(Gastmeier#et(al(2005;#Guebbels#et(al#2006;#Rioux#et(al#2007).##$However,#one#
of#my#concerns#in#detecting#outliers#is#the#importance#of#not#just#focusing#on#those#centres#
with#unusually#high#rates#but#also#considering#those#identified#with#unusually#low#rates.##This#
is#not#an#unusual#outcome,#in#a#study#evaluating#the#interpretation#of#funnel#plots#by#
Directors#of#Public#Health,#the#plots#were#found#to#increase#the#tendency#to#identify#and#
recommend#action#on#outlying#rates#however,#the#focus#tends#to#be#on#identifying#poor#
performance#rather#than#exemplary#practice#(Marshall#et(al(2004).#The#relevance#of#low#
outliers#in#relation#to#SSI#surveillance#is#two#fold.##As#cited#in#our#publication#low#rates#‘may(
signify(either(an(excellent(performance(worthy(of(emulation((ie,(by(sharing(best(practices)(or(
inadequate(surveillance(methods(and(a(low(sensitivity(of(case(finding’.#(Wilson#et(al#2008)##
Low#sensitivity#of#case#finding#is#a#particular#problem#in#the#surveillance#of#SSI,#because#of#
the#complexity#of#the#definitions#of#infection#and#lack#of#routinely#available#data#required#to#
identify#them.##Indeed,#Tanner#et#al#(2014)#have#also#pointed#to#variation#in#interpretation#of#
the#surveillance#protocol#as#a#factor#in#explaining#variation#in#rates#of#SSI#(Tanner#et(al#
2013b).##Therefore#a#key#area#for#future#research#is#exploring#rates#of#SSI#that#lie#below#the#
lower#90#and#95%#control#limits#and#the#extent#to#which#they#are#explained#by#caseEmix#
(patients#at#lower#risk#of#SSI#than#at#other#centres),#low#intensity#surveillance#or#high#quality#
practice.##I#would#intend#to#evaluate#quality#of#practice#at#participating#hospitals#with#low#
rates#by#adapting#methods#used#by#Campbell#et(al#(2008).##This#study#used#a#combination#of#
survey#questionnaire#and#review#visits#to#determine#the#practice#associated#with#low#and#
high#outlier#status#in#hospitals#participating#in#the#American#College#of#Surgeons#–#National#
Surgical#Quality#Improvement#Program#(ASCENSQIP)#and#identified#some#important#
structural#factors#in#American#operating#departments#such#as#theatre#efficiency#and#low#
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trainee#to#bed#ratio#that#were#linked#to#low#outlier#status#(Campbell#et(al#2008).##Similar#
research#in#the#UK#would#contribute#to#improving#understanding#of#what#factors#in#the#
surgical#patient#care#pathway#reduce#the#risk#of#SSI#and#enable#best#practice#to#be#shared.###
This#would#be#an#important#area#of#research#because#whilst#benchmarking#of#rates#of#SSI#has#
been#associated#with#marked#decline#in#rates#of#SSI#in#England,#there#has#been#no#research#
to#determine#how#these#trends#are#correlated#with#quality#of#care#(Astagneau#and#L’Heriteau#
2010,#Wilson#et(al#2009;#Appendix#7.1).###
#
7.3.2( Developing(data(capture(systems(that(support(robust(benchmarking(
My#second#area#of#further#research#is#focused#on#developing#methods#of#SSI#surveillance#
that#enable#robust#comparison#of#SSI#rates#in#the#context#of#reducing#postEsurgical#stay#in#
hospital.##The#work#on#exploring#comparison#in#rates#of#SSI#between#countries#contributing#
data#to#the#European#SSI#surveillance#network#(HELICS)#illustrated#the#difficulties#of#drawing#
robust#comparisons#where#differences#in#approach#to#surveillance#had#an#important#effect#
on#the#number#of#SSI#reported,#in#particular#methods#of#postEdischarge#surveillance#(PDS)#
and#application#and#interpretation#of#caseEdefinitions#(Wilson#et(al#2007;#Appendix#4.1).##The#
publication#on#surveillance#following#cesarean#section#delivery#illustrated#the#difficulty#of#
consistently#identifying#SSI#that#develop#postEdischarge#and#the#key#challenge#that#this#
presents#to#making#both#inter#and#intraEcountry#comparisons#since#this#publication#
demonstrated#that,#where#postEoperative#hospital#stay#is#short#the#rate#of#SSI#is#strongly#
associated#with#the#intensity#of#PDS,#and#that#the#intensity#of#PDS#varies#markedly#between#
hospitals#even#when#they#are#using#detailed,#standard#surveillance#protocol#(Wilson#et(al#
2014;#Appendix#4.3).##This#effect#seriously#hampers#the#ability#of#a#benchmarking#system#to#
detect#hospitals#with#high#rates#of#SSI#and#use#this#to#drive#improvements#in#infection#
prevention#practice.###Whilst#an#ideal#solution#may#be#to#ensure#complete#PDS#(Tanner#et(al#
2014;#Leaper#et(al#2014),#in#a#resource#constrained#a#healthcare#environment#such#as#the#
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UK,#adequate#funds#to#conduct#complete#PDS#of#all#surgical#patients#are#unlikely#to#be#
available#(Hall#et(al#2013).##Therefore#more#efficient#approaches#to#capturing#and#
benchmarking#surveillance#data#need#to#be#developed#which#meet#the#key#goal#of#
identifying#hospitals#with#high#rates#compared#to#other#hospitals.###
#
7.3.2.1# One#approach#that#I#would#explore#in#order#to#address#these#problems#identified#
with#SSISS#in#terms#of#the#robustness#of#benchmarking#would#be#to#develop#a#‘research#
quality#surveillance#system’#such#as#the#ASCENSQIP.##This#system#uses#designated#personnel#
at#participating#hospitals#to#capture#data#on#a#defined#set#of#procedures#to#be#used#for#
benchmarking.##Such#a#system#is#better#able#to#reliably#compare#rates#because#they#are#then#
based#on#high#quality,#validated#data#from#a#systematic#sample#of#surgical#procedures#and#it#
follows#all#patients#included#in#the#sample#up#for#30#days#post#operation#(Ingraham#et(al#
2010).###This#methodology#assures#data#quality#and#completeness#and#enables#benchmarking#
and#analysis#of#risk#factors#by#capturing#data#on#a#range#of#postEoperative#adverse#events#
not#just#SSI.##However,#whilst#able#to#provide#very#high#quality#data#on#which#to#base#
benchmarking,#its#disadvantage#is#that#is#resource#intensive,#does#not#support#surveillance#
for#SSI#on#a#wide#range#of#surgical#procedures#and#does#not#provide#data#that#is#easily#
interpreted#by#patients.####
#
7.3.2.2# Another#area#of#research#that#I#propose#to#develop#is#the#use#of#NHS#data#submitted#
to#Hospital#Episode#Statistics#as#a#source#of#comparative#information#on#rates#of#SSI.##Whilst#
the#quality#of#this#data#was#relatively#poor#in#previous#decades,#the#introduction#of#paymentE
by#results#has#introduced#a#financial#incentive#for#NHS#Trusts#to#capture#accurate#clinical#
data#on#patient#procedures#and#outcomes#and#as#a#result#the#quality#of#this#data#has#
improved#in#recent#decades#(Jenks#et(al#2014).##Procedures#are#captured#by#their#relevant#
OPCS#codes#and#data#on#outcome#can#be#gathered#from#ICD10#codes#derived#from#operation#
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notes,#laboratory#data#and#discharge#letters.##Evidence#suggests,#that#whilst#this#data#has#
limitations#it#has#an#accuracy#of#around#83%#for#diagnostic#and#procedure#codes#
(Mamidanna#&#Faiz#2012).##The#advantage#of#using#such#routinely#captured#data#for#
surveillance#is#that#it#would#considerably#reduce#the#resources#required#to#generate#rates#of#
HCAI#and#would#also#avoid#the#biases#associated#with#variation#in#intensity#of#care#finding.##
Rates#for#all#NHS#hospitals#could#be#calculated#by#combining#data#on#the#number#of#specific#
operations#performed#in#a#designated#period#(the#denominator)#with#cases#of#SSI#detected#
in#the#electronic#records#(the#numerator).##Hospitals#with#high#or#low#rates#of#SSI#could#then#
be#identified#using#the#funnel#plot#methodology#developed#in#Wilson#et(al#2008#(Appendix#
4.2)#and#those#above#or#below#control#limits#investigated#to#determine#the#cause.#However,#
the#value#of#this#approach#depends#on#the#reliability#of#the#coding#in#detecting#cases#of#SSI#
and#the#extent#to#which#there#is#interEhospital#variation#in#coding.##The#first#stage#in#this#
research#is#to#develop#an#algorithm#to#define#a#potential#SSI#from#ICD10#codes#that#are#
indicative#of#a#problem#with#wound#healing#or#infection#following#an#operation#and#apply#
these#to#records#of#patients#who#are#identified#to#have#undergone#a#specified#surgical#
procedure.##I#am#currently#conducting#a#preliminary#study#to#test#the#practicality#and#
reliability#of#this#algorithm,#including#measuring#the#sensitivity#and#specificity#by#comparing#
the#cases#of#SSI#it#detects#with#prospective#active,#surveillance#system#at#a#single#hospital.##
Further#studies#are#then#required#to#test#the#comparability#of#the#method#across#several#
centres.##Whilst#such#electronic#data#sources#are#unlikely#to#detect#all#cases#of#SSI,#especially#
the#less#severe#superficial#case,#if#the#method#reliably#detects#a#high#proportion#of#severe#SSI#
it#may#be#possible#to#develop#the#system#to#provide#a#high#level#mechanisms#of#monitoring#
and#comparing#rates#of#SSI#and#detecting#outliers#that#require#further#investigation.##In#
addition,#another#advantage#of#developing#methods#of#capturing#data#on#SSI#from#these#
electronic#records#is#the#potential#to#better#define#the#adverse#effects#associated#with#it.##
The#analysis#of#costs#and#mortality#we#published#in#2005#(Coello#et(al;#Appendix#3.1)#remains#
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the#best#available#data.##Currently,#whilst#all#Trusts#in#England#are#required#to#conduct#at#
least#three#months#of#SSI#surveillance#in#orthopedics#few#Trusts#undertake#surveillance#in#
other#categories#of#surgical#procedure#(HPA#2005).##This#means#that#there#is#little#data#on#the#
risk#of#infection#available#to#patients,#clinicians#or#health#service#managers#and#in#the#
absence#of#evidence#for#the#overall#burden#of#SSI#to#those#providing#and#receiving#
healthcare#means#that#infection#prevention#measures,#including#surveillance,#can#be#difficult#
to#justify.##As#demonstrated#by#the#SENIC#study#in#the#1980s,#the#availability#of#such#
surveillance#data#is#critical#to#driving#improvements#in#surgical#practice#and#assuring#patient#
safety#in#terms#of#preventing#SSI#(Haley#et(al#1985).#Analysis#of#HES#data#may#provide#an#
opportunity#to#increase#address#this#problem#by#providing#evidence#on#the#risks#of#
significant#SSI#following#a#wide#range#of#surgical#procedures.###
#
7.3.3( Developing(and(testing(validation(systems(
The#evaluation#of#SSI#surveillance#in#caesarean#section#delivery#highlighted#the#need#to#
develop#efficient#and#effective#validation#systems#that#can#be#used#to#assure#the#reliability#of#
hospital#surveillance#systems#and#accuracy#of#their#reported#rates#(Wilson#et(al#2013;#
Appendix#4.3).##This#is#particularly#important#where#surveillance#is#associated#with#
performance#management,#which#generates#perverse#incentives#to#avoid#reporting#cases#of#
SSI#especially#when#linked#to#a#message#of#‘zero#tolerance’#(Bratzler#2013).##Tanner#et(al#in#a#
survey#of#Trusts#participating#in#SSISS#found#variation#in#data#quality#and#collection#methods#
that#had#an#affect#on#the#rates#that#they#reported#(Tanner#et(al#2013).##They#also#found#that#
10%#of#Trusts#did#not#report#superficial#SSI,#reflecting#the#problem#of#conflating#surveillance#
definitions#with#clinical#diagnosis.##As#pointed#out#by#Talbot#et(al,#the#latter#are#in#part#based#
on#subjective#judgment#and#are#used#to#guide#treatment,#whilst#the#latter#are#ideally#based#
on#objective#criteria#derived#from#readily#accessible#data#(Talbot#et(al#2013).##I#propose#that#
further#work#is#therefore#required#that#identifies#mechanisms#of#validating#caseEfinding#by#
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participating#hospitals,#determines#interErater#reliability#of#caseEdefinitions#and#defines#
effective#systems#for#organising#surveillance#locally.##This#research#could#also#explore#the#use#
of#electronic#data#sources#and#the#potential#for#integrating#data#from#primary#care#with#
hospitalEbased#surveillance#systems.##These#developments#are#imperative#to#support#
effective,#high#quality#HCAI#benchmarking#systems#in#the#context#of#declining#lengths#of#
hospital#stays#and#challenges#of#capturing#data#in#community#settings.##
#
7.3.4( Determining(factors(contributing(to(the(increasing(trend(in(E.coli(bacteraemia# #
Data#captured#by#routine#laboratory#surveillance#systems#such#as#those#I#have#described#in#
Wilson#et(al#2011a#and#2011b#(Appendix#5.1#and#5.2)#are#useful#in#describing#emerging#
trends#but#of#limited#value#in#identifying#causative#factors.###The#MRSA#surveillance#system#
had#some#data#on#sources#of#the#infection#that#could#be#analysed#to#throw#light#on#potential#
causative#factors,#but#as#illustrated#in#the#publication,#this#data#was#limited#and#incomplete#
(Wilson#et(al#2011b;#Appendix#5.2).##However,#the#success#in#controlling#MRSA#as#a#cause#of#
severe#infection#in#the#UK#does#illustrate#the#importance#of#reacting#to#emerging#threats#and#
the#value#of#routine#surveillance#systems#in#providing#early#warning#of#changes#in#
epidemiology.##However,#whilst#the#strategies#targeting#the#reduction#in#MRSA#bacteraemia#
were#ultimately#successful,#it#is#difficult#to#know#what#factors#contributed#to#the#decline#
(Gagliotti#et(al(2011;#Johnson#et(al#2012;#Livermore#2012).##In#relation#to#E.(coli#bacteraemia,#
our#analysis#has#highlighted#the#emergence#of#E.(coli#as#the#predominant#pathogen#causing#
bacteraemia#(Wilson#et(al#2011a).##The#Department#of#Health#has#subsequently#established#a#
mandatory#surveillance#system#for#E.(coli#bacteraemia#and#is#striving#to#drive#prevention#
efforts#(Department#of#Health#2011;#Advisory#Committee#on#Antimicrobial#Resistance#and#
Healthcare#Associated#Infection#(ARHAI)#2013).##However,#currently#there#is#scanty#evidence#
for#the#important#drivers#for#these#infections#and#little#is#known#about#the#patients#who#
acquire#them#and#the#factors#that#contribute#to#the#acquisition#of#the#primary#infection.##
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Since#over#half#of#the#cases#appear#to#occur#in#individuals#who#have#not#had#contact#with#
healthcare#(Public#Health#England#(PHE)#2014)#investigation#of#the#underlying#causes#and#
contributory#factors#for#these#infections#is#more#complex#that#might#be#the#case#for#
infections#acquired#in#hospitals.##Understanding#these#factors#will#be#critical#to#developing#
effective#strategies#to#prevent#and#control#these#infections,#especially#as#interventions#are#
likely#to#be#required#at#a#community#level.##A#case#control#study#would#be#an#effective#
method#of#investigating#these#contributory#factors,#since#the#bacteraemia#is#relatively#rare#
infection#and#matching#cases#with#similar#patients#with#a#different#type#of#bacteraemia#
would#enable#risk#factors#to#be#distinguished.##A#better#understanding#of#the#factors#
associated#with#E.(coli(bacteraemia#would#enable#preventive#measures#to#be#more#
effectively#targeted.###
#
7.3.4.2# The#seasonal#trend#in#E.(coli#bacteremia#that#we#clearly#identified#in#our#analysis#may#
provide#important#clues#for#factors#driving#the#increasing#trend#in#infections#(Wilson#et#al#
2011a;#Appendix#5.1).##Evidence#suggests#that#at#least#50%#of#cases#relate#to#infection#of#the#
urinary#tract#with#a#preponderance#of#cases#in#the#elderly#and#a#background#of#repeat#
urinary#tract#infections#(UTI),#subEoptimal#antimicrobial#prescribing#and#increasing#
prevalence#of#resistant#E.(coli#strains#with#urinary#tract#virulence#factors#(PHE#2014,#
Livermore#2012,#Totsika#et(al#2011).##The#peak#of#cases#in#the#summer#months#that#we#
observed#suggests#that#dehydration#may#be#a#contributory#factor#to#these#infections,#and#
whilst#it#is#generally#accepted#that#dehydration#increases#the#risk#of#UTI#currently#there#is#
little#evidence#to#demonstrate#this#link#especially#in#the#elderly#(Su#et(al#2006;#Wang#2002;#
Rudaitis#et(al#2009).##The#elderly#are#particularly#vulnerable#to#dehydration#due#to#
physiological#changes#associated#with#aging#that#result#in#a#decrease#in#water#volume#in#the#
body,#including#the#loss#of#the#thirst#reflex,#decline#in#kidney#function#and#ability#to#
concentrate#urine,#and#loss#of#muscle#tissue#(Phillips#et(al#1991;#Bossingham#et(al#2005;#
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Mentes#et(al#1999).##In#addition,#cognitive#and#physiological#impairments#may#affect#the#
ability#of#the#elderly#to#consume#fluids#and#some#may#restrict#fluid#intake#due#to#fear#of#
incontinence#(Mentes#2006).##The#population#of#the#elderly#in#care#homes#would#provide#an#
opportunity#to#study#the#relationship#between#dehydration#and#risk#of#UTI.##Since#
dehydration#is#acknowledged#as#being#very#difficult#to#diagnose#(Chassagne#et(al#2006)#I#
would#take#the#approach#of#measuring#the#effect#on#morbidity#(including#UTI)#of#a#strategy#
to#optimize#hydration#of#residents.##I#would#use#a#stepped#wedge,#cluster#randomised#design#
(with#a#care#home#as#the#unit#of#randomisation)#to#minimise#the#risk#of#confounding.##This#
approach#would#have#the#benefit#of#both#establishing#whether#there#was#a#relationship#
between#hydration#and#UTI#and#determine#whether#a#strategy#aimed#at#optimising#
hydration#was#successful#in#reducing#the#associated#morbidity.##In#addition,#the#effect#of#
daily#temperature#on#incidence#of#infection#could#also#be#explored#in#such#a#study.###
#
7.4( Conclusion(
In#an#editorial#by#Richard#Platt#in#2005,#he#commented#on#the#current#status#of#HCAI#
surveillance#and#its#role#in#informing#clinicians,#healthcare#providers#and#patients#about#risks#
of#infection#and#quality#of#care#(Platt#2005).###He#pointed#to#the#benefits#that#the#increased#
attention#paid#by#society#to#these#infections#in#relation#to#investment#by#healthcare#
institutions#in#HCAI#reduction#and#improving#patient#safety.##However,#he#also#cited#key#
challenges#to#preventing#the#burden#of#mortality,#morbidly#and#costs#of#these#infections.##
These#included#the#lack#of#information#held#by#hospitals#on#their#own#infection#rates#that#
they#could#use#to#measure#their#performance,#monitor#effectiveness#of#prevention#strategies#
and#define#models#for#good#care#and#the#lack#of#information#for#patients#about#comparative#
risk#of#infection#between#institutions#that#they#could#use#to#inform#their#choices.##Platt#also#
pointed#to#the#need#for#surveillance#methods#to#be#able#to#inform#hospitals#that#have#a#high#
rate#compared#to#other#hospitals#so#that#they#can#take#corrective#action,#but#to#achieve#this#
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as#efficiently#as#possible#to#avoid#excessive#use#of#scarce#resources.#The#work#that#I#have#
described#in#this#thesis#has#contributed#to#addressing#some#of#these#challenges.##In#particular#
it#has#added#to#the#body#of#knowledge#on#outcomes#of#SSI#that#can#be#used#to#inform#
clinicians#and#patients#about#variation#in#practice#and#factors#that#are#important#when#
making#comparison#of#rates.##In#addition,#it#has#enhanced#methods#of#benchmarking#
hospitals#performance;#informed#the#design#and#delivery#of#surveillance#systems#by#
identifying#the#impact#of#risk#factors#and#caseEfinding#methods#on#rates;#and#informed#public#
health#strategy#by#investigating#emerging#trends#in#rates#of#HCAI#pathogens.###
#
# #
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